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I. Zusammenfassung 
 
Bislang wurden die kompletten Genomsequenzen von mehr als 100 Bakterien ermittelt. Mehr 
als ein Drittel dieser Organismen wird als pathogen eingestuft. Die Verfügbarkeit dieser 
Sequenzinformation vergrößert unser Wissen über die bakterielle Genomstruktur und –
plastizität sowie über mikrobielle Diversität und Evolution. Diese Daten bilden die Grundlage 
für viele Fortschritte auf dem Gebiet der Biotechnologie, der industriellen-, Umwelt- und 
medizinischen Mikrobiologie: neuartige Typisierung-, Diagnostik- und Therapieansätze sowie 
die Entwicklung neuer Medikamente und Impfstoffe basieren auf und profitieren von der 
ständig zunehmenden Menge an DNA-Sequenzen. Genomanalysen sind zusammen mit 
anderen molekularbiologischen Methoden wie PCR, DNA-Chiptechnologie, subtraktive 
Hybridisierung und Proteomanalysen von zunehmender Bedeutung für die Erforschung von 
Infektionskrankheiten und das öffentliche Gesundheitswesen. 
Ziel dieser Arbeit war die Analyse der Genomstruktur und des Genominhaltes des 
apathogenen Escherichia coli Stammes Nissle 1917 (O6:K5:H1) und der Vergleich mit 
verfügbaren Daten verschiedener pathogener und apathogener E. coli Stämme sowie anderer 
eng-verwandter Spezies. Eine Cosmid-Genbank des Stammes Nissle 1917 wurde nach Klonen 
durchsucht, die für Fitnessfaktoren kodieren, welche zur erfolgreichen Kolonisierung des 
menschlichen Verdauungstraktes und zum probiotischen Charakter dieses Stammes beitragen. 
Vier genomische Inseln (GEI I-IVNissle 1917) wurden nachgewiesen und charakterisiert. Auf 
diesen GEIs befinden sich verschiedene bekannte Fitness-Determinanten (mch/mcm, foc, iuc, 
kps, ybt), bislang nicht charakterisierte ORFs, mobile genetische Elemente und bislang für den 
Stamm Nissle 1917 nicht beschriebene Gene, die möglicherweise zur Fitness und 
Adaptabilität dieses Stammes beitragen. Die GEIs I-IVNissle 1917 sind jeweils mit einem tRNA-
Gen assoziiert und ähneln hinsichtlich ihrer Struktur und chromosomalen Lokalisation 
entsprechenden Inseln im Genom des uropathogenen E. coli Stammes CFT073 
(O6:K2(?):H1). Interessanterweise fehlen auf diesen wichtige Virulenzgene uropathogener E. 
coli (hly, cnf, prf/pap). Eine etwa 30 kb große Region der GEI IINissle 1917, die von IS2 
Elementen flankiert wird, kann spontan deletieren, was zum Verlust verschiedener 
Fitnessdeterminanten (iuc, sat, iha) führt. Darüber hinaus wurde der chromosomale 
Sequenzkontext von tRNA-Genen mittels PCR auf die Integration von „Fremd-DNA“ hin 
untersucht, die durch horizontalen Gentransfer erworben wurde (tRNA Screening), und mit 
denen anderer apathogener und pathogener E. coli Stämme verglichen. Der genomweite 
Anteil an tRNA-Gen-assoziierter, möglicherweise horizontal erworbener DNA, die im 
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apathogenen E. coli K-12 Stamm MG1655 fehlt, unterschied sich dabei nicht bedeutend im 
Stamm Nissle 1917 und den uropathogenen E. coli O6 Stämmen CFT073 und 536. Die 
Verbreitung von DNA-Regionen der GEIs des Stammes Nissle 1917 wurde mittels PCR bei 
apathogenen E. coli-Isolaten sowie bei uropathogenen E. coli O6:K5-Isolaten untersucht. Nur 
zwei UPEC O6:K5-Isolate enthielten alle GEI-Bereiche, die in diese Untersuchung 
einbezogen waren, unterschieden sich jedoch vom Stamm Nissle 1917 durch ihre Phänotypen. 
Die Makrorestriktionsanalyse der Genomstruktur des E. coli Stammes Nissle 1917 zeigte, daß 
letztere der des uropathogenen E. coli Stammes CFT073 sehr ähnelt. 
Um die Ursache für den semi-rauhen Phänotyp des Stammes Nissle 1917 zu untersuchen, 
wurden die wa* und wb* Determinanten dieses Stammes, die für die LPS-Biosynthese 
verantwortlich sind, kloniert und sequenziert. Das bislang unbekannte Serotyp O6-spezifische 
O-Antigenpolymerase-kodierende Gen wzy des Stammes Nissle 1917 wurde charakterisiert 
und mit dem des rauhen O6 Stammes 536 verglichen. Eine Punktmutation, die zu einem 
vorzeitigen Translationsstop der wzy-Transkripte des Stammes Nissle 1917 führt, wurde als 
Ursache für den semi-rauhen Phänotyp und damit auch die Serumsensitivität dieses Stammes 
verantwortlich gemacht. 
Zur Untersuchung der Kolonisierungsfähigkeit des E. coli Stammes Nissle 1917 wurden 
verschiedene Faktoren, die an der Biofilmbildung bzw. am multizellulären Verhalten beteiligt 
sind, sequenziert und näher analysiert. Die Seqenzierung der fim Determinante zeigte, daß das 
fimB Gen, das für die Expression der Typ 1-Fimbrien benötigt wird, durch die Insertion eines 
IS-Elementes inaktiviert wurde. Untersuchungen zum multizellulären Verhalten zeigten, daß 
der Stamm Nissle 1917 den sogenannten „rdar“ Morphotyp, hervorgerufen durch Expression 
von Curli-Fimbrien und Cellulose, bei 30 °C und bei 37 °C exprimiert, nicht jedoch die 
uropathogenen E. coli Stämme 536 und CFT073. Das Cellulosebiosynthese-Operon (bcs) 
sowie das Gen rfaH, das für einen Transkriptionsantiterminator kodiert, wurden im Stamm 
Nissle 1917 inaktiviert, um deren Bedeutung für den „rdar“ Morphotyp zu untersuchen. 
Während Cellulose für die Expression des „rdar“ Morphotyps benötigt wird, hatte die rfaH-
Inaktivierung keinen Einfluß auf dieses mulizelluläre Verhalten des E. coli Stammes Nissle 
1917. 
Die Ergebnisse dieser Arbeit zeigen, daß der apathogene E. coli Stamm Nissle 1917 durch 
eine spezifische Kombination phänotypischen Eigenschaften gekennzeichnet ist, die ihn von 
anderen bislang untersuchten E. coli Stämmen unterscheidet. An der Evolution dieses 
Stammes, möglicherweise aus einem pathogenen „Vorfahren“, waren vielfältige Gentransfer- 
und Deletionsprozesse sowie Punktmutationen beteiligt. 
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I. Summary 
 
In the last years more than one hundred microbial genomes have been sequenced, many of 
them from pathogenic bacteria. The availability of this huge amount of sequence data 
enormously increases our knowledge on the genome structure and plasticity, as well as on the 
microbial diversity and evolution. In parallel, these data are the basis for the scientific 
“revolution” in the field of industrial and environmental biotechnology and medical 
microbiology – diagnostics and therapy, development of new drugs and vaccines against 
infectious agents. Together with the genomic approach, other molecular biological methods 
such as PCR, DNA-chip technology, subtractive hybridization, transcriptomics and 
proteomics are of increasing importance for research on infectious diseases and public health. 
The aim of this work was to characterize the genome structure and -content of the probiotic 
Escherichia coli strain Nissle 1917 (O6:K5:H31) and to compare these data with publicly 
available data on the genomes of different pathogenic and non-pathogenic E. coli strains and 
other closely related species. A cosmid genomic library of strain Nissle 1917 was screened for 
clones containing the genetic determinants contributing to the successful survival in and 
colonization of the human body, as well as to mediate this strain’s probiotic effect as part of 
the intestinal microflora. Four genomic islands (GEI I-IVNissle 1917) were identifed and 
characterized. They contain many known fitness determinants (mch/mcm, foc, iuc, kps, ybt), 
as well as novel genes of unknown function, mobile genetic elements or newly identified 
putative fitness-contributing factors (Sat, Iha, ShiA-homologue, Ag43-homologues). All 
islands were found to be integrated next to tRNA genes (serX, pheV, argW and asnT, 
respectively). Their structure and chromosomal localization closely resembles those of 
analogous islands in the genome of uropathogenic E. coli strain CFT073 (O6:K2(?):H1), but 
they lack important virulence genes of uropathogenic E. coli (hly, cnf, prf/pap). Evidence for 
instability of GEI IINissle 1917 was given, since a deletion event in which IS2 elements play a 
role was detected. This event results in loss of a 30 kb DNA region, containing important 
fitness determinants (iuc, sat, iha), and therefore probably might influence the colonization 
capacity of Nissle 1917 strain. 
In addition, a screening of the sequence context of tRNA-encoding genes in the genome of 
Nissle 1917 was performed to identify genome wide potential integration sites of “foreign” 
DNA. As a result, similar “tRNA screening patterns” have been observed for strain Nissle 
1917 and for the uropathogenic E. coli O6 strains (UPEC) 536 and CFT073.  
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The molecular reason for the semi-rough phenotype and serum sensitivity of strain Nissle 
1917 was analyzed. The O6-antigen polymerase-encoding gene wzy was identified, and it was 
shown that the reason for the semi-rough phenotype is a frame shift mutation in wzy, due to 
the presence of a premature stop codon. It was shown that the restoration of the O side-chain 
LPS polymerization by complementation with a functional wzy gene increased serum-
resistance of strain Nissle 1917. 
The results of this study show that despite the genome similarity of the E. coli strain Nissle 
1917 with the UPEC strain CFT073, the strain Nissle 1917 exhibits a specific set of geno- and 
phenotypic features which contribute to its probiotic action. 
By comparison with the available data on the genomics of different species of 
Enterobacteriaceae, this study contributes to our understanding of the important processes 
such as horizontal gene transfer, deletions and rearrangements which contribute to genome 
diversity and -plasticity, and which are driving forces for the evolution of bacterial variants. 
At last, the fim, bcs and rfaH determinats whose expression contributes to the mutlicellular 
behaviour and biofilm formation of E. coli strain Nissle 1917 have been characterized. 
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II. Introduction 
 
1. Microbial genome research 
 
Since 1995, when the genome of the Haemophilus influenzae was completely 
sequenced (Fleischmann, et al., 1995), hundreds of microbial genomes from 
prokaryotic, as well as eukaryotic microorganisms, have been sequenced. These data 
are of crucial importance for diagnostics and therapy of infectious diseases, for the 
development of vaccines and the identification of novel target genes. Moreover, the 
increasing knowledge on bacterial genome structure and “comparative genomics” 
improves our understanding on the driving forces of microbial evolution like 
horizontal gene transfer, deletion formation, recombination, which result in 
development of new bacterial species or variants. 
In some cases, the genome of several strains of one bacterial species have been 
sequenced. The complete genome sequence of the E. coli K-12 laboratory strain 
MG1655 gives an idea on the genome structure of a non-pathogenic, commensal 
microorganism, which has lost many phenotypic features due to the decades of 
laboratory cultivation. Later on, several genomes of pathogenic E. coli strains have 
been sequenced: two from enterohaemorrhagic E. coli (EHEC) strains (EDL933 and 
“Sakai”; Perna et al., 2001; Hayashi et al., 2001) and one uropathogenic E. coli 
(UPEC) isolate (CFT073; Welch et al., 2002). The comparison of these three genomes 
revealed an unexpectedly extensive mosaic genome structure within the E. coli 
species, where only 39.2 % of the predicted proteins are shared by all of the 
investigated E. coli types (Fig. 1; Welch et al., 2002), which suggests that horizontal 
gene transfer and acquisition of foreign DNA elements played and important role 
during the evolution and adaptation of these variants.  
Similarly, the genomes of two Helicobacter pylori strains from different sources have 
been sequenced, namely of the isolate 26695 (Tomb et al., 1997) from duodenum 
ulcer and of strain J99 (Alm et al., 1999) isolated from a gastritis patient. 
Interestingly, 5.9 % of the identified ORFs in J99 and 7.3 % in 26695 were strain 
specific.  
In addition to the whole-genome sequencing approach, increasing data from the 
sequence analysis of partial genomes from different bacterial species is accumulating. 
The use of e. g. genomic libraries, specific PCR amplification products and of 
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subtractive hybridization techniques made it possible to characterize several 
“pathogenicity islands” of the UPEC strain 536, which contain various virulence-
associated factors and which are located in different positions of this strain’s 
chromosome (Dobrindt et al., 2002). In other studies, the “long-distance” PCR 
approach has been used to characterize extremely divergent gene clusters, encoding 
the enzymes involved in the LPS side-chain biosynthesis, which are always localized 
at a conserved chromosomal region (Paton et al., 1999; Marolda et al., 1998; Wang et 
al., 1998; Wang et al., 1998).  
In order to create an integrated picture of the genome organization, the sequence data 
can be combined with a physical map of the bacterial chromosome, using rare-cutting 
restriction endonucleases and pulsed-field gel electrophoresis, thus avoiding the 
expensive and time consuming whole genome sequencing approach. In such a way 
and with the help of mini transposon insertions, an integrated genomic map of the 
UPEC strain J96 has been created (Lyla et al., 2000). 
 
Fig. 1: Comparison of the number of predicted 
proteins shared by three E. coli strains (MG1655, 
CFT073, EDL933). The number of orthologs in 
each shared category and the numbers of strain-
specific proteins are given. Total number of 
proteins counted: MG1655, 4288; CFT073, 5016; 
EDL933, 5063 (modified from Welch et al., 
2002). These data are based on the complete 
genome sequence of the corresponding E. coli 
strains. 
 
 
 
One result of the availability of genome sequence data, the DNA-chip technology was 
developed, which allows genome comparison of multiple isolates. Thousands of 
specific PCR products or synthetic oligonucleotides are immobilized in an ordered 
manner on special matrices and hybridized with labeled genomic DNA from the 
investigated strains, resulting in a whole genome overview of the presence of genes of 
a particular reference genome. This approach gives the opportunity to study the 
distribution of specific genetic features associated with metabolic functions or 
infectious diseases.  
Furthermore, the DNA array technology enables genome-wide studies on 
transcription (“transcriptomics”). After hybridization with isolated RNA or cDNA, 
the global transcription profile of a distinct strain can be studied, in response to 
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II. Introduction                                                                                                                                         7 
different environmental conditions. The effect of mutations on the “transcriptome” 
can also be investigated (Marshall and Hodgson, 1998; Harrington et al., 2000). In 
this way, the regulation of metabolic pathways, as well as the cellular stress response, 
the adaptation to different environmental niches, or bacteria-host cell interaction can 
be examined on the transcriptional level. A commercially available DNA array 
containing probes specific for all translated ORFs identified in the genome of E. coli 
strain MG1655 was used to examine the differential gene expression of E. coli in 
minimal medium versus LB (Tao et al., 1999). DNA macroarray, containing probes 
specific for most of the genes encoding for virulence factors of different 
extraintestinal and intestinal pathotypes of E. coli and Shigella, enabled large scale 
epidemiological studies, as well as global examination of virulence gene regulation in 
UPEC strain 536 (Dobrindt et al., 2003; Michaelis, K., Dobrindt, U., unpublished 
data). 
On the other hand, the proteome approach enables the investigation of the protein 
modification, as well as and post-transcriptional and post-translation regulation, using 
two-dimensional gel electrophoresis. In this way, proteins whose expression is 
affected or which undergo specific modification under certain circumstances can be 
detected and isolated. Isolated proteins can then be identified by mass spectrometry or 
by N-terminal sequencing (Van Bogelen et al., 1999). 
 
2. Horizontal gene transfer and genome plasticity 
 
Horizontal gene transfer is an important mechanism contributing to the variability of 
bacterial genomes, therefore playing a crucial role for the evolution of 
microorganisms. This process entails the incorporation of genetic information 
transfered from another organism directly into the genome where they may form 
“genomic islands”, e.g., large blocks of DNA with signatures of mobile genetic 
elements (Hacker and Carniel, 2001; Fig. 3). Based on these findings, a new concept 
of “dynamic” bacterial genomes has been developed in the last years. According to 
this view, the bacterial genome consists of two gene pools, the “flexible gene pool” 
which includes the majority of the horizontally transferred DNA, and the conserved 
“core gene pool” which mainly represents the essential genetic information (Fig. 2).  
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Fig. 2: Model of the DNA pools in the genomes of the prokaryotes (modified from Hacker and Carniel, 
2001). 
                                
 
Fig. 3: Genome evolution by means of acquisition and loss of genetic information (modified from 
Dobrindt and Hacker, 2001). 
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processes, the “flexible gene pool” mainly comprises genes whose function reflects 
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bacteria under particular conditions. Therefore the “flexible gene pool” is important 
for adaptation and the survival in a new ecological environment, e. g. for symbiosis, 
host-cell interaction and pathogenicity (Hentschel et al., 2000). The number of 
horizontally acquired genes may vary, from 18 % (E. coli K-12) to <1 % 
(Mycoplasma) of the total genome (Lawrence and Ochman, 1998; Ochman et al., 
2000). Typically, the laterally transfered DNA differs in the overall G+C content and 
the codon usage from that of the core genome. Since the “flexible gene pool” consists 
of DNA fragments of different origin, the G+C content varies dramatically, thus 
representing the “mosaic” structure of the newly acquired DNA elements. For 
example, within the Salmonella Pathogenicity Island 3 (SPI-3) there are a regions of 
very low G+C content, despite the fact that the overall codon usage does not differ 
significantly from those of highly expressed Salmonella genes (Blanc-Potard et al., 
1999). The lac operon in E. coli differs in the codon usage compared to the genes 
from the core genome (Ochmann et al., 1996). This demonstrates that genes, which 
are part of the species-specific “core genome” and which encode certain metabolic 
traits, might also be acquired via horizontal gene transfer. In many cases the foreign 
DNA elements are preferentially integrated at specific positions in the “core 
chromosome” (“hot-spots”). Such integration sites for lysogenic phages and other 
mobile genetic elements include highly conserved tRNA-encoding genes (Hou, 1999; 
Cheetham and Katz, 1995). For example, the high-pathogenicity island (HPI) is 
typically associated with the asnT tRNA-encoding gene in enterobacteria (Carniel et 
al., 1996), but may also insert at other asn tRNA-encoding genes of Yersinia 
pseudotuberculosis. In other cases, one specific tRNA gene represents the 
chromosomal insertion site of different types of PAIs. Thus the selC tRNA gene 
serves as an insertion site for several different pathogenicity islands in different 
enterobacterial pathotypes (Blum et al., 1994; Fleckenstein et al., 1998; Moss et al., 
1999, McDaniel et al., 1995). However, there are also examples for other 
chromosomal insertion sites than tRNA-genes such as galF of E. coli (Tarr et al., 
2000).  
Many important phenotypic characteristics of bacteria, like antibiotic resistance, 
virulence traits and particular metabolic pathways are encoded on genes located on 
horizontally transferable, mobile genetic elements like plasmids, transposons, and 
phages. For example, the tetracycline resistance determinant and its regulatory genes 
are part of the Tn10 transposon, which is able to integrate into the chromosomes of 
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different bacteria (Lawley et al., 2000). The genes encoding the enzymes responsible 
for the lipopolysaccharide (LPS) O-side chain biosynthesis of Shigella sonnei are 
located on a plasmid. This gene cluster is very similar to those of the majority of other 
E. coli O-serotypes, which are located in the “galF island” on the chromosome. The 
LEE pathogenicity island of rabbit-pathogenic enterohaemorrhagic E. coli strains 
(REPEC), is integrated at the pheU tRNA gene. This PAI was shown to be 
spontaneously excised from the chromosome. The REPEC LEE-encoded integrase is 
able to mediate the site-specific integration at the pheU tRNA in the E. coli strain 
DH1 (Tauschek et al., 2002). This demonstrates that the entire LEE island of this 
REPEC isolate represents a distinct mobile genetic element, which can be deleted 
from the chromosome, transfered and integrated into the recipient`s chromosome.. 
Together with the acquisition of foreign DNA, the loss of genetic regions can play a 
significant role for the evolution of bacteria. Big deletions in the chromosome of some 
species, termed “black holes”, are enhancing the virulence of particular strains. The 
loss of a big fragment of the chromosome of Shigella spp. and enteroinvasive E. coli, 
where a gene encoding for lysine decarboxylase (LDC) is located, contributes to their 
pathogenicity. It was shown that cadaverine, a product of the reaction catalyzed by the 
LDC, inhibits the Shigella enterotoxin activity (Maurelli et al., 1998). Since many of 
the studied genomic islands are able to delete from the chromosome with frequency 
which vary dramatically under different environmental conditions (Middendorf, et al., 
2001), it seems to be likely that the loss of DNA fragments represents an important 
adaptive mechanism for multiplying in new ecological niches or host organism. For 
instance it is tempting to speculate that such reduction of the “flexible gene pool” 
contributes to the development of a chronic urinary tract infection (UTI) caused by 
UPEC strains, since such isolates lack many of the virulence factors typical for UPEC 
strains causing acute UTIs (Dobrindt, U., Hacker, J., personal communication). 
 
3. Pathogenicity islands and genomic islands 
 
Specific genes that encode virulence factors are present in the genome of pathogenic 
members of a species but absent in non-pathogenic variants. Initially, virulence 
associated genes were thought to be solely located on horizontally transferable 
extrachromosomal elements. In the 1980s blocks of chromosomal regions were 
identified, which carry virulence genes which are exclusively associated with virulent 
strains of the species. It has been demonstrated that these regions can delete from the 
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chromosome spontaneously, indicating their mobile character and the possibility of 
horizontal gene transfer (Hacker et al., 1983; Low et al., 1984). These chromosomal 
DNA regions have been designated pathogenicity islands (PAIs). The following 
characteristics are typical of the PAIs (Hacker and Kaper, 1999): 
- PAIs carry genes encoding at least one virulence factor, including 
adhesins, invasins, iron-uptake systems, toxins, type III and type IV secretion 
systems, 
- PAIs are present in virulent but absent from non-virulent members of 
the same or closely related species, 
- PAIs often consist of DNA whose G+C content is different from that 
of the core genome, and exhibit a different codon usage relative to the 
chromosomal backbone, 
- PAIs are often flanked by direct repeats (DR), 
- PAIs are commonly associated with tRNA genes, which frequently 
represent chromosomal attachment sites of bacteriophages. PAIs often carry 
bacteriophage integrases-encoding genes, indicating that these tRNA genes 
may serve as target sites for bacteriophage-derived elements located on PAIs, 
- PAIs carry often genes coding for mobility factors like transposases 
and insertion elements, 
- PAIs are frequently unstable genetic regions and deletions may occur 
upon recombination between the DR located on both ends or via site-specific 
recombination. 
Although PAIs share common features as described above, they are considered a 
heterogeneous group of genetic elements, according to their size, structure and 
encoded functions. Often unrelated to pathogenicity genes, cryptic ORFs, 
pseudogenes and “junk DNA” are also present on PAIs. PAIs seem to undergo 
constant evolutionary changes due to acquisition and deletion of DNA regions 
resulting in very complex structure.  
In the last years, the definition of PAIs has been extended to the more general concept 
of “genomic island” (GEI). GEIs increase the bacterial fitness, either directly or 
indirectly. Thus, being positively selected they may be called “fitness islands”. They 
can be divided into several subtypes, according to their encoded traits: “ecological 
islands” in environmental bacteria, and “saprophytic islands”, “symbiosis islands”, or 
PAIs in bacteria that interact with living hosts (Hacker and Carniel, 2001). 
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 In some cases PAIs of different strains are grouped into families according to similar 
gene content and structure. This may result from a similar evolution and transfer of a 
common PAI ancestor, indicative of a similar function in different isolates (Dobrindt 
et al., 2001). Nevertheless, the localization and sequence context of similar virulence 
genes may vary considerably. There are chromosomally localized genetic 
determinants which are clearly acquired through horizontal gene transfer, but share 
only some of the features of PAIs. The O-antigen-encoding gene clusters in E. coli 
and Salmonella have very low G+C content and it is evident that they have originated 
by means of interspecies lateral transfer and by homologous recombination of 
flanking DNA regions, but only few of them are associated with pathogenicity, and 
they are present in all members of these species. 
The exact mechanism of PAI acquisition is still not clear. It is speculated that 
cointegrate structures of bacteriophages and plasmids have been acquired and 
integrated at specific sites into the chromosome through gene transfer and 
recombination. The conserved 3'- ends of tRNA genes are the most common target for 
chromosomal integration (Hou, 1999). Once integrated, those “pre-PAIs” may have 
undergone deletion events and point mutations, in mobility genes, which lead to 
stabilization of the island in the chromosome. Some PAIs are able to delete 
completely from the chromosome, such as the HPI of Yersinia pseudotuberculosis. 
The deletion occurs through homologous recombination between two flanking 17 bp 
DR at both ends of the island. The HPI encodes a homologue of the bacteriophage P4 
integrase-encoding gene int, located in the vicinity of a putative bacteriophage P4 
attachment (attP) site (Buchrieser et al., 1998). The HPI in Y. enterocolitica and E. 
coli is not mobilizable as the 17 bp DR are not present, or as the P4-like integrase 
gene is inactivated by an internal stop codon (Schubert et al., 1999; Bach et al., 1999). 
The HPI is widely distributed in the genomes of Enterobacteriaceae, such as E. coli, 
Klebsiella, Salmonella, Enterobacter and Citrobacter (Schubert et al., 1998) 
including pathogenic as well as in non-pathogenic isolates. The “core” region of this 
island contains genes required for the expression of the yersiniabactin iron uptake 
system, thus contributing to the bacterial fitness during colonization and infection. 
PAIs are also present in genomes of Gram-positive bacteria. In Staphylococcus 
aureus, a 15.2 kb island flanked by two 17 bp DR has been identified and designated 
as Staphylococcus aureus Pathogenicity Island 1 (SaPI1). The gene coding for the 
“toxic shock syndrome”-toxin 1 (tst) as well as a homologue for superantigen-
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encoding determinant are located on this PAI (Lindsay et al., 1998). This island can 
be mobilized and transfered to other genomes by the bacteriophage 80α.  
A 500 kb “symbiosis island” was identified in the genome of Mesorhizobium loti. 
This island is integrated into the phe tRNA gene and carries a P4-like integrase gene, 
IS elements, as well as the genes coding for the nitrogen fixation and tuber 
development during the symbiosis (Sullivan and Ronson, 1998). Thus this genetic 
element is considered as a “symbiosis island”, contributing to the survival of bacteria 
in a new ecological niche. 
PAIs have been initially identified in the genome of UPECs (Blum et al., 1994). In the 
genome of UPEC strain J96, at least two PAIs carrying genes coding for toxins, 
adhesins, and other virulence determinants the have been identified (Swenson et al., 
1996). They are integrated into pheR and pheV tRNA genes, and flanked by imperfect 
DR.  
 
4. Escherichia coli 
 
The Bacterium coli commune was isolated and described by Theodor Escherich from 
the feces of a normal infant in 1885 and later renamed Escherichia coli. This is a 
Gram-negative bacteria species which constitutes about 0.06 % of the normal human 
intestinal flora, as well as distributed among animals. E. coli colonizes the infant 
bowel within the first hours of life and is usually a harmless commensal member of 
the intestinal flora. In addition to non-pathogenic variants, several E. coli pathotypes 
exist which cause intestinal and extraintestinal infections of humans and animals. The 
spectrum of diseases caused by E. coli is also due to the diversity of horizontally 
acquired virulence genes, harbored on plasmids, bacteriophages or PAIs.  
The E. coli strains are serotyped on the basis of their O (somatic), H (flagellar), and K 
(capsular) surface antigen profiles (Kauffmann, 1965), where the specific 
combination of these factors defines the serotype of an isolate. E. coli strains of a 
specific serotype can be associated with certain clinical manifestations. However, the 
surface antigens alone are not considered to confer pathogenicity themselves. Rather 
there are specific clonal lineages which have served as “hosts” for horizontally 
transfered virulence genes resulting in pathogenic clones (Zingler et al., 1992).  
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4.1 Pathogroups 
 
Pathogenic E. coli strains can be subdivided in several pathotypes according to the 
disease they cause. E. coli strains causing intestinal infections (i.e., diarrheagic E. 
coli) can be subdivided in at least six pathogroups: enterohaemorrhagic (EHEC), 
enterotoxigenic (ETEC), enteropathogenic (EPEC), enteroinvasive (EIEC), 
enteroaggregative (EAEC), and diffusely adherent E. coli (DAEC). Other strains are 
responsible for extraintestinal infections: uropathogenic E. coli (UPEC), newborn 
meningitis-causing E. coli (MENEC) and septicemia-causing E. coli (SEPEC). E. coli 
is responsible for one third of all cases of neonatal meningitis with an incidence of 
0.1 per 1000 live births (de Louvois et al., 1994), where the fatality rate varies 
between 25 to 40 %. The virulence properties of MENEC strains are partially 
identical to those of SEPEC, as the development of meningitis requires preliminary 
bacteremia. Important virulence factors are K1 capsular polysaccharide, IbeA, OmpA 
and SfaII fimbriae (Korhonen et al., 1985). 
UPEC strains cause 75-90 % of all community acquired urinary tract infections 
(UTIs) and about 50  % of the nosocomial UTIs (Rubin, 1990; Svanborg and Godaly, 
1997). UTI is the most common bacterial infection in the industrialized world: in the 
USA 7 million patient visits per year are counted with total costs exceeding one 
billion dollars (Bacheller et al., 1997). As many as 50 % of the women report to have 
had at least one UTI in their lifetime (Barnett and Stephens, 1997). UTI affects either 
the bladder (cystitis) or the kidneys and their collecting systems (pyelonephritis), or 
both. The bacterial colonization of the urinary tract may be completely free of clinical 
symptoms (“asymptomatic bacteriuria”, ABU). Moreover, a pyelonephritis can be 
acute or chronic. The last case is a more complex disorder where the bacterial 
infection plays a dominant role. However, other factors like vesicourethral reflux and 
obstruction or immunodeficiency are also critically involved in pathogenesis. UTI is 
normally an ascending infection (in a less common way UTI can be an ascending 
infection through the bloodstream) where the bacteria are derived from the patient’s 
own faecal flora. The initial step of the pathogenesis is colonization of the distal 
urethra and vagina in women by enterobacteria (Sobel, 1997). From the urethra, the 
pathogens may gain entrance into the bladder. Here, when the natural defense 
mechanisms (flushing of urine, IgA, uromucoid) are overwhelmed by the virulent 
bacteria, bacterial adhesion and colonization may occur evolving into UTI. The 
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colonization of the urinary tract provokes cellular responses e. g., activation of the 
epithelial cells, secretion of cytokines and neutrophile migration into the urothelium.  
 
4.2 Virulence and fitness factors of E. coli 
 
Some of the traits of the E. coli isolates contribute to their virulence and others are 
required for their survival within the host. In this chapter, the features of UPECs will 
be mainly discussed. 
-Adhesins 
Adherence factors enable the bacteria to adhere to the epithelial cells and include 
fimbrial (fimbriae, pili) and afimbrial adhesins. The fimbriae of UPEC are thin, rod-
shaped fiber structures, which are heteropolymeric structures. The P- , type 1, S- , and 
F1C fimbriae exhibit a composite structure, consisting of a rod-shaped shaft of 6-7 nm 
in diameter comprising over a thousand major subunits and minor subunits. The 
adhesin is located at the very tip of the fimbriae, often connected with the shaft via the 
so-called adapter pilus. The role of the major subunits is yet unclear, although they 
have been proposed to be important for adherence to mammalian extracellular matrix 
proteins (Korhonen, 2000). The adhesin and some other minor subunits are 
responsible for the specific binding to carbohydrate moieties on the surface of 
eukaryotic cells, therefore contributing to specific adherence. The synthesis, export, 
correct folding and ordered assembly during the fimbrial biogenesis occurs in a co-
ordinated manner (Smyth et al., 1996). In extraintestinal pathogenic E. coli, the 
determinants coding for the P- and S- family adhesins are often located on genomic 
islands. In diarrheagenic E. coli strains, some fimbrial or fimbrial-like gene clusters 
are also located on chromosomal islands or on plasmids, but their role for the 
virulence remains unclear (Kaper and Hacker, 1999). The P-, S- and F1C-fimbriae are 
more exclusively associated with extraintestinal E. coli isolates and the tip of these 
adhesins recognize carbohydrate moieties: Galα(1-4)Gal, α-sialyl-2,3-β-galactose, and 
GalNAcβ(1-4)Galβ, respectively. These fimbriae are factors contributing to the 
virulence potential of such strains, but they are not necessarily sufficient to cause 
disease (Mobley et al., 1994). 
Most of the UPEC strains also express curli fimbriae, which are composed of only 
one polymerized subunit. It is suggested that these fimbriae play a role only in the 
early phase of infection (e.g., adherence to periurethral skin surface), since they are 
frequently expressed only at 30  °C (Olsen et al., 1993). In the last years, isolates have 
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been detected in which co-expression of curli fimbriae and cellulose production 
occurs at 30  °C as well as at 37 °C (rdar morphotype), but the importance of this trait 
for the survival and colonization in the host organism remains unclear (Zogaj et al., 
2001). The genes coding for curli fimbriae and cellulose biosynthesis are located on 
the core chromosome of E. coli (csg and bcs operons, respectively). It was 
demonstrated that curli fimbriae are able to mediate internalization by eukaryotic cells 
(Gophna et al., 2001). 
Although type 1 fimbriae are also expressed by commensal E. coli strains (encoded by 
the fim cluster, located on the core chromosome), it is one of the most important 
adhesins of UPEC. It mediates the adhesion to mannose-containing oligosaccharides 
on bladder epithelial cells and is shown to be involved in bacterial invasion (Martinez 
et al., 2000). Recently, it has been reported that type 1 fimbriae are involved in 
uroepithelial apoptosis, a characteristic phenomenon of UTI (Klumpp et al., 2001).  
Dr family adhesins, including Dr fimbriae and AFA-I and AFA-II afimbrial adhesins 
bind the Dra blood group antigens and may facilitate ascending colonization of the 
urinary tract (Nowicki et al., 1990).  
The enterohaemorrhagic and enteropathogenic (EHEC and EPEC) express the non-
fimbrial adhesion factor intimin, which is necessary for the attaching and effacing 
(A/E) phenotype during the infection. The intimin-encoding gene eae is located on the 
LEE pathogenicity island (McDaniel et al., 1995). Recently, a new adherence-
conferring factor Iha (IrgA Homologue Adhesin) was characterized in EHEC 
O157:H7 strains (Tarr, et al., 2000). The iha gene is also distributed among UPEC 
strains, but it is not always expressed e. g. in E. coli strain CFT073. 
-Toxins and bacteriocins 
Toxins are prominent virulence factors of bacterial pathogens. Three toxins play a 
major role during UTI: the cytotoxic necrotizing factor 1 (CNF1), the cytolethal 
distending toxin (CDT) and α-haemolysin. CNF1 is widely distributed in 
extraintestinal pathogens (Andreu et al., 1997) and belongs to a toxin family which 
modifies Rho, a subfamily of small GTP-binding proteins that are regulators of the 
actin cytoskeleton (Aktories, 1997). The gene for CNF1 is chromosomally located on 
different pathogenicity islands of UPEC (Blum et al., 1995; Toth et al., 2003). 
Eukaryotic cells intoxicated with CNF1 exhibit membrane ruffling, formation of focal 
adhesions and actin stress fibers and DNA replication in absence of cell division. 
CDT is a secreted protein which has the capacity to inhibit cellular proliferation by 
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inducing an irreversible cell cycle block at the G2/M position (Comayras et al., 1997). 
CDT is composed of three polypeptides (CdtA, B and C) which are all required for 
CDT activity (Elwell et al., 2001). The direct role of the toxin in uroinfection, 
however, remains to be proven. The α-haemolysin is a member of the RTX toxin 
family, which is widely disseminated among pathogenic bacteria and widely 
distributed in UPEC as well as in EHEC isolates. The hly gene cluster encoding the 
toxin and the enzymes for its biosynthesis is located on PAIs or on plasmids. The type 
I secretion pathway, a posttranslational maturation and the presence of C-terminal 
calcium binding domain are characteristics of this pore-forming toxin (Wagner et al., 
1983; Holland et al., 1990).  
In addition, the so-called autotransporter proteins are widely distributed in E. coli 
(Henderson et al., 1998). This group includes a number of serine proteases in 
Enterobacteriaceae (SPATE) which are considered to be toxins: the plasmid-encoded 
toxin (Pet) of EAEC, the protease Pic of EAEC and Shigella flexneri, EspC of EPEC, 
EspP of EHEC, Tsh of avian pathogenic E. coli, SepA of Shigella flexneri, and Sat of 
UPEC (Dutta et al., 2002). The Sat (Secreted Autotransporter Toxin) is widely 
distributed in UPEC and was shown to have cytopathic activity (elongation and 
vacuolation of eukaryotic cells). Sat-specific antibodies were found in the serum of E. 
coli-infected mice. Nevertheless the inactivation of the sat gene did not attenuate the 
the E. coli strain CFT073 (Guyer et al., 2000). All SPATEs possess a characteristic 
GDSGS serine protease motif and it is tempting to speculate that their protease 
activity may serve as peptide-providing source for the bacteria.  
The Stx toxin family (Shiga-like Toxins e. g., Stx1 and Stx2), encoded on lambdoid-
like bacteriophages in the chromosome, are the most important virulence factors of 
EHEC (Kaper and Hacker, 1999). 
Other secreted compounds, such as colicins and microcins, are also widespread 
among E. coli strains and are believed to mediate antagonistic relationships, thus 
contributing to competitiveness and the effective colonization the host. Microcins are 
peptides of a relatively small size (1.18 to 9.00 kDa). They are considered as modified 
peptide antibiotics since they are synthesized as peptide precursors which are 
subsequently modified by other proteins. They exhibit wide range of cellular targets: 
colicin B17 has been shown to be an inhibitor of the DNA gyrase (Vizàn et al., 1991), 
colicin C7 inhibits protein synthesis (Guijarro et al., 1995), and colicin V disrupts the 
membrane potential (Yang and Konisky, 1984). Microcin H47, encoded by the 
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chromosomally-located mch gene cluster, was shown to be ribosomally synthesized as 
a peptide precursor (Rodriguez et al., 1999). 
-O-, K-antigens and serum resistance 
Falkenhagen and coworkers reported that the most frequent K antigens determined in 
253 UPEC isolates are K1 and K5 (31 % and 35 % of the cases respectively); 
nevertheless more than 26 different K-antigens were identified. High prevalence of 
these two capsular serogroups is not astonishing, since both capsular oligosaccharides 
mimic human antigens, thus preventing effective immune response against bacteria 
expressing them. The K1 capsule is present in all MENEC isolates and contributes to 
the the ability to cross of the blood-brain barrier (Kim, 2002). The capsule-encoding 
kps gene clusters of E. coli are located on the chromosome as part of different 
genomic islands (Whitfield and Roberts, 1999; Welch et al., 2002). 
Lipopolysaccharide (LPS) is a key component of the outer membrane of Gram-
negative bacteria. It comprises three distinct regions: Lipid A, the oligosaccharide 
core, and commonly a long-chain polysaccharide O antigen that causes a smooth 
phenotype (Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid A is the most conserved part of LPS. It is connected to the core part, which 
Fig. 4: Schematic representation of LPS structure in Gram-negative bacteria. The O side-chain 
consists of up to 40 polymerized units. 
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links it to the O repeating units (Fig. 4). In Escherichia coli, five different core 
structures (K-12 and R1-R4) have been described (Amor et al., 2000; Holst, 1999; 
Rietschel et al., 1992). The O repeating units are highly polymorphic, and more than 
190 serologically distinguished forms in E. coli are known today (Ørskov et al., 
1992). The genes coding for LPS core synthesis are located at a conserved position on 
the E. coli K-12 chromosomal map (81-82 min) (Berlyn, 1998). The wa* (formerly 
rfa) gene clusters contain the genes which code for the enzymes required for the core 
biosynthesis and assembly and consist of three operons, defined by their first genes 
gmhD, waaQ and waaA. Although the O repeating unit-encoding gene cluster (wb*, 
former rfb) is extremely polymorphic within the species E. coli, it is localized at a 
conserved position on the E. coli K-12 chromosome between the genes galF and gnd 
(45.4 min.) (Berlyn, 1998). These determinants consist of several sugar transferase-, 
epimerase- and isomerase-encoding genes, the O antigen flippase (wzx), the O antigen 
polymerase (wzy, formerly rfc) as well as the genes coding for enzymes involved in 
carbohydrate biosynthesis pathways. Until now, several E. coli O antigen-encoding 
gene clusters have been studied, e. g. those of serotypes O7, O111, O113, and O157 
(Marolda et al., 1999; Paton et al.,1998; Wang et al., 1998; Wang and Reeves, 1998). 
They show no significant nucleotide homology between each other, with the 
exception of some common genes such as manC and manB. However, they contain a 
conserved range of predicted enzyme activities. The O6 antigen is widely distributed 
among pathogenic and non-pathogenic faecal E. coli isolates and is often found in 
uropathogenic E. coli strains. Since LPS is located on the outer surface of bacterial 
cells, its expression is known to be responsible for many features of the cell surface of 
the Gram–negative bacteria, such as resistance to detergents, hydrophobic antibiotics, 
organic acids, serum complement factors, adherence to eukaryotic cells etc. 
(Goldmann, et al., 1984; Grossmann et al., 1991; Lukowski et al., 1996; Svanborg-
Edén et al., 1987; Barua, et al., 2002 ; Jacques, 1996). It has been suggested that some 
of these characteristics, especially resistance to the bactericidal effect of the 
complement system, are dependent on the length of the O side chain (Porat et al., 
1992). LPS is believed to significantly contribute to virulence by protecting bacteria 
from the bactericidal effect of serum complement (Hull et al., 1997; Reeves, 1995; 
Valvano, 1992). Moreover, it has recently been reported that the K5 capsule does not 
contribute as much to serum resistance of E. coli strains as the O antigen (Burns and 
Hull, 1998).  
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-Iron acquisition systems 
The availability of Fe(II) ions, an essential factor for bacterial growth, is limited in 
mammalian hosts. Most of the iron is located intracellularly, primarily bound to 
ferritin and chelated in haeme. Therefore bacteria have developed different 
mechanisms to release iron from host proteins. Low molecular weight chelators 
(siderophores) are secreted from E. coli. These molecules “liberate” Fe3+ ions from 
host carriers and – by recognizing specific receptors located in the bacterial outer 
membrane – transport it into the bacterial cell (Guerinot, 1994). The genes coding for 
the biosynthesis of such iron-uptake systems in E. coli may be located on plasmids or 
on the chromosome. The gene clusters encoding the enzymes for enterobactin (ent) 
and the ferric dicitrate transport system (fec) have a commonly conserved localization 
in the E. coli core genome. However the fec gene cluster has been identified to be 
PAI-encoded in Shigella flexneri (Luck et al., 2001). The iuc operon coding for 
aerobactin is either located on plasmids (pColV) or on different genomic islands, 
whereas the yersiniabactin-encoding HPI (fyu/irp) is widely distributed in 
Enterobacteriaceae and shows a rather conserved chromosomal localization at the 
asnT gene. This genetic element is able to “jump” between the asn tRNA genes in the 
chromosome of Yersinia pseudotuberculosis (Buchrieser et al., 1998). Recently, the 
chu haeme transport locus in the chromosome of EHEC O157:H7 strain has been 
characterized (Torres and Payne, 1997). This system enables the bacteria to utilize 
iron directly from the haeme and is widely distributed among UPEC isolates 
(Wyckoff et al., 1998). The iro gene cluster (coding for the enzymes required for 
salmochelin biosynthesis) first described for Salmonella enterica (Bäumler et al., 
1996) is involved in the uptake of catecholate-type siderophore compounds. The iro 
genes are widely distributed among E. coli isolates and can be chromosomally or 
plasmid-encoded (Dobrindt et al., 2003; Sorsa et al., 2003). The ability for iron 
acquisition of bacteria might be advantageous for their survival in the host organism, 
therefore it can be considered an important fitness factor.  
 
5. The Escherichia coli strain Nissle 1917 
 
The E. coli strain Nissle 1917 has been isolated by Prof. Dr. med. Alfred Nissle (1874 
– 1965), in 1917, from faeces of a non-commissioned pioneer officer, who, unlike his 
comrades had not suffered from any of the intestinal disorders then rampant in the 
region of Dobruja in south-eastern Europe (Nissle, 1918). Investigating the 
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antagonism of various E. coli strains against pathogenic intestinal bacteria, Nissle was 
the first who administered “antagonistically strong E. coli strains” to diarrhea patients. 
The Mutaflor® probiotic preparation consists of the Nissle 1917 strain (also 
designated strain DSM6601) that belongs to this group of E. coli isolates. 
The use of E. coli as a probiotic has the advantage that this microorganism is able to 
colonize successfully the human gut (Malchow et al., 1995). In early studies the 
Mutaflor® preparation exhibited antagonistic characteristics against Salmonella typhi 
(Nissle, 1925). This probiotic agent is widely used for treatment of chronic 
constipation, dyspepsia, colitis, enteritis, gastroenteritis, some cases of stomach and 
duodenum ulcers, as well as for preventing of Candida albicans intestinal infections 
after antibiotic treatment (Kruis et al., 2001; Malchow, 1997; Möllenbrink et al., 
1994; Rembacken et al., 1999; Lodnikova-Zadnikova, and Sonnenborn, 1997) . 
Roerig and Ulrich documented several cases of partially recurring UTIs that were 
treated orally with Mutaflor®. A certain beneficial effect on cancer patients is also 
observed, probably due to the restoration of normal microecological conditions in the 
gut. The E. coli strain Nissle 1917 also exhibits an inhibitory effect on Salmonella 
typhimurium invasion into epithelial cells (Ölschläger, A. T., and Altenhöfer, A., 
unpublished data). Nevertheless, the exact mechanisms of the probiotic activity of this 
strain are still unclear (Fig. 5). E. coli strain Nissle 1917 has been in part pheno- and 
genotypically characterized (Blum, et al., 1995; Tab. 1).  
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Fig. 5: Modes of action of MUTAFLOR®: application in inflammatory and functional bowel disease 
(modified from “Mutaflor®-Brief summary of therapeutic principles”, Ardeypharm GmbH). 
 
This strain does not express any of the so-called mannose-resistant haemagglutinating 
factors (MRHA) like P- or S-fimbriae, but expresses type 1 and F1C-fimbriae, which 
do not agglutinate erythrocytes. It exhibits a semi-rough O6 LPS phenotype, serum 
sensitivity and does not produce any known virulence-associated toxin. In addition, it 
produces microcins, exhibits the rdar morphotype, i. e. strongly co-expression of curli 
fimbriae and cellulose in a temperature-independent manner (30 °C and 37 °C) and 
possesses a surprisingly high number of iron-uptake systems (Tab. 1).  
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Table 1: Properties of different E. coli O6 strains and the E. coli K-12 strain MG1655 (modified from 
Blum et al., 1995; Welch et al., 2002) 
Strains and 
properties 
MG1655 
(non-pathogenic, 
laboratory) 
Nissle 1917 
(non-pathogenic, 
faecal) 
536 
(uropathogenic, 
pyelonephritis) 
CFT073 
(uropathogenic, 
urosepsis) 
Serotype K-12 
rough 
O6:K5:H1 
semi-rough 
O6:K15:H31 
smooth 
O6:K2(?):H1 
smooth 
Serum resistance - - + + 
α-haemolysin 
production 
- - + + 
CNF1 production - - - + 
P-fimbriae 
expression 
- - + + 
S-fimbriae 
expression 
- - + - 
Type1 fimbriae 
expression 
+ + + + 
F1C fimbriae 
expression 
- + - + 
Aerobactin 
expression 
- + - + 
Enterobactin 
expression 
+ + + + 
fec + + - - 
fyu/ irp - + + + 
chu - + + + 
Microcin 
production 
- + - + 
rdar morphotype 
30 °C 
37 °C 
 
- 
- 
 
+ 
+ 
 
+ 
- 
 
+ 
- 
Plasmids - +(2)1 - - 
1Blum-Oehler et al., 2003 
 
Aim of this work 
 
The aim of this work was to characterize the genome structure and genetic 
organization of determinants contributing to fitness of the E. coli strain Nissle 1917, 
and to compare them with those of the two well-studied uropathogenic E. coli O6 
strains 536 and CFTO73.  
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In the first part of the work, the genetic basis for the semi-rough phenotype of strain 
Nissle 1917 was investigated. The importance of the O6 side-chain synthesis for 
serum resistance was studied since serum sensitivity of strain Nissle 1917 is important 
in terms of biological safety and distinguishes this strain from pathogenic isolates. 
In the second part, sequence analysis and a detailed characterization of the fitness 
determinants was performed. In this context the presence of several genomic islands 
was described. Their genetic organization and localization in the chromosome as well 
as expression of the encoded genes of interest was studied and compared with 
available data of pathogenic E. coli O6 strains. These studies resulted in a deeper 
insight into the genetic background and molecular reasons for the probiotic action of 
strain Nissle 1917. 
Furthermore, the multicellular behaviour and the underlying mechanisms as a trait 
possibly associated with the probiotic character of strain Nissle 1917 were 
investigated. 
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III. Materials 
 
1. Bacterial strains 
The E. coli strains used in this work are listed in Tab. 2a and 2b. 
Table 2a: Laboratory E. coli strains used in this study 
E. coli K-12 
strain 
Characteristics Reference 
MG1655 F-, Lam-, fnr-267(del), rph-1 Blattner et al., 1997 
DH5α F-, endA 1, hsdR17(rk-, mk-, supE44, thi-1, 
recA1, gyrA96, λ-, ∆(argF-lac)U169 
Φ80dlacZ∆M15 
Bethesda Research 
Laboratories, 1986 
AAEC 189 ∆fim, ∆lac, recA-, endA-, hsdR-, hsdM+ Gally, et al., 1994 
Sm10 λpir Thi1, thr1, leuB6, supE44, tonA21, lacY1, 
recA::RP4-2-Tc::Mu, KmR, λpir 
Miller and Mekalanos, 
1988 
EN99 araD, ∆lac, aroB, rpsL, thi, TcR, pColV-
EN77 but no aerobactin synthesis 
Ott, M., et al., 1991 
XL1-blue SupE44, hsdR17, recA1, endA1, gyrA46, 
thi, relA1, lac-, F-(proAB+, lacIq, lacZ 
∆M15, Tn10 (tetr)) 
Bullock et al., 1987 
 
Table 2b: Laboratory and wild-type E. coli strains used in this study 
E. coli strain Characteristics Reference 
Nissle 1917  
(DSM6601, SK22) 
O6:K5:H1 ent+, iuc+, fec+, chu+, foc+, fim+, 
flagella+, microcin+ 
Nissle, 1918 
Nissle 1917  
(DSM6601, SK22) 
Smr 
O6:K5:H31 ent+, iuc+, fec+, chu+, foc+, fim+, 
flagella+, microcin+, Smr 
This study 
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Table 2b continued 
Nissle 1917 
(DSM6601, SK22) 
CR- 
O6:K5:H31 ent+, iuc+, fec+, chu+, foc+, fim+, 
flagella+, microcin+, congo red binding-
negative spontaneous mutant 
Gabor, N., 
unpublished 
Nissle 1917 
rfaH::cat 
rfaH inactivated by a cat cassette, SmR, CmR This study 
Nissle 
1917λPbla::wzy536 
wzy536 fused with Pbla integrated into the 
bacterial attachment site of the λ 
bacteriophage of Nissle 1917, ApR 
Grozdanov et 
al., 2003 
Nissle 
1917λPwb*Nissle 
1917::wzy536 
wzy536 fused with the upstream region of the 
wb*Nissle 1917 integrated into the attachment site 
of the λ bacteriophage in the chromosome of 
Nissle 1917, ApR 
Grozdanov et 
al., 2003 
Nissle 1917-wzy 536 wzyNissle 1917 replaced by wzy536 in the wb*Nissle 
1917 of the Nissle 1917 chromosome, SmR 
This study 
Nissle 1917∆bcs bcs gene cluster deleted from chromosome of 
Nissle 1917, SmR 
This study 
536 O6:K15:H31 ent+, chu+, fec-, hly+, fim+, 
sfa+, prf+, flagella+, microcin-, SmR 
Berger et al., 
1982 
536rfaH::cat Gene rfaH inactivated by a insertion of cat 
cassette, SmR, CmR 
Nagy et al., 
2000 
536-wzy Nissle 1917 wzy536 replaced by wzyNissle 1917 in wb*536 of 
the 536 chromosome, SmR 
This study 
CFT073 O6:K2(?):H1 ent+, iuc+, fec-, chu+, hly+ , 
foc+, prf/pap+, fim+, flagella+, microcin+, 
SmR 
Mobley et al., 
1990 
RZ439 O6:K5 aer+, hly-, pap/prf+, sfa/foc+, fim+ Zingler et al., 
1993 
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Table 2b continued 
RZ442 O6:K5 aer+, hly-, pap/prf+, sfa/foc+, fim+ Zingler et al., 
1993 
RZ526 O6:K5 aer
+
, hly-, pap/prf+, sfa/foc+, fim+ Zingler et al., 
1993 
RZ533 O6:K5 aer+, hly+, pap/prf+, sfa/foc+, fim+ Zingler et al., 
1993 
RZ446 O6:K53:H1 aer-, hly+, pap/prf+, sfa/foc-, 
fim+ 
Zingler et al., 
1992 
RZ537 O6:K53:H1 aer-, hly+, pap/prf+, sfa/foc-, 
fim+ 
Zingler et al., 
1992 
RZ424 O6:K14:H- aer-, hly+, pap/prf+, sfa/foc-, 
fim+ 
Zingler et al., 
1992 
RZ436 O6:K13:H1 aer-, hly+, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ447 O6:K13:H1 aer-, hly+, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ502 O6:K2:H- aer-, hly+, pap/prf-, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ496 O6:K+:H- aer-, hly+, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ532 O6:K+:H31 aer-, hly+, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ411 O6:K-:H1 aer-, hly-, pap/prf+, sfa/foc-, fim+ Zingler et al., 
1992 
RZ412 O6:K-:H1 aer+, hly+, pap/prf+, sfa/foc-, 
fim+ 
Zingler et al., 
1992 
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Table 2b continued 
RZ418 O6:K-:H1 aer+, hly+, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
RZ501 O6:K-:H1 aer+, hly-, pap/prf+, sfa/foc+, 
fim+ 
Zingler et al., 
1992 
 
2. Plasmids 
The plasmids used in this study are listed in Tab. 3. 
Table 3: Plasmids used in this study. 
Designation Description Reference 
pUC19 ApR, orif1, lacZ Yanisch-Perron et 
al., 1998 
SuperCos 1 Cosmid vector, ApR, Stratagene 
pGEM®-T Easy Cloning vector, ApR Promega 
pBluescript-II KS Cloning vector, ApR Stratagene 
pLDR8 int gene expression vector, KmR Diederich et al., 
1992 
pLDR9 Cloning vector for integration of wzy536 
into the λ-attB, KmR 
Diederich et al., 
1992 
 
pLDR11 Cloning vector for integration of wzy536  
into the λ-attB, TcR 
Diederich et al., 
1992 
pCVD442 oriR6K, mobRP4, sacB, ApR Donnenberg and 
Kaper, 1991  
pCos3YC6 Cosmid clone; insert contains the 
fimNissle1917 gene cluster, ApR 
Grozdanov et al., 
2004 
pCos8YA1 Cosmid clone; insert contains the selC 
tRNA-encoding gene and the wa*Nissle1917 
gene cluster, ApR 
Grozdanov et al., 
2004 
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Table 3 continued 
pCos9YB4 Cosmid clone; insert containing the 
iucNissle1917 gene cluster and satNissle1917, ApR
Grozdanov et al., 
2004 
pCos2YE4 Cosmid clone; insert overlaps with insert of 
pCos9YB4 and contains ihaNissle1917, ApR 
Grozdanov et al., 
2004 
pCos2RF2 Cosmid clone; insert overlaps with insert of 
pCos2YE4 and contains the K5-encoding 
kpsNissle1917 gene cluster, ApR 
Grozdanov et al., 
2004 
pCos3YE4 Cosmid clone; insert contains the 
mch/mcmNissle1917, focNissle1917 and 
iroNissle1917 gene clusters, ApR 
Grozdanov et al., 
2004 
pCos2RA4 Cosmid clone; insert overlaps with insert of  
pCos3YE4, ApR 
Grozdanov et al., 
2004 
pCos1YA7 Cosmid clone; insert contains the 
argWNissle1917 gene, ApR 
Grozdanov et al., 
2004 
pCos219 Cosmid clone; insert contains the 
glyUNissle1917 gene, ApR 
This study 
pGBC1917 PCR-amplified bcsNissle1917 gene cluster 
cloned in pGEM T®-Easy, ApR 
This study 
pSMK5 rfaH536 with CmR in pCVD442 Nagy et al., 2000 
pGDC1917 KpnI/MscI deleted bcsNissle1917 (∆ 
bcsNissle1917) gene cluster cloned in pGEM® 
T-Easy, ApR 
This study 
pCDB1917 SacI/SphI digested ∆bcsNissle1917 gene 
cluster subcloned in SacI/SphI digested 
pCVD442, ApR 
This study 
pPSD1917 7 kb-EcoRI/HindIII fragment of pCos9YB4 
containing satNissle1917 subcloned in 
EcoRI/HindIII digested pUC19, ApR 
Grozdanov et al., 
2004 
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Table 3 continued 
pGLW536 wzy536 cloned into pGEM®-T Easy, ApR Grozdanov et al., 
2003 
pGLW1917 wzyNissle1917 cloned into pGEM®-T Easy, 
ApR 
Grozdanov et al., 
2003 
pCVW536 wzy536 subcloned from pGLW536 into 
SacI/SphI digested pCVD442, ApR 
This study 
pCVW1917 wzyNissle1917 subcloned from pGLW1917 
into SacI/SphI digested pCVD442, ApR 
This study 
pGWB1917 PCR-amplified wb*Nissle 1917 cloned into 
pGEM®-T Easy, ApR  
Grozdanov et al., 
2003 
pGWB536 PCR-amplified wb*536 cloned into pGEM®-
T Easy, ApR 
Grozdanov et al., 
2003 
pBWB536 wb*536 subcloned from pGWB536 into 
pBluescript-II KS, ApR 
Grozdanov et al., 
2003 
pGLG2504 PCR-amplified 2504 bp of the 5'-proximal 
region of wb*536 (including JUMPstart 
region, wzx536 and the 986 bp-fragment of 
wzy536) cloned into pGEM®-T Easy, ApR 
Grozdanov et al., 
2003 
pBLG2504 2504 bp of the 5'-proximal region of wb*536 
(including JUMPstart region, wzx536 and 
the 986 bp-fragment of wzy536) subcloned 
from pGLG2504 into EcoR-digested 
pBluescript-II KS, ApR 
Grozdanov et al., 
2003 
pGLG2849 PCR-amplified 2849 bp of the 5'-proximal 
region of wb*536 (including JUMPstart 
region, wzx536 and the 1343 bp intact 
wzy536) cloned into pGEM®-T Easy, ApR 
Grozdanov et al., 
2003 
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Table 3 continued 
pBLG2849 2849 bp of the 5'-proximal region of wb*536 
(including JUMPstart region, wzx536 and 
the 1343 bp intact wzy536) subcloned from 
pGLG2849 into EcoRI-digested 
pBluescript-II KS, ApR 
Grozdanov et al., 
2003 
pLBW1 Pbla::wzy536 cloned into EcoRI-digested 
pLDR11, TcR 
Grozdanov et al., 
2003 
pGPW1 PCR-amplified PwbNissle 1917::wzy536 cloned 
into pGEM®-T Easy, ApR 
Grozdanov et al., 
2003 
pLPW1 PwbNissle 1917::wzy536 subcloned from 
pGPW1 cloned into EcoRI-digested 
pLDR9, KmR 
Grozdanov et al., 
2003 
 
3. Oligonucleotides 
 The oligonucleotides (primers) used in this study (Tab. 4) were obtained from 
commercial sources (Sigma-ARK Oligosys or MWG Biotech GmbH). For primers not 
designed in this study, a reference is given. Primers used for amplification of PAI III536-
specific sequences are listed in section VIII, Tab. 1. 
Table 4: Primers used in this work. 
Designation Sequence (5' - 3') Binding site of the primer  (reference) 
argQ1 GCAAGGCGAGTAATCCTCC 5' of argQ (Dobrindt, U., unpublished) 
argQ2 TGCCTGAGCAATACGCCAG in yqaB (Dobrindt, U., unpublished) 
glnX1 TCGCCATGCGTTGCAGTAC in yleB (Dobrindt, U., unpublished) 
glnX2 GTAAGTGCACCCAGTTGGG 5' of glnX (Dobrindt, U., unpublished) 
lysQ1 GGCAGCATAATCCCGCAAG 5' of lysQ (Dobrindt, U., unpublished) 
lysQ2 AAGCGCGCCATTTCCAGAG in nadA (Dobrindt, U., unpublished) 
thrT1 GCCCGAGACGATAAGTTCG 5' glyT (Dobrindt, U., unpublished) 
thrT2 CGGGGTGTCGTATTCAACG in tufB (Dobrindt, U., unpublished) 
glyU1 GCACTTGCTAAGGAGAGCG 5' of glyU (Dobrindt, U., unpublished) 
glyU2 CCCTCAACCAGACAGCATC in b2863 (Dobrindt, U., unpublished) 
serU1 TCCTGGCATCATGGCAACC 5' of serU (Dobrindt, U., unpublished) 
serU2 GAATGATGCCTCGCCGCAA in yodB (Dobrindt, U., unpublished) 
asnT1 TATTCGCCCCGTTCACACG 5' of asnT (Dobrindt, U., unpublished) 
asnT2 GATACCCGCAGTTAAGCGG in b1978 (Dobrindt, U., unpublished) 
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Table 4 continued 
asnW1 ATTGTGGGTGGGCATCGCT 5' of asnW (Dobrindt, U., unpublished) 
asnW2 GCCCTTGAAGATGACGACG in b1983 (Dobrindt, U., unpublished) 
asnU1 
CGCCGTTAAGATGTGCCTC 
5' of asnU/in yeeO (Dobrindt, U., 
unpublished) 
asnU2 TTCCCGTGGTTTCGTTGGC in cbl (Dobrindt, U., unpublished) 
argW1 AGCGGGTATACTCATGCCG 5' of argW (Dobrindt, U., unpublished) 
argW2 CTTCCAGCAGTTGCATCGG in intC (Dobrindt, U., unpublished) 
argU1 CGCGATTACACCGCATTGC 5' of argU (Dobrindt, U., unpublished) 
argU2 ACATGCAGCGACGAGTTGC in intD (Dobrindt, U., unpublished) 
wrbA1 TGGTAGCGAATCGCTACGG 5' of wrbA (Dobrindt, U., unpublished) 
wrbA2 GAGATGCCCATTCACCGAC in yccJ (Dobrindt, U., unpublished) 
ssrA1 GCGGCGCGAATGAACATCT 5' of ssrA (Dobrindt, U., unpublished) 
ssrA2 AGAGTAAGCCCGTCACCGT in intA (Dobrindt, U., unpublished) 
serW1 TATAGTAGCGCCCCGTTGC 5' of serW (Dobrindt, U., unpublished) 
serW2 CTGCTGTTTGGTTCGCTGG in clpA (Dobrindt, U., unpublished) 
serT1 ATAGTGCGCGTCATTCCGG 5' of serT (Dobrindt, U., unpublished) 
serT2 TTACGTCACCCATTCCGGC in yccA (Dobrindt, U., unpublished) 
proL1 ATTAGCAGCCACGAGTCGG 5' of proL (Dobrindt, U., unpublished) 
proL2 GGGTTGACGGATTGTGGAG in yejO (Dobrindt, U., unpublished) 
proK1 TCTGCGCAGTAAGATGCGC 5' of proK (Dobrindt, U., unpublished) 
proK2 CCAAGCTTCAGCATCCCTG in dppA (Dobrindt, U., unpublished) 
pheV1 ACGAGACGAGGCGAATCAG 5' of pheV (Dobrindt, U., unpublished) 
pheV2 CCGTTGAGCGAACGGATTG in yghD (Dobrindt, U., unpublished) 
pheU1 TACGGTTTAATGCGCCCCG 5' of pheU (Dobrindt, U., unpublished) 
pheU2 ACAAGCCATTCGCCAACGC in cadC (Dobrindt, U., unpublished) 
metY1 CGGTACACCAAATCCCAGC 5' of metY (Dobrindt, U., unpublished) 
metY2 AACGGGCGTAGTGTTCAGC in yhbC (Dobrindt, U., unpublished) 
leuU1 GACCAGCGATATCCCGAAC 5' of leuU (Dobrindt, U., unpublished) 
leuU2 ACCATATGCGCTCCGGAAG in yhbX (Dobrindt, U., unpublished) 
asnV1 ATATGCGCCCCGTTCACAC 5' of asnV (Dobrindt, U., unpublished) 
asnV2 ACACTCGGCGCGAATATGC in erfK (Dobrindt, U., unpublished) 
ileY1 CCAAGGTGAATGGGAACGC 5' of ileY (Dobrindt, U., unpublished) 
ileY2 ATGAGCATAGCCACGCTCC in b2651 (Dobrindt, U., unpublished) 
proM1 GTATTTCGGCGAGTAGCGC 5' of prom (Dobrindt, U., unpublished) 
proM2 GCCGTTAGTCTGGAAGCTG in aslB (Dobrindt, U., unpublished) 
metV1 GACGCGGTGACGAATTACG in mltA (Dobrindt, U., unpublished) 
metV2 GCCGTACTAAAGGCACCAG in b2817 (Dobrindt, U., unpublished) 
leuZ1 TTCGTTCAGACGCTCTGCG in yecA (Dobrindt, U., unpublished) 
leuZ2 CAGGCTGAAAGGCCTGAAG 5' cysT, leuZ (Dobrindt, U., unpublished) 
leuV1 CCAGGCGGATAAACTCCAG in fhuF (Dobrindt, U., unpublished) 
leuV2 CGCACCAAACGAGGCGATA 5' leuV (Dobrindt, U., unpublished) 
glyY1 GTGCTGTAAGGCACAGACC 5' glyY (Dobrindt, U., unpublished) 
glyY2 TTGGTCACCTGCGTTGGCT in yjeS (Dobrindt, U., unpublished) 
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Table 4 continued 
valW1 
TTGCCACCTTCCCACTCTG 
5' of valV, yalW (Dobrindt, U., 
unpublished) 
valW2 CTGTCAGGCGAGTTTTGCC in b1667 (Dobrindt, U., unpublished) 
tyrV1 TTCACATAGACCCTGCTTCG in narI (Dobrindt, U., unpublished) 
tyrV2 CCACCATAATTCACCACAGC in tyrT (Dobrindt, U., unpublished) 
lysV1 CACCACTTTCTCGCCAGCT 5'valY (Dobrindt, U., unpublished) 
lysV2 TGATAGCGGACAGCTACGC in xapR (Dobrindt, U., unpublished) 
alaX1 ACGTAAACGCATCGTGGGG 5' of alaX (Dobrindt, U., unpublished) 
alaX2 GAGCATGACCGCAGTCTGT in yfeA (Dobrindt, U., unpublished) 
serX1 CTCTCTTGCGCATTTTGATTG 5' ycdV (Dobrindt, U., unpublished) 
serX2 AGACAGGAACGACAATTTGG 5' serX (Dobrindt, U., unpublished) 
thrW1 AAGGCCATTGACGCATCGC 5' of thrW (Dobrindt, U., unpublished) 
thrW2 CCATTTACCCCACTCAGCG in yafW (Dobrindt, U., unpublished) 
selC1 GCGTGTATTAGGCGGAAAAAAC 5' of selC (Dobrindt, U., unpublished) 
selC2 CCCTGAACTTCCCCACAAC in yicL (Dobrindt, U., unpublished) 
leuX1 GTGGCGTGCGACAGGTATA 5' of leuX (Dobrindt, U., unpublished) 
leuX2 GTTTCTCCGGCCCTAAGAC in yi21_6 (Dobrindt, U., unpublished) 
ileX1 GAACACCGACTACACGCTG 3' of rpoD (Dobrindt, U., unpublished) 
ileX2 CAGATGCAAATCCCTGCCG in yqjH (Dobrindt, U., unpublished) 
yicJ-up ATTGTGCGTCGTGAGTGAGT in yicJ (Blum-Oehler, G., personal 
communication) 
yicJ-down TTGGTTATGGCATGGGAGAC in yicJ, reverse (Blum-Oehler, G., 
personal communication) 
yicK-up AACGGCTACCACTCCATCAA in yicK, (Blum-Oehler, G., personal 
communication) 
yicK-down TAATTCCGTCAACAGAGCCG in yicK, reverse (Blum-Oehler, G., 
personal communication) 
yicL-up GTTCTGATTGCCGCCGTGTT in yicL (Blum-Oehler, G., personal 
communication) 
yicL-down ATCAGCAGCGTTCCCAGCCA in yicL, reverse (Blum-Oehler, G., 
personal communication) 
csrA-1 TTCAGCCTGGATACGCTGG in csrA 
csrA-2 GATCGTGTGAAAGCAGGGG in csrA, reverse 
csrAIPCR-1 CCAGCGTATCCAGGCTGAA in csrA, complementary to csrA-1  
csrAIPCR-2 CCCCTGCTTTCACACGATC in csrA, complementary to csrA-2  
b1976-1 CCTGGCAGGAAGCACTATC in csrA 
b1976-2 AGCGTGATGCAGTCTCTGC in csrA, reverse 
yfdC-1 CATGAGCATATCCGCCAGG in yfdC 
yfdC-2 AGTAGGTAGTGCGAAGGGC in yfdC, reverse 
fimZ-1 TATCGAGCGTTAGCCAGCG in fimZ 
fimZ-2 TTGCCGGAACAGACGGTT in fimZ, reverse 
b2865-1 TTTGGCTTGCTGCCCTGAG in b2865 
b2865-2 CAGGAACGTATTCCGGCTC in b2865, reverse 
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yqgA-1 CTGCTCAGCCAACGCTTAC in yqgA 
yqgA-2 CCAGCAGCAATAAACCGCC in yqgA, reverse 
yejM-1 CATTCTGTCGACCCGTACG in yejM 
yejM-2 CCCAGTAATGACGGCGTTG in yejM, reverse 
yfeC-1 GCTATAGCCGCCAGACCAT in yfeC 
yfeC-2 TAGCCACACCGAGGCATTC in yfeC, reverse 
purU-1 GCGCTGTGCCAGTACTTTG in purU 
purU-2 CTCGATAGCGCATTGCCAG in purU, reverse 
ybgF-1 ACTGGTTGGTATAGCGGCC in ybgF 
ybgF-2 CACCAGCGCAATAGCTGCA in ybgF, reverse 
ybgFIPCR-1 GGCCGCTATACCAACCAGT in ybgF, complementary to ybgF-1  
ybgFIPCR-2 TGCAGCTATTGCGCTGGTG in ybgF, complementary to ybgF-2 
yeeO-1 TCCCATCCAGACACCAACC in yeeO 
yeeO-2 ATCCAGCAGCTGCCATCAC in yeeO, reverse 
yhjW-1 GCGGGATGTGACACCAGTT in yhjW 
yhjW-2 TCGTGAGCAGATTGGTCGG in yhjW, reverse 
ycdW-1 CCACCGACCACGGATTTGT in ycdW 
ycdW-2 GCCAGGTTTGCAGACTCTG in ycdW, reverse 
gltX-1 GACCGTCATAACGCGGCTT in gltX 
gltX-2 AAACTCGCTTCGCGCCAAG in gltX, reverse 
gltXIPCR-1 AAGCCGCGTTATGACGGTC in gltX, complementary to gltX-1  
gltXIPCR-2 CTTGGCGCGAAGCGAGTTT in gltX, complementary to gltX-1  
nac-1 CTGCGCCACATAACGAACG in nac 
nac-2 TATCGCACAACCAGCGCTC in nac, reverse 
proA-1 CCGATGAACTGGAAGCACAAAG in proA  
proA-2 TTTGTGTGCTTACCGCCACTTC in proA, reverse 
proAIPCR-1 CTTTGTGCTTCCAGTTCATCGG in proA, complementary to proA-1 
proAIPCR-2 AAGTGGCGGTAAGCACACAAA in proA, complementary to proA-2 
yjgB-1 ACTTTATCGGCACCCATCG in yjgB  
yjgB-2 GCATGAGGTGATTGGGCG in yjgB, reverse  
yjgBIPCR-1 CGATGGGTGCCGATAAAGT in yjgB, complementary to yjgB-1  
yjgBIPCR-2 CGCCCAATCACCTCATGC in yjgB, complementary to yjgB-2  
argQCFT073 ACACTATCCAGCAGCATACT in c3247 
glyUCFT073 GTCGCTTATCTCATCATCTG in c3442 
metVCFT073 CATTACCGTTTCCGTTTAGC in c3385, reverse 
serUCFT073 CAGAGAGTTCAGGCGTGG in c2416 
asnVCFT073 TTGGTCCTAATGGCTCAATG in c2445 
leuXCFT073 GCTGTTGAAGGCGGGAAG in c5371, reverse 
thrWCFT073 ACCTCAGGATACACACCTAG in c0391, reverse 
selCCFT073 TCTTCCTTTTTTGCCTCCCC in intC, reverse 
alaXCFT073 TCAATCCATAACGCCAACGC in yfeA 
proLCFT073 AAAGCAACAGGTGATTTCA in c2727, reverse 
aspVCFT073a CATTGTGCGTCAGGCAAGTA in dnaQ 
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aspVCFT073b GCACAGCAACCACTATGAGG in c0253, reverse 
upxCFT073-up ATGTGCGTCGGAGTGAGTCAGAAGCC in c0360 
upxCFT073-up1 AAGAAACTCGCCAACAGAAC in c0361, reverse 
upxCFT073-down AACAACAACCTGCCACTAAACATACATTCA in c0364, reverse 
upxCFT073-down1 GGATGGATTTATGGTGGCAGT in c0363 
iha-up ATGCGAATAACCACTCTGGCTTCCG in iha  
iha-down ACTGATAGTTCAGCGACATCCCG in iha, reverse  
K5-1-up AGATGGAAGCGGACCTGCGGAACTTG in kpsE  
K5-1-down GGGGTATTGTCGAAGCCGCTCATGTTT in kpsD, reverse  
kfi-up TTTCAAAATAACATTAGTGATAAAGT in kfiD  
kfi-down TATCTTCTCTCCAGAATTTTTACG in kfiD, reverse  
K5reg3-up CTTATCGTCTGGATGGCAGGT in kpsM  
K5reg3-down CCATTACGACCAATAAAGGCAA in kpsT, reverse  
iuc-up GTATGAGCAGGTTTTCCACGC in iucC  
iuc-down TTTTCCTGCCAGACCTGACTG in iucC, reverse  
manC-up TATCATTATGGCTGGTGGTTCAGGCAGTCGGTTG in manC  
manB-down GTAGCCCTCAATAAACTGCCCTTTTTCGTCAA in manB, reverse  
Z2005-down TGATGGTGGTGGGGGAAGGAT 3' in Z2005  
Z4201-down CAGACAGCATCATAGTGGGTTTC 3' in Z4201  
Z1664-down GACAACAGGCTGACCGACTC 3' in Z1664  
Z0696-down GTAACATCATCAACGATTATCTG 3' in Z0696  
Z3672-down GGATTTAGAAGGGATACATTCAGA 3' in Z3672  
Z4314-down CGAAAGAGAGTTGTAAATCAGGGA 3' in Z4314  
Z0307-down GTATTGAAAAAACAAATCGGTAATCAT 3' in Z0307  
Z5878-down GGGATTGAAGGGGCGGAGTTC 3' in Z5878  
shiA-forw CGCCTGCAGGATGAACGATAGATTATGC shiA (Moss et al., 1999) 
shiA-rev GCGGATCCCTGATACTGGATGCTTGAATG shiA, reverse (Moss et al., 1999) 
chu1 GGTATTTATGGTTCAGTGATG upstream of shuV (Nagy, G. personal 
communication) 
chu4 TTTTCTCACTCAAATTGAACG downstream of shuS, reverse (Nagy, G. 
personal communication) 
bcs-up CTATCTGAAAACTTACCAGTCGGCGTA downstream of yhjL (This study) 
bcs-down AACGGAAAGTCAAAAAGTGAGCAAATTC upstream of yhjR (This study) 
curli 1 TGCCGCCACAATCCAGCGTAA upstream of csgD promoter (Dobrindt, 
U., unpublished) 
curli 2 CGCACCCAGTATTGTTAACATCATAAA downstream of csgD, reverse (Dobrindt, 
U., unpublished) 
curli 3 GCTATCAAAAAGCACCAGACAGTC in csgD (Dobrindt, U., unpublished) 
ygaG-up GGCTTTTTTCAATTAATTGTGAAG in ygaG (Dobrindt, U., personal 
communication) 
ygaG-down CTGGGAAGAAAGAGTTCAGAAAA in ygaG, reverse (Dobrindt, U., personal 
communication) 
ygaGIPCR-1 GCATCAACAGCAACGAAGAACTG in ygaGNissle1917-specific IPCR product  
 
III. Materials                                                                                                                                                   36 
Table 4 continued 
ygaGIPCR-2 CTTTGTTCGGCACGCAGAAGC in ygaGNissle1917-specific IPCR product  
ygaGIPCR-uni2 ACGCCACAAGACCCTTGAGCA in ygaGNissle1917-specific IPCR product  
ygaGIPCR-rev2 TGCCTCTTCTTTTGCCTGTTG in ygaGNissle1917-specific IPCR product 
3YE4-1 CAGAGTGATGTTGTTACTTTGTTGCCT right-hand end of pCos3YE4 insert 
3YE4-2 GGACCAACAATCACAAGCAAGCGAGGA right-hand end of pCos3YE4 insert, 
reverse 
cva13 GGCATTGTTACTATGCGGTATGCAT between mcmA and mcmM, reverse 
(Patzer et al., 2003) 
cva15 TGTTCTTTTATATTCCGGTGTCATT in mcmI (Patzer et al., 2003) 
cva21 TATCCCGACGATGATTATCAGTGAC in mchE, reverse (Patzer et al., 2003) 
cva28 CTTGAACCGATAAGAAACACAGTGT between mchC and mchD (Patzer et al., 
2003) 
cva31 CTCATCTGGCAGTATTCTCCGTTTC in mchC, reverse (Patzer et al., 2003) 
cva34 TGTCTTTGTCTGGGTGAGGTCAGGT in mchX (Patzer et al., 2003) 
IS2-1 ACAGAACTTGATGGTATGCCTGCG in left-hand IS2 of GEI IINissle 1917 
ORF-2 CTCAATGCTGTTTCTGCCATCGTC in shiF (GEI IINissle 1917), reverse 
iha-1 CTGTGACTCCGTGGGATAAGGAAT in iha (GEI IINissle 1917)  
IS2-2 CTATTTCTCTGGCGTAAGCAATACC in right-hand IS2 of  GEI IINissle 1917, 
reverse 
mutaistyp-1 TTAGCGTTGGCGTAAGGCGAA in IS-element located in fimNissle 1917 
(fimB)  
mutaistyp-2 TTCCCTTACGAGATAAAAATACCC in fimANissle 1917, reverse  
GEI I-L1 CGCAAAGCCGACGATTTCACC in ORF5 of GEI INissle 1917 
GEI I-L2 TTACTGGCGTATGAAAATGCGGT in ORF5 of GEI INissle 1917, reverse 
GEI I-R1 GGAAACTGGCTACTGGACAATGC in ORF81 of GEI INissle 1917 
GEI I-R2 TCACCTGCTCCTGAATCATTGCC in ORF81 of GEI INissle 1917, reverse 
GEI II-L1 CGACAGGAGAATGACTTTATTGATG in ORF2 of GEI IINissle 1917 
GEI II-L2 CAGATTTCCGCACAGTATTTCTG in ORF2 of GEI IINissle 1917, reverse 
GEI II-R1 ACAAACCATAGCGAGATAATAAACCA in ORF75 of GEI IINissle 1917 
GEI II-R2 CAAGAACTTTTTATTTGTAATGCTGTA in ORF75 of GEI IINissle 1917, reverse 
GEI III-rev GGAAGCGGGCTCTTATATTGCGA in ORF25 of GEI IIINissle 1917, reverse 
asnT1 CACGATTCCTCTGTAGTTCA asnT (Karch et al., 1997) 
int3 TCCTTTTTCGTGTCGTAACCC int, reverse(Karch et al., 1997) 
ybtQup CGGGCGGCCTCTTCTACCT ybtQ (Karch et al., 1997) 
ybtQ1lp GCGATGCGGCGACAAATGC ybtQ, reverse (Karch et al., 1997) 
ybtEup GCAAGATAGACAAAAAAACGCC ybtE (Karch et al., 1997) 
fyuybtE GCTGACAACGGTAGACGAGA fyuA, reverse (Karch et al., 1997) 
50A ATTGATCCACCGTTTTACTC IS100 (Karch et al., 1997)  
50B CGAACGAAAGCATGAAACAA IS100, reverse (Karch et al., 1997) 
int5 ATGGAATCGGGTTTATGGG int (Karch et al., 1997) 
ybtSlp GCTATTGCTGAACTGGAGG ybtS, reverse (Karch et al., 1997) 
ybtQup GCCGCCAGTCTATCCACA ybtQ (Karch et al., 1997) 
ybtA1lp GAATCGGCCACAATAGGA ybtA, reverse (Karch et al., 1997) 
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ybtAup GGTATGGATATTTTGCTCTGG ybtA (Karch et al., 1997) 
irp2 RP TCGTCGGGCAGCGTTTCTTCT irp2, reverse (Karch et al., 1997) 
irp-1up TTCCGGTCCCCTGTCTCA irp1 (Karch et al., 1997) 
ybtTlp ATCCGCCAATGTCTATCA ybtT, reverse (Karch et al., 1997) 
ybtAup GGTATGGATATTTTGCTCTGG ybtA (Karch et al., 1997) 
ybtAlp GGTAATGCTCTCGAATCGG ybtA, reverse (Karch et al., 1997) 
irp1up TGAATCGCGGGTGTCTTATGC irp1 (Karch et al., 1997) 
irp1lp TCCCTCAATAAAGCCCACGCT irp1, reverse (Karch et al., 1997) 
ybtTup TGCAAAAACAGCCCAGTA ybtT (Karch et al., 1997) 
fyuA1lp CATTCCATCCCACATAGG fyuA, reverse (Karch et al., 1997) 
irp2 FP AAGGATTCGCTGTTACCGGAC irp2 (Karch et al., 1997) 
irp2 RP TCGTCGGGCAGCGTTTCTTCT irp2, reverse (Karch et al., 1997) 
irp1-1up TTCCGGTCCCCTGTCTCA in ybtU (Karch et al., 1997) 
ybtTlp ATCCGCCAATGTCTATCA in ybtU, reverse (Karch et al., 1997) 
III.33 CCACAAATCGTCTTCGGCC in iroB (Dobrindt et al., 2001)  
III.34 GGCCGAAGACGATTTGTGG in iroB, reverse (Dobrindt et al., 2001) 
IS2-up CATACATCACTACGCCCACGAAA upstream of the left-hand copy of IS2 in 
GEI IINissle1917  
IS2-down ACAGCACTCTATGAGGACTTAGTA downstream of the right-hand copy of 
IS2 in GEI IINissle1917, reverse  
1A GCCAGCAGCAGGACACGACTT in 30 kb serX – iroC region of E. coli 
CFT073 
1B CCAGTCTGTCGGTGAGACTGAAATCG in 30 kb serX – iroC region of E. coli 
CFT073, reverse 
2A GGCAGAATGGAGAAACAACAGAACCT in 30 kb serX – iroC region of E. coli 
CFT073 
2B CCCGCTTTTCCCCATAATGCCAATCAC in 30 kb serX – iroC region of E. coli 
CFT073, reverse 
3A ATCATCAGGGGCTATTCTACAGCAAAC in 30 kb serX – iroC region of E. coli 
CFT073 
3B TTCGTCACCATAACGGTAAGTCAGTGC in 30 kb serX – iroC region of E. coli 
CFT073, reverse 
4A GCGATTAGCCAGTCGTTTTGGTTATAC in 30 kb serX – iroC region of E. coli 
CFT073 
4B CATCTTCATAGCATTCTTTTCCCTGAAG in 30 kb serX – iroC region of E. coli 
CFT073, reverse 
focG-up GTGAATTAATACTTCCCGCACCAGCAT in focG  
focG-down CTGTTACAGGGAGGGTATTGCCAC in focG, reverse  
pheVshiA-1 ACTATGGCACTGACTGACGCAAAAAT in int gene immediately downstream of 
pheV 
pheVshiA-2 CCAGTATGTTTCATGCCTGCCGCTGA in shiA, reverse 
sat-up CGGAGATAAATTCTCTTTCCATAATC in sat  
sat-down TAAATGTAAATCCCTGACCGTTTATG in sat, reverse  
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MUTA-up TCCTGAAAAACAAT in wzyNissle1917  
MUTA-down TAACATTAAATATTT in wzyNissle1917, reverse  
Muta-1 ATACTACGACGGTAAATGGT in the variable central part of fimANissle1917 
(Blum-Oehler et al., 2003) 
Muta-2 TACATCAGTATCGGTAGCAT in the variable central part of 
fimANissle1917, reverse (Blum-Oehler et al., 
2003) 
Muta-5 AACTGTGAAGCGATGAACCC non-coding region in pMUT1 
(Blum-Oehler et al., 2003) 
Muta-6 GGACTGTTCAGAGAGCTATC non-coding region in 
pMUT1 
(Blum-Oehler et al., 2003) 
Muta-7 GACCAAGCGATAACCGGATG non-coding region in pMUT2 
(Blum-Oehler et al., 2003) 
Muta-8 GTGAGATGATGGCCACGATT non-coding region in pMUT2 
(Blum-Oehler et al., 2003) 
Muta-9 CGGAGGTAACCTCGAACATG mobBD region in pMUT2 
(Blum-Oehler et al., 2003) 
Muta-10 CGCCGTATCGATAATTCACG mobBD region in pMUT2 
(Blum-Oehler et al., 2003) 
R1C3l GGGATGCGAACAGAATTAGT 5' in waO6 (Amor et al.) 
R1K15 TTCCTGGCAAGAGAGATAAG 3' in waO6, reverse (Amor et al.) 
waalücke 1 CGCACTCACTGATGCCCAGCA in waaC, reverse  
waalücke 2 AGTCCAATCCATGCTTTACGCCAT in waaC 
482 CACTGCCATACCGACGCCGATCTGTTGCTTGG 5' in JUMPStart (Coimbra et al.) 
412 ATTGGTAGCTGTAAGCCAAGGGCGGTAGCGT 3' in gnd, reverse (Coimbra et al.) 
M13–uni TGTAAAACGACGGCCAGT Promega, Mannheim (Germany) 
M13-rev CAGGAAACAGCTATGAC Promega, Mannheim (Germany) 
SuperCos-F CGGCCGCAATTAACCCTCAC SuperCos 1 sequence primer 
SuperCos-R GCGGCCGCATAATACGACTCACT SuperCos 1 sequence primer 
LG1 GTTTCTTGTATTCAGTATGCT in wbO6 , reverse  
LG2 TGG GTT TGC TGT GTA TGA GGC in wbO6, reverse  
LG3 TAT GAG CCC TGT TAT AAC TTG GGA in wbO6, reverse  
LG4 CACCTTGCCCTCCTGAACCATTAT in wbO6, reverse  
LG5 GAATAGTTTACCTGAGGATTTTTTATC in wbO6, reverse  
LG6 GTCTTCCTACACCCAGCATCTCCA in wbO6, reverse  
LG7 CCAGCCATAATGATAGGTGTAA in wbO6, reverse  
LG8 AACCTGAAAGAAGGGGCGAAG 5' in galF (position 841–861), 
amplification of wbO6 upstream region 
LG9 GCTCTAGAGCTTAGGTGTAATTATATTATT in wbO6, XbaI restriction site, reverse  
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LG15 CCATCGATGGGTGCCTGACTGCGTTAGCAATTTAA
CTGTGATAAACTACCGCATTAAAGCTTATCGATGA
TAAGAGAGGTTTCTTGTATTCAGTATTGCT 
in wbO6, Pbla fused to primer LG1  
LG16 GCTCTAGAGCGTTTCTTGTATTCAGTATGCT in wbO6, XbaI restriction site fused to 
primer LG1  
 
4. Chemicals and enzymes used in this study 
The chemicals and enzymes used in this work were provided by the following 
companies: 
Amersham Biosciences, Buckinghamshire; Clontech, Heidelberg; Difco, Augsburg; 
Fluka, Deisenhofen; Invitrogen, Karlsruhe; MBI Fermentas, St. Leon-Rot; Merck, 
Darmstadt; Molecular Probes, Poort Gebouw; New England Biolabs, Frankfurt am Main; 
Oxoid, Wesel; Pharmacia Biotech, Promega, Heidelberg; Quiagen, Hilden; Roche 
Diagnostics, Mannheim; Roth, Karlsruhe; Sigma, Deisenhofen; Schleicher & Schuell, 
Dassel; Stratagene, Heidelberg. 
The following kits are used: 
- “ECLTM Direct Nucleic Acid Labeling And detection System”,  Amersham Biosciences, 
Buckinghamshire 
- “PRISMTM BigDyeTerminator-Cycle Sequenzierkit“, PE Applied Biosystems, 
Weiterstadt 
- “Expand Long Template PCR System“, Roche, Mannheim 
- “pGEM® T-Easy Vector System I”, Promega, Heidelberg 
- “QIAquick Gel Extraction Kit”, Qiagen, Hilden 
- “QIAGEN Midi And Maxi Kit“, Qiuagen, Hilden 
- “Gigapack III XL packaging mixture”, Stratagene, Heidelberg 
- “EnzCheck® Protease Assay Kit“, Molecular Probes, Leiden 
 
5. Equipments 
 
- Autoclave     Webeco 
- Camera     Nikon F301 
- Centrifuge     Heraeus Biofuge 13R 
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      Heraeus Megafuge 1.0R 
      Eppendorf 5415 C 
      Beckman J 2-21 
- Cleanbench      Nunc Inter Med 
- Computer program    Microsoft Office 2000 
- Electronic balance    Chyo Balance Corp. 
- Electrophoresis chamber   Bio Rad 
- Electroporator    BioRad, Gene Pulser transfection 
- X-ray films, autoradiography  Hyperfilm, ECL 
- Fluorescence imager    Typhoon 8300 
- Freezer     Revco 
- Gene linker     BioRad, Gel Doc 2000 
- Hot Plate     Eppendorf Thermostat 5320 
- Hybridization oven    HybAid 
- Ice machine     Scotman AF-20 
- Incubator     Mammert Tv40b 
      Heraeus B5050E 
- Magnetic strirrer    GLW 
- Micro pipettes    Gilson, Eppendorf 
- Microwave oven    Moulinex 
- Nylon membrane    Byodine, Nytran 
                                       Optitran BA-S 85 
- PCR-Thermocycler    Biometra, T3 Thermoblock 
- pH-Meter     WTW pH523 
- Photometer     Pharmacia Ultrospec 3000 
- Platform Shaker    Bühler E55 swip 
      Innova TM 4300 
- Power Supply    BioRad 200mA, 500V 
- Printer     Laserjet 2100C 
- Rotation mixer    Eppendorf mixer 5432 
- Scanner     HP ScanJet IIcx 
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- Sequence analyser    ABI Prism 310 Genetic Analyzer 
- Shaker     GLW 
      GFL Wasserbad 
      Innova TM 4300 
- Speedvac-concentrator   UNIVAPO 150H Uniequipe 
- Sterile filter     Schleicher & Schuell 0.22µm 
- Fluorescence imager    Typhoon 8600 
- Vacuum-blotter    Pharmacia 
- Vacuum oven    Heraeus instruments VTR 5036 
- Video printer    Mitsubishi, Cybertech Cb1 
- Vortexer     GLW  
- Water bath     GLW 1083 
 
6. Media and supplements 
 
- Distilled water was used for all media. 
- All media were autoclaved for 20 minutes. 
- For agar plates, 15 g bacteriological agar (Difco Laboratories, Detroit, MI, USA) per 
one liter of medium (15  % (w/v)) was added before autoclaving. 
 
6.1 LB- (Luria-Bertani-) medium (Sambrook et al., 1989)  
 
Tryptone 10 g 
Yeast Extract 5 g 
NaCl 5 g 
dH2O add 1000 ml; pH 7.5 
 
6.2 X-Gal medium 
 
LB-medium supplemented with the following additives: 
IPTG (0.1 M) 0.5 ml/l 
X-Gal (2  %, (w/v) in N,N'-dimethylformamide) 3 ml/l 
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6.3 Yeast-tryptone medium (YT) 
 
Tryptone 16 g 
Yeast extract 10 g 
NaCl 10 g 
dH2O add 1000 ml  
 
6.4 Medium for detection of aerobactin expression (Braun, et al., 1983; Ott, et al., 
1991) 
 
Aerobactin agar plates: 
Nutrient broth 4 g 
NaCl 2.5 g 
Agar 6 g 
Dipyridyl (200 mM) 5 ml 
Titriplex (10 mM) 5 ml 
dH2O add 500 ml 
Soft agar for aerobactin agar plates: 
Nutrient broth 0.8 g 
NaCl 0.5 g 
Agar 0.75 g 
Dipyridyl 200 mM 1 ml 
Titriplex 10 mM 1 ml 
E. coli strain EN99 
overnight culture (YT, 
Tc) 
4 ml 
dH2O add 100 ml 
 
 6.5 M9 medium 
 
The M9 salts, 1M MgCl2, 1M CaCl2 were autoclaved separately and added to the 
autoclaved and pre-cooled (45 °C) dH2O, supplemented with 15  % (w/v) agar. The 
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casamino acids, glucose and thiamine stock solutions were prepared in dH2O, filter 
sterilized (0.22 µm) and added to the autoclaved pre-cooled dH2O supplemented with 15  
% (w/v) agar and M9 salts. 
 
 
5 × M9 salts: 
Na2HPO4 × 2 H2O 
KH2PO4 
NaCl 
NH4Cl 
H2O 
 
60 g 
15 g 
2.3 g 
5 g 
add 1000 ml 
casamino acids (10  %) 30 ml 
1M MgCl2 2 ml 
1M CaCl2 0.1 ml 
Glucose (20  %) 10 ml 
Thiamine (0.2  %) 1 ml 
dH2O add 750 ml 
 
6.6 Congo red medium 
 
The congo red and Coomassie brilliant blue stock solutions were sterilized by filtration 
through a 0.22 µm sterile filter and added to the autoclaved medium. 
Trypton 10 g 
Congo-red (0.4 mg/ml) 1 ml 
Coomassie brilliant blue (0.2 mg/ml) 1 ml 
dH2O add 1000ml 
 
6.7 Antibiotics 
 
Stock solutions of water soluble antibiotics were prepared in distilled H2O and sterilized 
by filtration through a 0.22 µm sterile filter. The ethanol soluble antibiotics were 
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dissolved in 96 % ethanol. All antibiotics were added after cooling the medium to 45 °C 
in ratio of 1:1000 (v/v) from the stock solution. 
 
Antibiotics Stock solution (µg/ml) 
Ampicillin 100 
Chloramphenicol 30 
Kanamycin 50 
Streptomycin 50 
Tetracycline 15 
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IV. Methods 
 
-If not explicitly mentioned, an Eppendorf (Centrifuge 5415 C) table centrifuge has been 
used (13 000 rpm) for centrifugation. 
 
1. Construction of a cosmid genomic library of the E. coli strain Nissle 1917 and 
selection of clones 
 
1.1 Construction of a cosmid genomic library of the E. coli strain Nissle 1917 
 
The cosmid library has been constructed using the Gigapack III XL packaging mixture 
(Stratagene), following the instructions of the manufacturer (Blum-Oehler, G., and 
Waldtschmidt, A., personal communication), using E. coli XL1-blue MR as a host strain. 
 
1.2 Screening of the genomic cosmid library by colony blot hybridisation 
 
The cosmid clones were grown overnight on LB agar plates, supplemented with 
ampicillin. After cooling to 4 °C, the colonies were transfered from the agar plate to 
nylon membrane (Biodyne B, 0.45 µm). The bacterial cells were lysed and the DNA was 
denaturated by laying the membranes (with the colonies on the upper side) for 5 min on 
Whatman filter paper saturated with solution I. After short drying, the membranes were 
laid on Whatman filter paper saturated with neutralization solution 2 for 5 min. The DNA 
was fixed by “baking” for 30 min at 80 °C and afterwards the membranes were incubated 
in solution III for 6-12 h at 37 °C. After removal of  the cell debris for 1 min in 2 × SSC 
the colony blots were ready for hybridization. 
 
 
 
 
 
 
 
Solution I 0.5 N NaOH; 1.5 M NaCl 
Solution II 0.5M Tris-HCl, pH 7.5; 1.5M NaCl 
Solution III 50 mM Tris-HCl, pH 7.5; 50 mM NaCl 
0.1 % SDS; 100 µg/ml proteinase K 
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1.3 Screening the genomic cosmid library by PCR 
 
The cosmid clones from one agar plate were collected after overnight growth and 
suspended in 1 ml sterile dH2O. The suspension was heated for 10 min at 90 °C and 
stored at -20°C. For performing the screening PCR (50 µl reaction volume), 1µl of the 
cell suspension of every plate was used as template. 
 
1.4 Screening the genomic cosmid library by dot blots 
 
Cosmid DNA was isolated as described in IV.2.1.1 and precipitated by addition of 0.7 vol 
isopropanol followed by incubation on ice for 15 min and 15 min centrifugation. The 
DNA pellet was washed once with 70 % ethanol (v/v) and dried at 37° C. After 
dissolving the DNA in 20 µl sterile dH2O, 5 µl were transfered to a nylon membrane 
(Biodyne B, 0.45 µm) by pipetting. The DNA was then denaturated and neutralized as 
described above (see section IV.1.2). The cosmid DNA was fixed to the membrane by 
exposure to UV for 90 sec. After pre-incubation for 5 min in 2 × SSC, the membranes 
were ready for hybridization. 
 
Solution I 50mM Tris-HCl pH 8.0; 10 mM EDTA; 100 µg/ml RNaseA 
Solution II 0.2 N NaOH; 1 % SDS 
Solution III 3 M Na-acetate 
 
2. Isolation of DNA 
 
2.1 Isolation of plasmid (cosmid) DNA 
 
2.1.1 Small-scale preparation of plasmid DNA (Sambrook, et al., 1989) using      
phenol-chloroform extraction and ethanol precipitation 
 
Bacteria were grown overnight in 5 ml of LB medium supplemented with ampicillin. 1.5 
ml of the overnight culture was centrifuged for 2 min. The pellet was resuspended in 100 
µl of ice-cold solution I by vigorous vortexing. 200 µl of freshly prepared solution II 
were added, mixed with the cell suspension by inverting the Eppendorf tube and 
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incubated on ice for 5 min. After addition of 150 µl ice-cold solution III and carefully 
mixing by inverting, the tube was stored for 5 min on ice. Cell debris and chromosomal 
DNA were pelleted by centrifugation (15 min) and the supernatant was transfered to a 
new Eppendorf tube. After transferring the plasmid DNA into a new Eppendorf tube, 1 
vol phenol:chloroform:isoamylalcohol (25:24:1, v/v/v) was added, carefully mixed and 
centrifuged for 5 min. The supernatant was transfered into a new tube and 1 vol 
chloroform:isoamylalcohol (24:1, v/v) was added. After careful mixing by inverting the 
tube and centrifugation for 5 min the supernatant was transfered into a new tube. The 
DNA was precipitated by addition of 2.5 vol 96 % ethanol followed by 15 min incubation 
on ice. The DNA was then pelleted by 15 min centrifugation and washed two times with 
70 % (v/v) ethanol. The pellet was dried at 37 °C, dissolved in 20 µl sterile dH2O. and 
stored at -20 °C. 
 
2.1.2 Large-scale preparation of plasmid (cosmid) DNA (Sambrook et al., 1989, 
modified) 
 
Bacteria were grown overnight in 50 ml LB medium supplemented with appropriate 
antibiotics. The cells were harvested by centrifugation for 15 min at 4 °C and suspended 
in 4 ml solution I (see section IV.1.4) supplemented with 5 mg/ml lysozyme. After 5 min 
incubation at room temperature (RT), 8 ml solution II (see section IV.1.4) was added and 
carefully mixed by inverting. The mixture was incubated for 10 min on ice (or until the 
solution became clear), and then 6 ml solution III (see section IV.1.4) were added. The 
cell debris and the genomic DNA were precipitated by centrifugation for 30 min. at 4°C. 
The supernatant was transfered to a new tube. The plasmid DNA in this solution was 
precipitated by addition of 0.7 vol isopropanol and collected after 30 min incubation at 
RT by centrifugation for 15 min. The pellet was washed with 2 ml 70 % ethanol and 
transfered to new Eppendorf tube. After centrifugation and drying at 37 °C, the pellet was 
dissolved in 0.5 ml sterile dH2O and subsequently 50 µl 3 M Na-acetate were added. The 
solution was subjected to phenol- and phenol/chloroform extractions and ethanol 
precipitation as described above (section IV.2.1.1). Finally, the plasmid (cosmid) DNA 
was dissolved in 100 µl sterile dH2O. 
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2.2 Isolation of genomic DNA (Grimberg, et al., 1989) 
 
Bacteria were cultivated overnight and cells from 1 ml culture were harvested by 
centrifugation for 2 min in an Eppendorf tube. After washing with 1 ml TNE buffer the 
cells were centrifuged for 5 min and then suspended in 270 µl TNEX solution. 30 µl 
lysozyme (5 mg/ml) were  added and the cells were incubated for 30 min at 37 °C. 
Afterwards, 15 µl proteinase K (20 mg/ml) were added and further incubated for 1-2 h at 
65 °C (or until the solution became clear). The genomic DNA was precipitated by 
addition of 0.05 vol 5 M NaCl (15 µl) and 500 µl ice-cold ethanol and then collected by 
centrifugation for 15 min. After washing two times with 1 ml 70 % (v/v) ethanol, the 
DNA pellet was dried on air and dissolved in sterile dH2O. 
 
TNE 10 mM Tris-HCl, pH 8.0; 10 mM NaCl ; EDTA, pH 8.0 
TNEX TNE; 1 % (v/v) Triton X-100 
 
2.3 Isolation of high molecular weight genomic DNA for pulsed-field gel 
electrophoresis (PFGE) 
 
The bacteria were grown overnight in 10 ml LB medium at 37 °C. 4 ml of the culture 
were harvested by centrifugation and the pellet was washed two times with SE buffer. 
After resuspending the cells in 1 ml SE, the OD600 was measured (100 µl cells + 900 µl 
SE buffer). When necessary, the OD600 had to be adjusted in the range between 0.6 and 
0.7. A 2 % LGT agarose solution was prepared and cooled to 45-50 °C. 900 µl of the 
bacterial suspension were mixed with 900 µl agarose and poured into appropriate moulds 
by pipetting. After solidifying at 4 °C, the agarose blocks were cut in pieces with an 
approximately identical size (0.5 × 0.3 × 0.1 cm), and then incubated in 5 ml NDS 
solution (freshly supplemented with 2 mg/ml proteinase K) overnight at 50 °C on a 
shaker. For the complete removal of the proteinase K, the blocks were afterwards washed 
at least four times for 2 h with TE buffer. The blocks were then stored at 4 °C in TE 
buffer for at least one week before they could be used for restriction. 
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SE buffer 75 mM NaCl; 25 mM EDTA, pH 7.5 
TE buffer 10 mM Tris-HCl, pH 7.5; EDTA, pH 7.5 
NDS buffer N-laurylsarkosine; EDTA, pH 9.5; proteinase K (2 mg/ml) 
LGT buffer Tris-HCl, pH 7.5; MgCl2; EDTA, pH 7.5; LGT agarose 2 % 
 
3. DNA 
 
3.1 DNA agarose gel electrophoresis 
 
3.1.1 Horizontal gel electrophoresis 
 
For routine analytical and preparative separation of DNA fragments, horizontal gel 
electrophoresis was performed under non-denaturing conditions. Depending on the size 
of the DNA fragments to be separated, the agarose concentration varied between 0.8-2 % 
(w/v) in running buffer (1 × TAE or 1 × TBE). In order to have a visible running front 
and to prevent diffusion of the DNA, 0.2 vol Stop-Mix was added to the samples before 
loading. The electrophoresis was carried out using a voltage in the range between 16-120 
V. The gels were stained in an ethidium bromide solution (10 mg/ml), then washed with 
water and photographed under a UV-transilluminator.  
 
50 × TAE buffer: 
Tris 
Acetic acid 
0.5 M EDTA, pH 8.0 
dH2O 
 
242 g 
57.1 ml 
100 ml 
add 1000 ml 
10 × TBE buffer: 
Tris 
Boric acid 
0.5 M EDTA, pH 8.8 
dH2O 
 
108 g 
55 g 
40 ml 
add 1000 ml 
10 × Stop-Mix: 
Bromphenol blue 
 
0.25 % 
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Xylene cyanol  
Ficoll type 400 
0.25 % 
25 % 
 
3.1.2 Isolation of DNA fragments from agarose gel (“QIAquick® Gel Extraction 
Kit”) 
 
The agarose pieces containing the DNA fragment of interest were cut out of the gel, and 
subsequently melted for 10 min at 50 °C in QG buffer (supplied by the manifacturer). 
The DNA was separated from the rest of the solution by applying the mixture to 
QIAquick® spin columns followed by centrifugation for 1 min. The columns were then 
washed with 750 µl PE buffer (supplemented with ethanol). Then the PE buffer was 
completely removed by centrifugation (2 × 1 min). Finally, the DNA was by eluted from 
the column with 20-50 µl sterile dH2O. 
 
3.1.3 Determination of the DNA concentration 
 
The DNA concentration was measured at 260 nm in quarz cuvettes with a diameter of 1 
cm. An absorption A260=1 corresponds to 50 µg/ml double-stranded DNA or 33 µg/ml 
single-stranded oligonucleotides. The purity of the DNA was determined by measuring 
the absorption of the sample at 280 nm. DNA is sufficiently pure if the ratio A260/A280 is 
higher than 1.8. 
 
3.1.4 Pulsed field gel electrophoresis (PFGE) 
 
High molecular weight DNA (see section IV.2.3) was separated on an 0.8 % (w/v) 
agarose gel (1 × TBE buffer; see section IV.3.1.1) by horizontal electrophoresis. The gels 
were run for 21-24 h with pulse periods of 0.5-50 s. After staining in an ethidium 
bromide solution (10 mg/ml), the gels were photographed on UV-transilluminator. 
 
 
3.1.5 DNA gel size markers 
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In order to determine the approximate size of the DNA fragments after gel 
electrophoresis, the following commercially available DNA size markers were used: 
 
Mass RullerTM DNA 
Ladder Mix 
(MBI Fermentas) 
Gene RulerTM DNA 
Ladder Mix 
(MBI Fermentas) 
Lambda Ladder 
PFGE Marker 
(New England 
Biolabs) 
Low Range PFGE 
Marker 
(New England 
Biolabs) 
Fragment Size bp Fragment Size bp Fragment Size kb Fragment Size kb 
1 10000 1 10000 1 1018.5 1 194.0 
2 8000 2 8000 2 970.0 2 145.5 
3 6000 3 6000 3 921.5 3 97.0 
4 5000 4 5000 4 873.0 4 48.5 
5 4000 5 4000 5 824.5 5 23.1 
6 3000 6 3500 6 776.0 6 9.42 
7 2500 7 3000 7 727.5 7 6.55 
8 2000 8 2500 8 679.0 8 4.36 
9 1500 9 2000 9 630.5 9 2.32 
10 1031 10 1500 10 582.0 10 2.03 
11 900 11 1200 11 533.5 11 0.56 
12 800 12 1031 12 485.0 12 0.13 
13 700 13 900 13 436.5 13 - 
14 600 14 800 14 388.0 14 - 
15 500 15 700 15 339.5 15 - 
16 400 16 600 16 291.0 16 - 
17 300 17 500 17 242.5 17 - 
18 200 18 400 18 194.0 18 - 
19 100 19 300 19 145.5 19 - 
20 80 20 200 20 97.0 20 - 
- - 21 100 - 48.5 - - 
 
3.2 DNA restriction 
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3.2.1 Restriction of plasmid or genomic DNA with restriction endonucleases 
 
The DNA was dissolved in dH2O and mixed with 0.2 vol 10 × reaction buffer and ca. 5 U 
of restriction enzyme(s), so that the final volume of the sample was 20 µl. The mixture 
was incubated at 37 °C or 30 °C, depending of the specific requirements of the 
enzyme(s). Whereas plasmid and cosmid DNA was digested for one or two hours, 
respectively, digestion of genomic DNA was carried out overnight. The reaction was 
stopped with 0.2 vol Stop-Mix (see section IV.3.1.1). When required, inactivation of the 
restriction enzyme(s) was carried out by heating for 20 min at 65 °C or by phenol-
chloroform extraction. 
 
3.2.2 Restriction of high molecular weight DNA 
 
LGT agarose blocks containing the high molecular weight DNA (see section IV.2.3) were 
transfered into a new Eppendorf tube. The blocks were preincubated 1 h at 50 °C in 1 ml 
1 × restriction buffer subsequently. Restriction was carried out overnight at 37 °C in an 
150 µl overall reaction mixture containing 1 × restriction buffer and 30 U restriction 
enzyme. 
10 × reaction buffer: 
Tris-acetate 
K-acetate 
Mg-acetate 
 
100 mM 
500 mM 
100 mM 
 
3.3 Southern blot analysis 
 
3.3.1 Vacuum southern blotting 
 
A nylon membrane (Biodyne B) of appropriate size was shortly preincubated in dH2O 
and then soaked for 10 min in 20 × SSC. Afterwards, DNA was transfered from an  
agarose gel to the membrane using a vacuum blotter (Amersham-Pharmacia) by applying  
a 50 mbar vacuum. DNA transfer from a pulsed-field gel required UV irradiation (for 
fragmentation of the high molecular weight DNA). The following solutions were applied 
on the surface of the agarose gel during the blotting procedure: 
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Depurinization solution 0.25 N HCl 8 min 
Denaturation solution 0.5 N NaOH; 1.5 M NaCl 8 min 
Neutralization solution 0.5 M Tris-HCl, pH 7.5; 1.5M NaCl 8 min 
20 × SSC 0.3 M Na-citrate, pH 7.0; 3 M NaCl 45 min – 1 h 
 
After DNA transfer, the nylon membrane was incubated for 1 min in 0.4 N NaOH and 1 
min in 0.25 M Tris-HCl, pH 7.5 (for neutralization). The membrane was then shortly 
dried and the DNA was fixed on the membrane by exposure to UV light. 
 
3.3.2 DNA labelling (“ECLTM Kit“, Amersham) 
 
For labelling of DNA probes the “ECLTM-Kit” (enhanced chemo luminescence) was 
used. The binding of a DNA probe to the complementary sequence on the nylon 
membrane was detected by chemo luminescence. Positively charged horseradish 
peroxidase molecules were mixed with the negatively charged DNA probe. Addition of 
glutaraldehyd covalently links the horseradish peroxidase molecules with the DNA 
probes. Reduction of H2O2 by the peroxidase requires the oxidation of luminol which 
results in light emission, which can be detected by suitable light-sensitive films, e.g. the 
Hyperfilm ECL. 
For labelling of the probe 0.1 µg DNA resuspended in 10 µl dH2O was denatured for  10 
min at 90 °C and cooled for 5 min on ice. Then 10 µl labelling reagent and 10 µl 
glutaraldehyd were added. The mixture was incubated for 10 min at 37 °C and then added 
to the hybridization reaction. 
 
3.3.3 Hybridization and detection of the membrane 
 
Hybridization of the membrane was carried out overnight at 42 °C in hybridization 
solution (10-15 ml), after the nylon membrane has been preincubated at 42°C in the 
hybridization solution for 1 h. On the next day, the membrane was washed twice for 20 
min at 42 °C with wash solution I and two times for 10 min at RT with wash solution II. 
The membrane was placed on Whatman paper to remove the rest of the wash solution, 
IV. Methods  54 
and then incubated for 1 min in 5-10 ml detection solution I and detection solution II 
provided with the kit and mixed immediately (1:1) before applycation to the membrane. 
The membrane was superficially dried on Whatman paper and packed in saran wrap 
avoiding air bubbles on the top surface of the membrane. Chemoluminescence was 
detected by exposure of the membrane to Hyperfilm ECL. The exposure time depended 
on the signal intensity. 
 
Wash solution 1 0.5 × SSC; 0.4 % (w/v) SDS 
Wash solution 2 2 × SSC 
 
3.4 Polymerase chain reaction (PCR) 
 
3.4.1 Standart PCR  
 
For routine PCR-amplification Taq DNA polymerase kits of different suppliers 
(QIAGEN, Invitrogen) were used. The reaction was performed in a final reaction volume 
of 50 µl. 
 
10 × DNA Taq polymerase buffer 5 µl 
20 mM dNTP mix 1 µl 
0.5 µg/µl primer 1 1 µl 
0.5 µg/µl primer 2 1 µl 
100 ng/µl template DNA or boiled cells 1 µl 
Taq DNA polymerase 0.15 µl 
25 mM MgCl2 2 µl 
dH2O 38.85 µl 
 
The PCR cycles were designed according to the annealing temperature of the individual  
primers and the length of the expected amplification product: 
Initial 
denaturation 
2 min, 95 °C 
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1. Denaturation 30 sec, 95 °C 
2. Annealing  30 sec (42-72 °C) 
3. Elongation 30 sec-5 min, 72 °C 
 
25-30 cycles 
4. Final 
elongation  
2 min, 72 °C  
 
3.4.2 Long distance PCR (Expand Long Template PCR system, Roche) 
 
When DNA fragments longer than 4 kb were amplified, or proof reading was required, 
the Expand Long Template PCR system was used, following the instructions of the 
manifacturer. For fragments longer than 10 kb high molecular weight genomic DNA was 
used as a template. For this purpose, a LGT agarose block prepared for PFGE was melt 
for 10 min at 65 °C in 100 µl dH2O. 10 µl of this mixture was used as a template, and the 
reaction was performed as follows: 
 
Initial 
denaturation 
1 min, 90 °C 
1. Denaturation 10 sec, 90 °C 
2. Annealing  30 sec, 52-68 °C 
3. Elongation 1-15 min, 68 °C  
 
25-30 cycles 
Final elongation  1-15 min, 68 °C  
 
3.4.2. Inverse PCR (IPCR) 
 
In order to amplify unknown DNA with the help of a small region of known DNA 
sequence inverse PCR was carried out. Amplification of unknown DNA flanking regions 
of a particular gene by IPCR requires previous digestion of genomic DNA and 
identification of the corresponding fragment which contains a part of the known sequence 
as well as unknown flanking sequences by Southern hybridization. The size of the 
required fragment should not exceed 1 – 3 kb to facilitate amplification by PCR. 
Genomic DNA was then digested with the chosen restriction enzymes. The sample was 
diluted and the restriction fragments were ligated in order to obtain circular DNA 
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fragments. PCR amplification was performed with primers complementary to the ones 
used for probe, using the circularized genomic DNA fragments as a template. 
 
3.5 Cloning procedures 
 
3.5.1 A/T cloning of PCR products using the pGEM-T® Easy vector system 
 
This kit enables rapid cloning of PCR fragments without digestion by overhanging  
adenine nucleotides at their 3' ends into a linearized vector that contains overhanging 5' 
terminal thymidine residues. pGEM-T® Easy vector allows cloning of DNA fragments in 
a multiple cloning site which is flanked by T7 and SP6 RNA polymerase promoters, 
respectively. This vector expresses the α-peptide of the β-galactosidase, thus enabling  
“blue-white” screening of successful DNA integration. The ligation reaction was 
performed overnight at 4 °C or for 2 h at RT and was prepared as follows: 
 
2 × T4 DNA ligation buffer 10 µl 
pGEM-T® Easy vector 1 µl 
PCR product 1-8 µl 
T4 DNA ligase 1 µl 
dH2O to final volume of 20 µl 
 
3.5.2 Cloning of DNA fragments digested with restriction enzymes 
 
DNA fragments digested with restriction enzymes were cloned in vectors that were cut 
with appropriate enzymes (“sticky ends ligation”). For ligation, digested vector and insert 
were mixed in a ratio of 1:3. The ligation reaction was performed overnight at 4 °C or 16 
°C, or for 2 h at RT and was prepared as follows: 
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Linearized vector 0.5-1 µl 
Restriction enzyme-digested DNA fragment 1-17.5 µl 
5 × T4 ligase buffer  2 µl 
T4 ligase (New England BioLabs), 2 U/ µl 1 µl 
dH2O to final volume of 20 µl 
 
When the vector and the insert were cut with only one restriction enzyme or for blunt end 
ligation, the ends of the linearized vector molecule were dephosphorylated before ligation  
using calf intestinal alkaline phosphatase in order to prevent religation of the vector. 
Removal of the 5'-phosphate residue was carried out by addition of 0.1 vol alkaline 
phosphatase buffer (ZnCl2 10 mM; MgCl2 10 mM; Tris-HCl (pH 8.3), 8 mM; H2Obidest.), 
1U alkaline phosphatase and incubation for 1 h at 37 °C. The reaction was stopped either 
by heating for 10 min at 65 °C or by phenol-chloroform extraction followed by ethanol 
precipitation of the DNA. 
 
3.5.3 Generation of blunt end DNA fragments 
 
For blunt end generation, the following reaction mixture was incubated for 30 min at 25 
°C. The reaction was stopped either by heating for 15 min at 65 °C or by phenol-
chloroform exctraction. 
 
dNTP mixture (0.5 mM of each 
nucleotide, dATP, dCTP, dGTP, dTTP) 
4 µl 
10 × Klenow buffer (Tris-HCl  pH 7.2 
 50 mM; MgSO4, 10 mM; DDT 0.1 mM; 
BSA, 50 mg/ml; dH2O) 
2 µl 
DNA dissolved in dH2O 12 µl 
Klenow DNA polymerase (5 U/ µl) 2 µl 
 
3.6 Transformation and conjugation of bacterial cells 
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3.6.1 Preparation of competent bacterial cells (CaCl2 procedure) and heat-shock 
transformation 
 
The bacteria were grown overnight and 1 ml of this culture were used for inoculation of a 
fresh 50 ml LB culture. The cells were then grown to an OD600 of 0.5 and incubated for 
30 min on ice. The culture was centrifuged for 5 min at 2000 × g at 4 °C and the pellet 
was resuspended in 17.5 ml ice-cold 0.1 M CaCl2 and incubated on ice for 30 min. After 
a second centrifugation, the cells were resuspended in 2.5 ml ice-cold 0.1 M CaCl2 and 
either used immediately for transformation, or prepared for freezing at – 80 °C by 
addition of 50% (v/v) glycerol. 
50 µl of competent cells were thawed on ice and ca. 100 ng of plasmid DNA was added 
for transformation. After incubation on ice for 30 min, the cells were incubated at 42 °C 
for 90 sec and then again placed immediately on ice for 5 min. 1 ml LB was added and 
the cells were incubated at 37 °C for 1 h, allowing the expression of the selection marker 
before the mixture was plated on selective LB agar. 
 
3.6.2 Preparation of electrocompetent cells and electroporation 
 
LB medium was inoculated with 500 µl of an overnight culture of the strain of interest 
and grown OD600 of 0.5. The cells were collected by centrifugation at for 10 min at 2000 
× g at 4 °C. The pellet was left on ice for 30 min and then washed with 50 ml ice-cold 
dH2O. After a second centrifugation step, at the same conditions the pellet was 
resuspended in 25 ml 10 % glycerol, centrifuged again and finally resuspended in 600 µl 
10 % (v/v) glycerol. The cells were stored as 50 µl aliquots at -80 °C. For electroporation,  
one aliquot was thawed on ice and mixed with ca. 0.5 µg DNA. The mixture was applied 
into a “Gene pulser” cuvette with an electrode gap of 0.1 cm and incubated for 10 min on 
ice. The cells were electroporated using a Gene pulser transfection apparatus (BioRad) at  
the following conditions: 2.0 kV, 600 Ω, 25 µF. 1 ml LB medium was added to the 
culture, and the mixture was transfered into a new tube and incubated at 37 °C for 1 h 
before the cells were plated on selective agar plates. 
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3.6.3 Conjugation 
 
For conjugation the E. coli strain Sm10λpir was used as donor strain in order to transfer 
the plasmid of interest to the recipient strain. Overnight cultures of the donor and 
recipient strain were used for inoculation of fresh cultures (1 % v/v), which were grown 
to an OD600=0.7. 100 µl of both cultures were then mixed on LB agar plate and grown 
overnight without selective pressure. Then, the cells were collected, properly diluted in 
sterile 0.9 % NaCl and plated on selective LB agar plates. 
 
3.7 DNA sequence analysis (AmpliTaq® FS-BigDye Terminator, PE Applied 
Biosystems) and annotation 
 
This method allows nucleotide sequence determination by the use of didesoxynucleotides  
(Sanger et al., 1977) which are each labelled with a different fluorescence dye and 
unmodified PCR primers are used. For a final reaction volume of 10 µl 4 µl “Premix” and 
10 pmol primers were used. The concentration of the DNA template varied between 0.1-1 
µg depending on the quality and the source (cosmid, plasmid, or PCR product). The 
sequencing reaction includes the following steps: 
 
Initial 
denaturation 
1 min, 96 °C 
1.Denaturation 30 sec, 96 °C 
2. Annealing  15 sec, 50-60 °C 
3. Elongation 4 min, 60 °C  
 
26-30 cycles 
Final elongation  4 min, 60 °C 
 
90 µl H2Obidest. (Merck), 250 µl 100 % ethanol and 10 µl 3 M Na-acetate (pH 4.6) were 
added after the reaction and the mixture was transfered to a new tube and centrifuged for  
15 min. The DNA pellet was washed with 70 % (v/v) ethanol, dried in a Speedvac 
concentrator, finally dissolved in 30 µl TSR (“Template Suppression” Reagent) and 
denatured for 2 min at 90 °C. 
The large-scale sequence determination of plasmid and cosmid clones was performed at  
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Göttingen Genomics Laboratory, Georg-August-Universität Göttingen. For this purpose, 
small insert libraries (2-2.5 kb) were generated by mechanical shearing of DNA (Oefner 
et al., 1996). After end repair with T4 polymerase, the fragments were ligated into the 
prepared pTZ19R vector. Isolated plasmids were sequenced from both ends using the dye 
terminator chemistry and analyzed on ABI337 sequencers (Applied Biosystems). The 
Phrap software implemented in the Staden software package was used for assembly and 
editing of the sequence data (Staden et al., 2000). 
 
3.8. Annotation of DNA sequences 
 
Homology searches as well as searches for conserved protein domains were performed 
with the BLASTN, BLASTX and PSI- and PHI-BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/) programs of the National Center for 
Biotechnology Information (NCBI) (Altschul et al., 1997). Putative ORFs were identified 
using Vector NTI® (InforMax) and the NCBI ORF finder 
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html) software. Prediction of membrane-
spanning regions of proteins was carried out with the TMpred software 
(http://www.ch.embnet.org/software/TMPRED_form.html). The sequences were 
submitted to the EMBL nucleotide sequence database. 
 
4. Isolation of lipopolysaccharides (LPS) and proteins 
 
4.1 Isolation of LPS 
 
The cells from 1 ml overnight culture were collected by centrifugation and treated as 
described for the isolation of genomic DNA (see section IV.2.2; Grimberg et al., 1989). 
After incubation with proteinase K, 600 µl phenol were added to the clear solution, 
carefully mixed and centrifuged for 10 min. The supernatant was transfered to a new tube 
and 20-50 µl were used for electrophoresis.  
 
4.2 Preparation of secreted proteins form culture supernatant 
 
IV. Methods  61 
10 ml overnight culture were centrifuged for 5 min at 13000 rpm (Eppendorf C5415 
centrifuge) and the supernatant was transfered to a new 15 ml tube. 1 g trichloroacetic 
acid (TCA) was added and mixed by vortexing until the TCA crystals were completely 
dissolved. After overnight incubation at 4 °C, the precipitated proteins were collected by 
centrifugation and dissolved in 100 µl 0.1 N NaOH. After heating for 10 min at 90 °C in 
loading buffer (see section IV.5.2) the samples could be analysed by PAGE as described 
above (see section IV.5.2). 
 
5. Analysis of LPS and proteins by polyacrilamyde gel electrophoresis 
 
5.1 Polyacrylamid gel electrophoresis (PAGE, Laemmli et al., 1970) 
 
Protein samples or isolated LPS were separated and analysed by polyacrylamide gels. 
The size of the gels was 15 × 17.5 × 0.5 cm, and the electrophoresis was performed at 
RT, overnight at 30 V in electrophoresis buffer. The samples were loaded on the 
concentration gel after heating for 10 min at 90°C in 4 × loading buffer. 
 
Separation gel (13 % (w/v)) 
30 % Acrylamyde, 0.8 % 
Bisacrylamyde 
13 ml 
1.5 M Tris-HCl, pH 8.8 7.3 ml 
dH2O 9 ml 
10 % SDS 300 µl 
APS (100 mg/ml) 150 µl 
TEMED  10 µl 
Collecting gel (5 % (w/v)) 
30 % Acrylamyde, 0.8 % 
Bisacrylamyde 
2.7 ml 
1.5 M Tris-HCl, pH 8.8 4 ml 
dH2O 9 ml 
10 % SDS 160 µl 
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APS (100 mg/ml) 160 µl 
TEMED  8 µl 
10 × Electrophoresis buffer 
Tris 30 g 
Glycin 144.4 g 
10 % SDS 100 ml 
dH2O to a final volume of 1000 ml 
4 × Loading buffer 
0.25 M Tris-HCl, pH 6.4 2.5 ml 
SDS 0.25 g 
EDTA 4 mg 
86 % Glycerin (w/v) 4 ml 
β-Mercaptoethanol 0.5 ml 
Bromphenol blue  0.4 mg 
dH2O to a final volume of 10 ml 
 
5.2 Staining of proteins in polyacrylamide gels with Comassie Brilliant Blue 
(Laemmli et al., 1970) 
 
After electrophoresis the polyacrylamide gels were incubated for 2 h in 1 % (w/v) 
staining solution. Protein bands were visualized by destaining the gel in destaining 
solution for 2-6 h. 
Staining solution 
Coomassie Brilliant 
Blue 
1 g 
Destaining solution 100 ml 
Destaining solution  
Acetic acid 100 ml 
dH2O  500 ml 
Methanol 400 ml 
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5.3 Staining of proteins or LPS in polyacrylamide gels with silver nitrate (Tsai et al., 
1982) 
 
After electrophoresis, the polyacrylamide gels were stained with AgNO3. All used 
devices were carefully washed with 70 % ethanol. The gels were fixed overnight in 100 
ml 1 × fixation solution. The next day, the solution was replaced by 100 ml 1 × periodate 
solution and the gels were incubated for 5 min. After that the gels were washed three 
times for 30 min with dH2O. Then the gels were incubated for 10 min in silver nitrate 
solution and subsequently washed three times for 10 min with dH2O. The gels were 
developed in developing solution preheated to 60 °C, and when the intensity was 
satisfying, the reaction was stopped by washing with 50 mM EDTA solution for 10 min. 
 
2 × fixation solution 
Isopropanol 250 ml 
Acetic Acid 70 ml 
dH2O to final volume of 500 ml 
Periodate solution 
Na m-periodate (NaIO4) 0.87 g 
1 × Fixation solution 100 ml 
Silver nitrate solution 
1 M NaOH 1.4 ml 
NH3 (33 %) 1 ml 
dH2O  70 ml 
20 % AgNO3 1.25 ml 
Developing solution 
2.5 % Na2CO3 100 ml 
40 % Formaldehyde  27 µl 
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6. Western blot analysis of proteins 
 
For the preparation of crude cell extracts, 1 ml overnight culture was adjusted to an 
OD600=1. The cells were harvested by centrifugation for 5 min at 13000 rpm (Eppendorf 
C5415 centrifuge) and the pellet was resuspended in 100 µl TE buffer and 25 µl 5 × 
Laemmli buffer. After heating the mixture for 10 min at 90 °C the cell debris was 
collected by centrifugation for 5 min. The supernatant was transferred to a new tube and 
used for PAGE. After PAGE, separated proteins were transfered to a nitrocellulose 
membrane (Schleicher & Schuell BA S85 reinforced, 0.45 µm). The transfer of the 
proteins was carried out between two graphite plates in western blotting apparatus, using 
12 Whatman paper slices, soaked with Anode buffer I, II or Cathode buffer. The 
membrane was incubated for 15 min in Anode buffer II. The lower graphite plate (anode) 
was moistened with water and covered with 6 slices of Whatman paper soaked with 
Anode buffer I, followed by 12 slices of Whatman papers soaked with Anode buffer II. 
At the upper side of the whatman papers the nitrocellulose membrane was laid, followed 
by the polyacrylamide gel and 3 slices of  Whatman paper soaked in Cathode buffer. The 
air bubbles were carefully removed before laying the second graphite plate at the top 
(cathode). The transfer was carried out applying an electric current of 0.8 mA/cm2 for 1 h 
at RT. 
 
Anode buffer I 0.3 M Tris, 20 % methanol 
Anode buffer II 25 mM Tris, 20 % methanol 
Cathode buffer 25 mM Tris, 40 mM ε-amino-n-caprone acid, 20 % methanol 
 
7.  Hybridization and detection of proteins by antibody reaction 
 
After the transfer the proteins the membrane was incubated for 1 h at RT in TBST 
solution (0.05 M Tris-HCl, pH 7.5; 0.15 M NaCl; 0.05 % Tween 20) supplemented with 
10 % fat-free dry milk. Then, the blot was incubated with antibody 1 for 1 h at RT. The 
concentration of antibody 1 depended on the titre of the serum which was diluted in 
TBST supplemented with 1 - 3 % dry milk. After washing the membrane with TBST 
three times for 5 min, the solution (diluted 1:100) containing the secondary antibody 
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(peroxidase-conjugated) was added and incubated for 1 h at RT. Finally, the membrane 
was washed three times for 10 min with TBST at RT. Signal detection was performed as 
described above (see section IV.3.3.3). 
 
8. Phenotypic assays 
 
8.1 Detection of microcin expression 
 
M9 medium agar  plates were prepared. 1 ml of an overnight culture of the E. coli strain 
DH5α was mixed with 100 ml M9 soft agar (0.75 %(w/v); see section III.6.5) media, pre-
cooled to 42 °C. A thin layer of (0.5 mm) of the mixture was poured on the surface of the 
M9 agar plates. The bacterial strains to be tested for microcin expression were grown 
overnight on the plates. Microcin production was assessed by the occurrence of clear 
zones of growth inhibition of the indicator strain DH5α around the colonies of the tested 
strains after overnight incubation at 37 °C. 
 
8.2 Detection of aerobactin expression 
 
Aerobactin media plates were prepared. 1 ml of an overnight culture (YT, Tc) of the 
indicator E. coli strain EN99 was mixed with 100 ml aerobactin soft agar (0.75 %(w/v), 
see section III.6.4) medium, pre-cooled to 42 °C. A thin layer (0.5 mm) of the mixture 
was poured on the surface of the aerobactin plates. The bacterial strains to be tested were 
grown overnight in 1 ml LB medium. Sterile susceptibility discs (Oxoid) were soaked 
with cells of the overnight culture and were placed on the aerobactin plates and incubated 
overnight at 37 °C. Aerobactin production was assessed by the presence of growth zones 
of the iron-deficient indicator strain EN99 around the colonies of the tested strains. 
 
8.3 Detection of type 1 fimbrial expression 
 
Overnight cultures of the strains to be tested and of a positive (E. coli strain Nissle 1917) 
and of a negative (E. coli strain AAEC189) control were grown. The mannose-dependent 
yeast agglutination assay was carried out by mixing 10 µl of the different bacterial 
overnight cultures with 10 µl yeast cells-suspension (1 mg/ml Saccharomyces cerevisiae 
IV. Methods  66 
cells diluted in 0.9 % (w/v) NaCl, with or without 2 % (w/v) mannose) on microscope 
slides (75:25:1 mm). The slides were kept on ice until the aggregation of bacterial and 
yeast cells was observed in absence of mannose. 
 
8.4 Detection of F1C fimbrial expression 
 
Overnight cultures of the strains to be tested and of a positive (E. coli strain Nissle 1917) 
and of a negative (E. coli strain AAEC189) control were grown. For the 
immunoagglutination assay a polyclonal α-F1C fimbriae rabbit antibody was used 
(provided by S. Kahn, Wuerzburg), that was diluted 1:1000 in 1 × PBS. The 
immunoagglutination assay was carried out by mixing 10 µl of the bacterial overnight 
culture with 10 µl of the α-F1C fimbriae antibody solution on microscope slides (75:25:1 
mm) and incubation on ice until the aggregation of the bacterial cells was clearly 
observed. 
 
1 × PBS  
NaCl 8g 
KCl 0.2 g 
Na2HPO4 1.4 g 
K2HPO4 0.24 g 
NaOH add to pH 7.4 
dH2O to a final volume of 1000 ml 
 
8.5 Serum resistance assay 
 
Serum resistance of E. coli strains was usually analyzed by incubating the bacteria in 90 
% human serum. An overnight culture of the bacteria was diluted 1:100 in LB and grown 
to 90 Klett units. The bacteria were diluted 1:10 in human serum and incubated at 37 °C. 
After 0 h, 1 h, 3 h, and 24 h, survival of the strains was tested by plating an aliquot on LB 
agar plates containing the appropriate antibiotic (Hughes, et al., 1982). In addition, to 
determine the serum resistance of strain Nissle 1917 after complementation with a single 
chromosomal copy of the wzy536 gene or with a plasmid-encoded entire wb*536 gene 
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cluster, growth of bacterial strains in 50 % human serum was also measured. Reactivity  
of the serum was routinely checked by incubation of the strains in heat-inactivated serum 
(56 °C, 30 min). After heat-inactivation, serum-sensitive strains multiplied in the heat-
inactivated serum but not in untreated serum. 
 
8.6 Detection of protease activity 
 
For the detection of serine-protease activity, the EnzCheck® Protease Assay Kit E-6638 
(Molecular Probes) was used following the instructions of the manifacturer. Briefly, 
casein derivatives, heavily labelled with pH-sensitive green-fluorescent BODI®PY FL 
dye, were used as a substrate. Protease-catalyzed hydrolysis releases highly fluorescent 
BODI®PY FL peptides, and the corresponding fluorescence proportional to the protease 
activity was measured using the fluorescence imager “Typhoon 8600”. 5 ml LB culture 
were inoculated with 50 µl of an overnight culture of the strain to be tested and then 
grown to OD600=0.6, the cells were collected by centrifugation for 5 min and diluted 
1:100 in LB. 95 µl from the diluted cells were used for performing the reaction in a 
microtiter plate. 5 µl of the substrate solution (10 µg/ml BODI®PY FL in the supplied 1 × 
digestion buffer) were added and the mixture was incubated for 1 h at RT protected from 
light. The fluorescence was measured at wavelength of 500 nm. 
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V. Results 
 
1. Analysis of the genome structure of E. coli strain Nissle 1917 
 
1.1 Characterization of the E. coli strain Nissle 1917 genome by PFGE 
 
In order to perform a genome-wide comparison between the three investigated E. coli 
O6 strains, a genomic restriction analysis by PFGE was used. As shown in Fig. 6a the 
E. coli strains Nissle 1917 and CFT073 exhibited similar genomic restriction patterns 
when digested with one of the restriction enzymes NotI, XbaI and SfiI. This indicates 
a common clonal origin of these strains. Nevertheless, some differences in the 
restriction pattern were evident, which is not surprising, since both strains differ in the 
presence of at least one genomic island (pheU-associated GEICFT073) and having in 
mind that also minor genetic events like single nucleotide differences or gene 
rearrangements and deletions may significantly alter the genomic restriction pattern. 
The restriction pattern of strain 536 differed more significantly from that of strain 
Nissle 1917 than the one of strain CFT073.  
In addition, the enzymes CeuI and AvrII were used to compare the genomic restriction 
pattern of the three E. coli O6 isolates. As seen form Fig. 6b the AvrII-specific 
restriction patterns of the investigated strains differed significantly, but no 
considerable differences were observed between the strains when digested CeuI and 
AvrII together or with AvrII alone. The restriction enzyme CeuI cuts the E. coli 
chromosome specifically in the ribosomal RNA operons (7 restriction sites), whereas 
AvrII cuts 16 times in the E. coli strain MG1655 genome and 30 times in the genome 
of E. coli strain CFT073. At least two Nissle 1917-specific aditional AvrII restriction 
sites were identified in the sequence of GEI IINissle 1917 (see section V.2.2).  
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Fig. 6. Restriction analysis of genomic DNA of different E. coli strains by PFGE. A. lane 1, Low 
Range PFGE Marker; lane 2, Lambda Ladder PFGE Marker; lane 3, NotI-digested DNA of E. coli 
strain MG1655; lane 4, NotI-digested DNA of E. coli strain Nissle 1917; lane 5, NotI-digested DNA of 
E. coli strain CFT073; lane 6, NotI-digested DNA of E. coli strain 536; lane 7, XbaI-digested DNA of 
E. coli strain MG1655; lane 8, XbaI-digested DNA of E. coli strain Nissle 1917; lane 9, XbaI-digested 
DNA of E. coli strain CFT073; lane 10, XbaI-digested DNA of E. coli strain 536; lane 11, SfiI-digested 
DNA of E. coli strain MG1655; lane 12, SfiI-digested DNA of E. coli strain Nissle 1917; lane 13, SfiI-
digested DNA of E. coli strain CFT073; lane 14, SfiI-digested DNA of E. coli strain 536; lane 15, 
Lambda Ladder PFGE Marker. B. lane 1, Lambda Ladder PFGE Marker; lane 2, CeuI-digested DNA 
of E. coli strain MG1655; lane 3, CeuI-digested DNA of E. coli strain Nissle 1917; lane 4, CeuI-
digested DNA of E. coli strain CFT073; lane 5, CeuI-digested DNA of E. coli strain 536; lane 6, 
CeuI/AvrII-digested DNA of E. coli strain MG1655; lane 7, CeuI/AvrII-digested DNA of E. coli strain 
Nissle 1917; lane 8, CeuI/AvrII-digested DNA of E. coli strain CFT073; lane 9, CeuI/AvrII-digested 
DNA of E. coli strain 536; lane 10, AvrII-digested DNA of E. coli strain MG1655; lane 11, AvrII-
digested DNA of E. coli strain Nissle 1917; lane 12, AvrII-digested DNA of E. coli strain CFT073; lane 
13, AvrII-digested DNA of E. coli strain 536; lane 14, Low Range PFGE Marker. 
 
1.2 Genome-wide tRNA screening 
 
Since tRNA genes are common sites for chromosomal integration of foreign DNA 
elements, a PCR-based screening for sequence context alterations of tRNA genes of 
the E. coli strains Nissle 1917 and 536 was carried out, using primers which are 
binding within the ORFs located up- and downstream of tRNA genes in the genome 
of the E. coli MG1655. Usually monocistronic tRNA genes as well as the most 
promoter distal tRNA gene of polycistronic operons have been included into this 
study. tRNA-genes located within tRNA-encoding operons have not been included 
into the tRNA-screening (Dobrindt, U., unpublished). In several cases in which no 
PCR product was obtained with E. coli K-12-specific primers, primer pairs were used 
which allow amplification of the E. coli strain CFT073- or EDL933-specific sequence 
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context of the specific tRNA gene of interest. For some of the tRNA genes of interest 
the corresponding upstream genes were amplified and used as probes for dot blot 
screening of the genomic cosmid library of strain Nissle 1917. In several cases in 
order to obtain sequence information of unknown DNA regions flanking tRNA gene 
of interest, inverse PCR (IPCR) was carried out. The results from the tRNA screening 
approach are summarized in Tab. 5. Generally, an unexpectedly high degree of 
similarity of the genome organization of E. coli strain Nissle 1917 with that of the 
uropathogenic strain CFT073 and only to a lesser extent to that of the uropathogenic 
strain 536 was observed. 
 
Table 5: Identification of chromosomally inserted putative horizontally acquired DNA 
regions by a PCR-based tRNA screening of the E. coli Nissle 1917 and 536 genome. 
     
Strain 
 
tRNA 
gene 
MG1655 
(K-12 
primers) 
536 
(K-12 
primers) 
Nissle 
1917 
(K-12 
primers) 
Upstream 
located gene 
Downstream 
located gene 
(Nissle 1917) 
Cloning  
strategy 
(Nissle 1917)  
argQ  + - - csrA c3247 IPCR 
glnX + + +    
lysQ + (+) (+) ybgF  IPCR 
thrT + + +    
glyU + - - b2865 c3442 PCR 
serU + - - b1976 c2416 PCR 
asnT + - - b1976 HPI pCos220 
asnW + (+) (+)    
asnU + + +    
argW + - - yfdC c2893 pCos1YA7 
argU + - - fimZ   
wrbA + + +    
ssrA + + +    
serW + (+) +    
serT + + +    
lysV + (+)smaller (+)smaller gltX  IPCR 
proK + (+)smaller (+)smaller    
proL + - - yejM   
pheV + - - yqgA Z4313  PCR 
pheU + + +    
metY + + +    
leuU + + +    
asnV + - - nac c2445  PCR 
ileY + + +    
proM + + +    
metV + - - purU c3385 PCR 
leuZ + + +    
leuV + + +    
glyY + + +    
valW + + +    
tyrV + + +    
serW + (+) (+)    
alaX + + +    
serX + - - ycdW, csg  c1291  PCR 
leuX + - - yjgB c5371 IPCR 
thrW + - - proA c0391 IPCR 
aspV + - + dnaQ c0253 PCR 
selC + - - yicK ∆P4 integrase pCos8YA1 
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Results from the tRNA screening indicate that 15 of 37 studied tRNA genes serve as 
integration sites of foreign DNA in the genome of E. coli strain Nissle 1917.  
Interestingly, the strains Nissle 1917 and 536 exhibited almost an identical “tRNA-
screening pattern”, indicating that the same tRNA genes in both strains are target sites 
for chromosomal insertion of horizontally acquired DNA. However, the genetic 
structure and the size of the integrated fragments differ dramatically, e. g. in the case 
of the selC, leuX, thrW, serX, and pheV tRNA genes (Dobrindt et al., 2002). Most of 
the regions located immediately downstream of the tRNA genes in the genome of 
Nissle 1917 which are not identical to those of strain MG1655 seem to be identical to 
those in the E. coli strain CFT073, which indicates a possibly similar DNA content 
and organization of the horizontally acquired DNA in the latter two strains.  
A 100 kb aspV-associated genomic island, containing a determinant coding for a 
putative member of the RTX toxin family (upxBDA)  is present in the genome of 
CFT073 (Welch et al., 2002). Using primers derived from the E. coli strain CFT073 
sequence, a CFT073-specific aspV PCR product of about 10 kb was detected only in 
the strains CFT073 and Nissle 1917, but not in strain 536, for which an E. coli K-12-
specific PCR product was detected (Tab. 5). In addition, the upxBDA gene cluster was 
successfully amplified (using the primers upx-up, upx-up1, upx-down and upx-
down1) from genomic DNA of the strains CFT073 and Nissle 1917, but not from 
genomic DNA of strain 536. This is an indication that the aspV-associated genomic 
island of E. coli strain CFT073 is at least partially present in the genome of strain 
Nissle 1917, but absent from the genome of strain 536. Interestingly, the strains 
Nissle 1917 and 536 do not posses pheU-associated island (Tab. 5), whereas a pheU-
associated island is present in the genome of strain CFT073 which carries a pap 
fimbrial determinant. No PCR product for the 536-specific argW tRNA-encoding 
gene was obtained when either E. coli K-12- or strain CFT073-specific primers were 
used. 
 
2. Characterization of genomic islands of E. coli strain Nissle 1917 (GEI I – 
IVNissle 1917) 
 
In this work four genomic islands have been detected and characterized in the 
genome of E. coli strain Nissle 1917. These islands are located at tRNA-encoding 
V. Results 72
genes (serX, pheV, argW , asnT; Fig. 7), and contain determinants coding for known 
fitness-conferring factors, as well as putative fitness factors, mobility genes, ORFs of 
unknown or putative functions. In addition several genomic islets, most of which 
localized in the core chromosome, coding for (putative) fitness-conferring factors 
have been partially characterized. 
 
 
Fig. 7: Chromosomal localization and gene content of E. coli Nissle 1917-specific genomic islands and 
islets. 
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2.1 Characterization of the Genomic Island I of E. coli strain Nissle 1917 
 (GEI INissle 1917) 
 
In order to identify a cosmid clone containing the entire microcin-encoding genetic 
determinants of Nissle 1917, the cosmid genomic library was screened by printing the 
clones on microcin detection plates. The microcin expressing cosmid clone 
pCos3YE4 was identified (Fig. 8) and further characterized.  
 
 
 
 
 
 
 
 
 
 
 
Using PCR and Southern hybridization analysis, it was demonstrated that the 
pCos3YE4 cosmid insert contains both mch and mcm microcin-encoding gene 
clusters (Patzer et al., 2003), the foc operon coding for F1C fimbriae synthesis, and 
the iro cluster encoding the salmochelin siderophore system (Hantke et al., 2003). 
The expression of F1C fimbriae by E. coli XL1-blue harbouring pCos3YE4 as well as 
by the fimbriae-negative E. coli strain AAEC189, when transformed with pCos3YE4, 
was demonstrated by immunoagglutination using an α-F1C polyclonal rabbit serum  
(Khan, S., personal communication).  
The structure and DNA content of the pCos3YE4 insert resembled those of PAI III536 
(Dobrindt et al., 2001; Fig. 9; Fig. 10), thus representing a possible genomic island. 
An overlapping clone (pCos2RA4) was identified, using primers specific for the 3'-
end of the pCos3YE4 insert (3YE4-1 and 3YE4-2; Fig. 9; see section VIII, Tab.2). 
Another cosmid overlapping with the 5' end of pCos3YE4 was also identified and 
shown to contain the serX tRNA gene. Since the structure of this genomic island 
Fig. 8: Identification of the microcin-producing cosmid clone pCos3YE4 (indicated by an arrow). 
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(GEI INissle 1917) was very similar to that of the serX-associated island in the genome of 
E. coli strain CFT073 (serX-associated GEICFT073; Welch et al., 2002), overlapping 
PCR reactions based on the E. coli strain CFT073 genome sequence were established, 
and used for amplification of the CFT073- and Nissle 1917-specific DNA regions 
between serX and iroC (ca. 30 kb; primers: 1A + 1B, 2A + 2B, 3A + 3B, 4A + 4B; 
Fig. 9). In the chromosome of E. coli strain CFT073 this region contains mostly 
putative ORFs coding for hypothetical proteins. The PCR products were subsequently 
sequenced and assembled with the available sequence data from the cosmid clones. 
The structure and DNA content of the entire 100 kb region located downstream of the 
serX tRNA-encoding gene is highly similar in both E. coli O6 strains. This genomic 
island contains several determinants which code for fitness-conferring traits  
(microcins, adhesion, iron uptake).
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Fig. 9: Characterization of GEI INissle 1917  A. Sequence analysis and structural organization of the ORFs located in  GEI INissle 1917. B. G+C content of 
the DNA in  GEI INissle 1917. 
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Fig. 10. Sequence alignment of  GEI INissle 1917 and PAI III536. The homologous regions between the two islands are depicted by interrupted lines. 
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The GEI INissle 1917 exhibits typical characteristics of genomic islands. It is associated 
with the serX tRNA gene, carries several mobility-related genetic elements as well as 
ORFs with unknown or putative function. The genetic organization of GEI INissle 1917 is 
partially similar to that of PAI III536, where also microcin-related ORFs (but not the 
entire mch/mcm gene cluster) are located together with the sfaI cluster (required for 
the biosynthesis of S-fimbriae) and the iro genes (Dobrindt et al., 2001; Schubert et 
al., 2003). Since foc and sfa code for members of one and the same fimbrial family 
and the structural similarity of both islands is high, it is tempting to consider them 
members of the “S-fimbrial PAI family ” with possibly similar evolutional origin. 
Nevertheless, there are significant differences in the DNA content of GEI INissle 1917 
and PAI III536  as well as in their chromosomal integration site which are serX and 
thrW, respectively. The tRNA screening approach indicated that thrW is another 
putative integration site for foreign DNA in the genome of Nissle 1917 (see section 
V.1.2). In addition, the PCR-based screening of the 40 kb E. coli strain MG1655-
specific region located downstream of thrW (thrW – yagU) was performed, since it is 
known that this DNA region represents the E. coli K-12 strains-specifc CP4-6 
prophage and is absent in non-K-12 wild type commensal or pathogenic E. coli 
strains (Dobrindt et al., 2001). The results indicated that this region is absent in the 
chromosome of E. coli Nissle 1917 just like in the chromosome of 536. 
 
2.2 Characterization of the Genomic island II of E. coli strain Nissle 1917  
(GEI IINissle 1917)  
 
The aerobactin gene cluster (iuc) is known to be located within different genomic 
islands on the chromosome of E. coli, Salmonella and Shigella strains as well as on 
plasmids (Purdy et al., 2001; McDougall et al., 1984; Moss et al., 1999; Vokes et al., 
1999). In order to characterize the aerobactin-encoding gene cluster of E. coli strain 
Nissle 1917 and its chromosomal context, an aerobactin-expressing cosmid clone 
pCos9YB4 was identified (Fig. 11) by colony blot with a probe generated by PCR  
using primers iuc-up and iuc-down. Two overlapping cosmid clones pCos2YE4 and 
pCos2RF2 were identified by PCR, using the primers iha-up, iha-down, and K5-1-up, 
K5-1-down, respectively. The iuc, sat, iha and kps genes are located in the pheV-
associated genomic island of the chromosome of E. coli strain CFT073. Since the 
genome structure of the E. coli strain Nissle 1917 is similar to that of the strain 
CFT073, the presence of the iuc, iha, sat genes and the genes comprising the three 
V. Results 78
regions of the K5-capsule-encoding kps cluster in the chromosome of the E. coli 
strain Nissle 1917 as well as in the identified cosmid clones was proven by Southern 
hybridization. 
 
 
 
 
 
 
 
 
 
 
 
The three cosmid clones were sequenced and assembled as depicted in Fig. 12a, thus 
representing a genomic island of about 100 kb (designated as Genomic Island II of E. 
coli strain Nissle 1917, GEI IINissle 1917, see section VIII, Tab. 3). This genomic island 
contains the determinants coding for several fitness factors, as well as many putative 
ORFs with so far unknown functions and a considerable number of transposon-related 
features, IS elements and integrases (Fig. 12a). The G+C content varies considerably 
from that of the E. coli core chromosome (Fig. 12b), indicating a possible 
heterogeneous origin of the DNA regions assembled within the island. The 
organization and DNA content of GEI IINissle 1917 resembles those of the pheV-located 
pathogenicity island of E. coli strain CFT073 (pheV-associated GEI CFT073; Fig. 13). 
Moreover, the tRNA screening approach revealed that in strain Nissle 1917 
downstream of pheV the same putative P4 integrase-encoding gene is located (c3556, 
Z4313) as in the E. coli strains CFT073 and EDL933 strains. Since the pheV tRNA-
encoding gene was not located on the identified cosmids, the pheV - shiA region of 
strain Nissle 1917 was amplified by PCR and sequenced using primers derived from 
the E. coli strain CFT073 genome sequence (pheVshiA-1 and pheVshiA-2). 
Interestingly, the ShiA protein encoded by the Shigella flexneri SHI-2 pathogenicity 
island has been shown to attenuate the host inflammatory response (Ingersoll et al., 
XL1 blue 
XL1 blue (pCos9YB4) Nissle 1917 
Fig. 11: Detection of aerobactin -xpression of cosmid clone pCos9YB4. The growth zone around the 
aerobactin-expressing strains is seen as white halos.. 
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2003), but the importance of the E. coli strain Nissle 1917-specific shiA-homologue 
determinant remains so far unknown. 
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Fig. 12: Characterization of GEI IINissle 1917. A. Sequence analysis and structural organization of the ORFs located in  GEI IINissle 1917. B. G+C content 
of the DNA in  GEI IINissle 1917. 
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Fig. 13: Sequence alingment of  GEI IINissle 1917 and pheV-associated GEICFT073. The homologous regions between the two islands are depicted by interrupted 
lines with the corresponding colour. 
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Two autotransporter protein-encoding genes are located on GEI IINissle 1917: sat and 
sap. The sap gene is an agn43 homologue, whose gene product plays a possible role 
for cell aggregation and biofilm formation, whereas the sat gene is coding for a serine 
protease with cytopathic effect. In order to find out whether the Sat protein is secreted 
and active, the E. coli strain Nissle 1917-specific sat gene was cloned and 
overexpressed (Fig. 14) . For this purpose a 7 kb HindIII/EcoRI fragment from 
pCos9YB4 which carries the intact sat gene was cloned into HindIII/EcoRI digested 
pUC19 thus resulting in pPSD1917. The presence of the overexpressed Sat protein in 
the culture supernatant of host cells (Fig. 14a) was demonstrated as well as its 
protease activity (Fig. 14b). Protease activity of the E. coli strains Nissle 1917 and 
CFT073 was not detected probably due to weaker expression of Sat protein compare 
to the strain DH5α (pPSD1917) and low sensitivity of the assay. 
 
A.                                                                                                                   B. 
 
 
 
 
 
 
 
 
 
 
 
 
Two regions with a transposon-like structure were identified in  GEI IINissle 1917 
(Fig. 15). One of them is ca. 30 kb in size, contains the iuc gene cluster as well as sat 
and iha genes, and is flanked by two IS2 elements in opposite orientation. The second 
one (ca. 4 kb) exhibits contains a transposase-encoding gene and remnants of the 
papX gene flanked by IS10 elements.  
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Fig. 14: Analysis of protease activity of the Sat protein encoded on GEI IINissle 1917. A. Detection of Sat 
protease in cluture supernatants. After separation of proteins by PAGE, the polyacrylamid gel was 
stained with Coomassie brilliant blue. Lane 1, DH5α (pPSD1917); lane 2, DH5α (pCos9YB4); lane 3, 
DH5α; lane 4, E. coli Nissle 1917; lane 5, E. coli 536; E. coli CFT073. The 142 kDa Sat proteine band
is indicated by an arrow. B. Detection of protease activity by fluorescence. 
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Fig. 15: Structure of the identified putative mobile genetic elements in GEI IINissle 1917. The primers 
used for detection of deletion events are indicated by arrows and designated with bold letters. A. 30 kb 
iuc, sat, iha region flanked by IS2 elements. B. 4 kb transposon-like element containing remnants of 
the pap determinant.  
 
For the 30 kb DNA region primers were designed which are located up- or 
downstream of the left-hand and right-hand IS2 elements, respectively. This primer 
pair allows the detection of the deletion of the chromosomal region flanked by the IS2 
elements by PCR amplification of a 1.2 kb PCR product (exclusion PCR; Fig. 16). 
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Fig. 16: Detection of the deletion event of 30 kb genetic element within GEI IINissle 1917 by exclusion 
PCR. Lane 1, E. coli straim MG1655; lane 2, E. coli strain 536; lane 3, E.coli strani CFT073; lane 4, 
E. coli strani Nissle 1917; lane 5, 1 kb DNA ladder. 
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The 1.2 kb PCR product could only be amplified from an overnight culture of strain 
Nissle 1917, whereas no PCR product was obtained from the strain CFT073 and 536 
as well as from the negative control strain MG1655. This indicates that this DNA 
region can delete by recombination between the flanking IS2 elements.  
The obtained PCR product was directly sequenced. The sequence analysis revealed 
the presence of two inverted repeats (IRL; Lewis et al., 2001). Interestingly, in the 
pheV-located island of E. coli strain CFT073 only one copy of the IS2 element is 
present, the order of the included genes differs from that of the 30 kb region of GEI 
IINissle 1917, and the entire 4 kb transposon-like structure is absent but replaced by a 30 
kb region containing the functional hly and pap determinants. Only remnants of the 
pap gene cluster are present in GEI IINissle 1917 .  
The loss of the 30 kb genetic element due to deletion event may influence the fitness 
of E. coli strain Nissle 1917, since it results in the simultaneous loss of the aerobactin 
iron-uptake system, the serine protease activity of the Sat protein and the putative 
adhesion/siderophore receptor activity of Iha. 
 
2.3 Analysis of the sequence context of argW tRNA-encoding gene in the genome 
of E. coli strain Nissle 1917 (GEI IIINissle 1917) 
 
One of the tRNA genes which was found to be a putative integration site of foreign 
DNA was argW. A cosmid clone containing the argW tRNA gene was identified by 
dot blot hybridization with a probe representing the yfdC gene located upstream of 
argW . The presence of argW in this cosmid was proven by Southern blot 
hybridization and the cosmid insert was subsequently sequenced (Fig. 17; see section 
VIII, Tab. 4). 
The identified putative ORFs exhibit high overall homology to E. coli CFT073 
sequences, although the order of the ORFs differs in the argW upstream region 
significantly between the two strains. Interestingly, a large ORF (ORF26)  whose 
gene product exhibits similarity on the protein level to the putative autotransporter 
YapH of Y. pestis seemed to be truncated due to the presence of an internal stop 
codon in strain CFT073 but not in strain Nissle 1917. ORF 12 – 17 represent a 
putative fimbriae encoding gene cluster. The argW downstream region represents a 
part of a genomic island ( GEI IIINissle 1917). 
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Fig. 17: Characterization of the argW sequence context in strain Nissle 1917. A. Genetic structure of the argW sequence context. B. G+C content of DNA in the argW 
sequence context in strain Nissle 1917. 
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2.4 Detection and sequence analysis of GEI IVNissle 1917 
 
The presence and genetic organization of the DNA region which encodes the 
siderophore system yersiniabactin (Carniel et al., 1996) was verified in strain Nissle 
1917 by sample sequencing of PCR products obtained with primers described before 
(Buchrieser et al., 1999; Karch et al., 1999). According to the results, we conclude 
that by analogy to the HPI of Y. pseudotuberculosis, the asnT-associated GEI IVNissle 
1917 is about 30.2 kb in size and has a G + C content of 57 %. The left and right 
junction of GEI IVNissle 1917 have already been sequenced and flanking repeat 
structures have not been reported (Schubert et al., 1999). This island is also present in 
the same chromosomal insertion site in uropathogenic E. coli O6 strains CFT073 and 
536 (Dobrindt et al., 2002; Welch et al., 2002) as well as in many non-human 
pathogenic Salmonella enterica subspecies III and VI and in commensal E. coli 
isolates (Dobrindt et al., 2003; Ölschäger et al., 2003). 
 
3. Molecular analysis of genomic islets in E. coli strain Nissle 1917 chromosome 
 
Several genomic islets which possibly contribute to the fitness of E. coli strain Nissle 
1917 have been detected and characterized. These include: wa* gene cluster coding 
for the enzymes required for the R1 type core LPS biosynthesis, wb* gene cluster 
coding for the enzymes required for the O6 side chain LPS; determinants which are 
known to contribute to the rdar morphotype (csg and bcs); type 1-fimbriae-encoding 
gene cluster fim and the chu determinant, which is responsible for the biosynthesis of 
the haeme iron-uptake system. All of them (except chu) are part of the E. coli core 
genome. 
 
3.1 Molecular analysis of the lipopolysaccharide biosynthesis determinants of E. 
coli strain Nissle 1917. 
 
3.1.1 Identification and sequence analysis of the wa* gene cluster of E. coli strain 
Nissle 1917. 
 
In order to identify a cosmid clone containing the wa* gene cluster encoding the 
enzymes for the R1 core of the LPS, the genomic cosmid library was screened by 
PCR using primers R1C3 and R1K15 (Amor et al., 2000). One cosmid was identified 
and the presence of the wa* gene cluster was confirmed by Southern blot 
hybridization and sequence analysis of the ends of the cloned insert using the primers 
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SuperCos-F and SuperCos-R, as well as R1K15 and R1C3. The entire cosmid was 
sequenced and analyzed. The E. coli strain Nissle 1917-specific wa* gene cluster 
exhibited 97 % homology on the DNA level to the already published R1 core type-
encoding wa* gene cluster of E. coli (Heinrichs et al., 1998) and a conserved 
localization on the E. coli chromosomal map upstream of kdtB (at 81 min on the E. 
coli K-12 chromosome; Fig. 18; see section VIII, Tab. 5). Since the 5' end of waaC 
was not included into the cosmid insert a PCR was carried out to amlplify the missing 
part using primers waaClücke-1 and waaClücke-2, that are based on the nucleotide 
sequence of the already published wa* gene cluster. The obtained PCR product was 
subsequently sequenced.  
Interestingly, at the 3' end of the insert a tRNA-encoding gene selC was identified. 
Downstream of the selC gene an ORF with homology to P4-like integrase was 
identified, indicating that a genomic island is located at this position in the 
chromosome of Nissle 1917 (see sections V.1.2 and VIII, Tab. 5). The highest overall 
DNA sequence homology of the cosmid insert is to the genome of the E. coli CFT073 
(98 %). ORF32 - 39 are present in the genome of CFT073 but absent from the E. coli 
MG1655 chromosome.
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Fig. 18: Analysis of the wa* determinant of the E. coli strain Nissle 1917. A. Genetic organization of 
the wa* gene cluster and flanking regions of E. coli strain Nissle 1917. B. G+C content of the DNA in 
the insert. 
 
3.1.2 Identification and sequence analysis of the wbO6 gene cluster of E. coli 
strain Nissle 1917. 
 
Since wb* gene clusters have a conserved localization in the E. coli chromosome 
between galF and gnd genes (45.4 min on the E. coli K-12 chromosome), a PCR 
amplification using proofreading DNA polymerase was carried out in order to identify 
wbO6 gene cluster. Amplification of the entire wbO6 gene cluster of E. coli strains 
Nissle 1917 and 536, using the already published primers 412 and 482 binding in the 
wb* flanking regions (Coimbra et al., 1998; Fig. 19), resulted in both E. coli strains in 
a DNA fragment of ~11 kb (Fig. 19a).  
The PCR products of both strains were cloned into the plasmid pGEM®-T Easy 
resulting in the plasmids pGWB1917 and pGWB536, respectively, which exhibited an 
identical restriction pattern after digestion with EcoRI (Fig. 19b).  
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Fig. 19: A. Amplification of the wbO6 determinant of E. coli strains Nissle 1917 and 536: lane 1, E. coli 
Nissle 1917; lane 2, E. coli 536; M, 1 kb DNA ladder. B. Restriction pattern after EcoRI digestion of 
the cloned wbO6 gene clusters: lane 1, pGWB1917; lane 2, pGWB536; M, 1 kb DNA ladder. 
 
The E. coli strain Nissle 1917-specific DNA fragment was sequenced and the genetic 
structure was analyzed in detail (Fig. 20). The wbO6 gene cluster of strain Nissle 1917 
is 11037 bp in size and exhibits an overall G+C content of 36.4 % suggesting an 
acquisition of the wbO6 determinant by horizontal gene transfer. Nine tightly linked, 
sometimes overlapping putative open reading frames (ORFs) were identified ( Fig. 20 
and Tab. 3). The G+C content did not vary markedly between the different ORFs with 
the exception of the genes manC and manB which exhibited an even higher G+C 
content than the overall E. coli chromosome (50.8 %). The identical genetic 
organization of the wbO6 gene clusters of E. coli O6 strains Nissle 1917 and 536 was 
demonstrated by PCR, using the primers whose position within the wbO6 determinant 
is depicted in Fig. 20 (primers LG1 – LG8). The deduced amino acid sequences of 
these ORFs were analyzed with regard to the presence of conserved domains and 
similarity to other protein sequences. Based on the obtained results, the identified 
putative ORFs of the wbO6 determinant were predicted to encode putative glycosyl- or 
mannosyl transferases (ORFs 3, 4, 5 and 7), a putative O6 antigen flippase Wzx (ORF 
1), a putative O antigen polymerase Wzy (ORF 2), a putative UDP-N-
acetylglucosamine-4-epimerase or UDP-glucose-4-epimerase (ORF 6), a mannose-1-
phosphate guanosyl transferase (ORF 8) and a phosphomannomutase (ORF 9) 
(Tab. 6). The nucleotide sequences of ORFs 1-7 showed no homology on the DNA 
level to available sequences from public databases.  
 
 
 
 
A.           1                   2                     M         B.         1                       2                M    
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Fig. 20: Analysis of the wbO6 determinant of E. coli strain Nissle 1917 and 536. A. Genetic structure of 
the O6 side chain-encoding determinant of E. coli strains Nissle 1917 and 536. The identified ORFs 
and the binding sites of the used primers are marked by arrows. The position of the point mutation in 
E. coli strain Nissle 1917-specific O6 antigen polymerase-encoding gene wzyNissle 1917 is indicated by 
bold letters. B. G + C content of the DNA in E. coli Nissle 1917-specific wbO6 gene cluster.
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Table 6: Characteristics of the ORFs located in the O6-specific wb gene cluster of E. coli strain Nissle 1917 
Putative 
ORF 
Length 
[bp] 
G+C 
content 
[%] 
No. of 
aa of 
encoded 
protein 
Conserved domain (s) of the 
encoded protein 
Similarity to already known proteins  
(accession no.) 
% identity /  
% similarity 
(no. of aa) 
Putative function of 
wbO6-encoded protein 
ORF1 1256 31.3 418 Polysaccharide biosynthesis 
proteins 
Putative O antigen transporter RfbX protein, 
Shigella dysenteriae (S34963) 
O antigen transporter E. coli K-12 (I69652) 
24 / 45 (396) 
 
23 / 44 (415) 
O antigen flippase 
Wzx 
ORF2 986 a) 
1343 b) 
30.5 328 a) 
447 b) 
- Hyp. protein, Streptococcus pneumoniae R6 
(AAL00026) 
beta-1,3-glucan synthase GSC-1, 
Pneumocystis carinii (AAG02216) 
25 / 48 (447) 
 
24 / 40 (1944) 
O antigen polymerase 
Wzy 
ORF3 860 31.2 286 Glycosyl transferase family 2 Glycosyl transferase, Bacillus halodurans 
(BAB07432) 
putative beta 1,3-glucosyl transferase WaaV, 
E. coli F470 (AAC69672) 
38 / 58 (303) 
 
31 / 50 (327) 
 
Glycosyl transferase 
ORF4 1032 33.6 343 Glycosyl transferases group 1 Predicted glycosyl transferases, 
Thermoanaerobacter tengcongensis 
(AAM23571) 
glycosyl transferase, Pyrococcus furiosus 
DSM 3638 (AAL80431) 
28 / 45 (404) 
 
 
27 / 45 (336) 
Glycosyl transferase 
ORF5 1145 28 381 - Glycosyltransferase, Clostridium 
acetobutylicum (AAK80991) 
putative mannosyltransferase, Yersinia pestis 
(CAC92344) 
28 / 43 (393) 
 
25 /39 (380) 
Glycosyl transferase 
ORF6 1007 35.6 335 NAD dependent epimerase/ 
dehydratase family 
UDP-glucose 4-epimerase, GalE, 
Haemophilus influenzae Rd (AAC22012) 
UDP-galactose 4-epimerase, H. influenzae 
(CAA40568) 
UDP-N-acetyl-glucosamine 4-epimerase, E. 
coli O55 (AF461121) 
54 / 71 (338) 
 
 
54 /71 (338) 
 
23 / 39 (331) 
UDP-N-acetyl-
glucosamine 4-
epimerase or  
UDP-glucose 4-
epimerase 
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Table 6 continued 
ORF7 401 30.4 401 Glycosyl transferases group 1 WbaD (Orf7.17) function unknown, 
Salmonella enterica (AAB49389) 
Glycosyltransferase, Clostridium 
acetobutylicum (AAK80997) 
51 / 67 (399) 
 
26 / 47 (420) 
Glycosyl transferase 
ORF8 483 38.1 483 Mannose-6-phosphate isomerase 
family 2 
Mannose-1-phosphate guanyltransferase, E. 
coli O157:H7, (BAB36277) 
mannose-1-phosphate guanyltransferase, E. 
coli K-12 (AAC75110) 
71 / 84 (478) 
 
 
71 /84 (478) 
Mannose 1-P 
guanosyl transferase 
ORF9 456 55.1 456 Phospho-glucomutase / 
phosphomannomutase, alpha/ 
beta/alpha domain I and alpha/beta/ 
alpha domain II 
Phosphomannomutase E. coli O6 
(AAG41759) 
Phosphomannomutase E. coli O41 
(AAG41754) 
99 / 99 (456) 
 
98 / 98 (456) 
Phosphomanno-
mutase 
a) Length of wzy or Wzy in semi-rough E. coli strain Nissle 1917 
b) Length of wzy or Wzy in smooth E. coli 5
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Comparison of of the O6-specific O antigen polymerase-encoding gene wzy of E. 
coli strains Nissle 1917 and 536  
Due to its localization downstream of the putative wzx gene of the wbO6 determinant, 
ORF 2 was predicted to be the putative O6 specific O antigen polymerase-encoding 
gene wzy. This was corroborated by the fact that 12 transmembrane helices were 
predicted from the deduced amino acid sequence of ORF 2 using the TMpred 
software (data not shown). To find out whether the putative wzy genes of the serum-
sensitive strain Nissle 1917 and its serum-resistant counterpart strain 536 differ from 
each other, the corresponding DNA sequences were compared. Interestingly, 
sequence comparison of the putative E. coli Nissle 1917- and 536-specific wzy genes 
demonstrated that in wzyNissle 1917 a point mutation (C to A transition at position +986 
with respect to of the translational start of wzyNissle 1917) resulted in an internal stop 
codon (TCA to TAA) and consequently in truncation of the ORF in comparison to 
wzy536 (Fig. 20). This internal stop codon causes premature translation termination of 
wzyNissle 1917 transcripts, thus leading to a non-functional O6-specific O antigen 
polymerase. Therefore, the point mutation within wzyNissle 1917 is proposed to be the 
reason for the semi-rough phenotype of E. coli strain Nissle 1917. This supports the 
results of the biochemical analysis of this strain’s LPS that consists of only one O 
repeating unit linked to the R1-type core (Grozdanov et al., 2002). 
Determination of O6 side chain length and serum resistance of the wild type 
strain E. coli Nissle 1917 and of different wzy-complemented derivatives 
To verify the proposed function of the putative wzy gene, and to prove that the 
identified point mutation within wzyNissle1917 is the reason for the semi-rough 
phenotype of strain Nissle 1917, complementation experiments were performed. 
Strain Nissle 1917 was transformed with the entire wbO6 gene cluster of E. coli strain 
536 harbored on a plasmid (pBWB536). In addition, two fragments of the E. coli 536-
specific wbO6 gene cluster were subcloned into pBluescript-II KS, using the NotI 
restriction enzyme, and transfered into strain Nissle 1917. One of these plasmids 
contained the O antigen flippase gene (wzx) and a fragment of wzy536 with the size of 
the truncated ORF wzyNissle 1917 (pBLG2504). The other one consisted of the complete 
wzx and wzy genes of E. coli strain 536 (pBLG2849; Fig. 21). 
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To avoid gene dosage effects, E. coli strain Nissle 1917 was also chromosomally 
complemented by integration of a single copy of wzy536 fused with promoters of the β-
lactamase-encoding gene of pBR322 (Pbla::wzy536), or with the upstream region of the 
wbNissle 1917 gene cluster (Pwb*Nissle1917::wzy536) into the chromosomal attachment site 
of the bacteriophage λ. The wbO6-specific upstream region of strain Nissle 1917 is 97 
% identical to the previously studied wbO7 promoter (accession no. U23775). The 
resulting strains, in which a functional wzy536 copy has been stably integrated, were 
designated E. coli Nissle 1917λPbla::wzy536 and E. coli Nissle 1917λPwb*Nissle 
1017::wzy536, respectively (Fig. 22). The promoters P1 and P2 of the β-lactamase-
encoding gene (bla) of pBR322 together with a Shine-Dalgarno sequence were fused 
with the wzy536 gene by PCR using primers LG7 and LG10, cloned into pGEM®-T 
Easy (resulting in pGPW1) and subcloned in plasmid pLDR11. The resulting plasmid 
pLBW1 (Tab. 5; Fig. 22a) was subsequently used for the integration of the Pbla::wzy536 
fusion into the bacteriophage λ attachment site of the E. coli Nissle 1917 
chromosome. Using the primers LG15 and LG16, the upstream region of the wbO6 
gene cluster which is expected to contain the promoter(s) of the wbO6 determinant of 
strain Nissle 1917 was amplified (~450 bp). In parallel, the wzy536 gene was amplified 
Fig. 21: Plasmids used for complementation analysis of the O6 LPS side chain expression in E. coli 
Nissle 1917 (see Fig. 20). The primers used for amplification of the cloned fragments are indicated 
with small arrows. A. pBWB536 B. pBLG2504 C. pBLG2894 
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using primers LG8 and LG10. After digestion with XbaI, the two fragments were 
ligated and a PCR reaction was performed with primers LG15 and LG10 using the 
ligation mixture as a template. The obtained PCR product represents the wzy536 gene 
under transcriptional control of the wbNissle 1917-specific promoter (Fig. 22b). The 
fragment was then cloned into pLDR9 vector, thus resulting in pLPW1 which was 
used for integration of the strain Nissle 1917-specific Pwb*Nissle 1917::wzy536 fusion into 
the bacteriophage λ attachment site of the E. coli Nissle 1917 chromosome (Fig. 22). 
For this purpose, pLPW1 and pLBW1 were digested with NotI restriction 
endonuclease and the fragment of interest was re-ligated, leading to closed circular 
DNA molecules lacking a replication origin and carrying ampicillin resistance, which 
were then integrated into the attP site of the E. coli strain Nissle 1917 (Fig. 23). 
 
Fig. 22: Construction of different promoter::wzy536 fusions used for complementation of E. coli strain 
Nissle 1917. A. Construction of E. coli Nissle 1917λPbla::wzy536 B. Construction of E. coli Nissle 
1917λPwb*Nissle 1917::wzy536 strains. The primers used for amplification (small arrows). NotI digestion 
of pLBW1 and pLPW1, circulization by ligation and transformation in E. coli Nissle 1917 (pLDR8). 
For details see the text. 
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Fig. 23: Verification of integration of wzyO6 in the bacteriophage λ attachment site of the E. coli Nissle 
1917 chromosome by Southern blot hybridization of EcoRI-digested genomic DNA. PCR-amplified 
wzyNissle 1917 (primers LG1 and LG3) was used as a probe. A. Lane 1, E. coli Nissle 1917λPbla::wzy536; 
lane 2, E. coli Nissle 1917; lane 3, E. coli 536. B. Lane 1, E. coli MG1655; lane 2, E. coli Nissle 1917; 
lane 3, E. coli 536; lane 4, E. coli Nissle 1917 (pBWB536); lane 5, E. coli Nissle 1917λPwb*Nissle 
1917::wzy536.  
 
As seen from Fig. 23, an additional hybridization signal for the wzyO6 gene was 
detected in E. coli strain Nissle 1917λPbla::wzy536 and E. coli strain Nissle 
1917λPwb*Nissle 1917::wzy536 (1.3 kb and 1.2 kb, respectively) compare to the control 
strains Nissle 1917 and 536. 
Expression of O6 side chains was studied by SDS-polyacrylamide gel electrophoresis. 
With regard to LPS side chain expression, strain Nissle 1917 and its derivatives were 
grouped into three classes: semi-rough, smooth, and smooth with reduced amount of 
O antigen (Fig. 24a).  
Only transformation of E. coli strain Nissle 1917 with a construct containing the 
entire wbO6 determinant (pBWB536) of strain 536 resulted in a smooth phenotype. 
Introduction of the shortened wzy536 fragment (pBLG2504) representing the size of 
the truncated gene wzyNissle 1917, had no complementing effect (Fig. 24a). Derivatives 
of strain Nissle 1917 complementation with plasmid-encoded wzy536 (pBLG2849) 
alone as well as the chromosomally complemented strains E. coli Nissle 
1917λPbla::wzy536 and E. coli Nissle 1917λPwb*Nissle 1917::wzy536 showed a smooth 
phenotype with reduced amounts of O antigen. The level of the O6 LPS side chain 
synthesis in strain Nissle 1917 (pBLG2849) was markedly lower than in the smooth 
strains Nissle 1917(pBWB536) and 536, but higher than that of the chromosomally 
complemented strains (Fig. 24a). Therefore, we conclude that the E. coli strain 536-
specific wzy gene encodes the functional O6 antigen polymerase. 
12 kb . 12 kb 
1.3 kb 
1.8 kb 
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A.                                                                           B. 
      1           2           3          4          5          6          7 
Fig. 24: Influence of O6 LPS side chain expression on serum resistance. A. SDS-PAGE analysis of the 
O6-specific LPS side chain length of E. coli strains Nissle 1917, 536 and derivatives. Lane 1, E. coli 
536; lane 2, E. coli Nissle 1917; lane3 E. coli Nissle 1917 (pBWB536); lane 4, E. coli Nissle 
(pBLG2504); lane 5, E. coli Nissle (pBLG2849); lane 6, E. coli Nissle1917λPwb*Nissle1917::wzy536; lane 
7, E. coli Nissle 1917λPbla::wzy536. B. Serum resistance of E. coli strains Nissle 1917, 536 and 
derivatives. Serum resistance assays were performed in 90 % (indicated by black symbols) and 50 % 
human serum (indicated by white symbols). The percentage of surviving cells were plotted against 
incubation time in human serum. Cell numbers within the different inoculi (t = 0) were set 100 %. 
  
With one representative of these three groups of strains (semi-rough, smooth and 
smooth but reduced amounts of O antigen), serum resistance assays were performed 
to analyze whether the presence and amount of longer LPS side chains may contribute 
to serum resistance in E. coli strain Nissle 1917 (Fig. 24b). The smooth strain E. coli 
Nissle 1917 (pBWB536) showed a markedly increased resistance to 50 % and 90 % 
human serum compared to that of the semi-rough wild type strain E. coli Nissle 1917, 
which was not detectable after 1 hour incubation in 50 % and 90 % human serum. In 
comparison to the wild type strain, the smooth strain with reduced amount of O 
antigen (strain Nissle 1917λPwb*Nissle1917::wzy536) survived better and was still 
detectable after 24 hours of incubation (0.007 ± 0.001 % survival of the inoculum in 
50 % serum) (Fig. 24b). Generally, serum resistance was in accordance with the 
amount of O6 repeating units produced in the different strains, e.g., serum resistance 
was higher in strains with higher amounts of O6-specific repeating units. This 
underlines that wzy536 encodes the O6–specific antigen polymerase and that the C to A 
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transition at position +986 in wzyNissle1917, which results in a non-functional O antigen 
polymerase, is responsible for the semi-rough phenotype of E. coli strain Nissle 1917. 
We therefore identified the O6 antigen polymerase-encoding gene wzy, proved its 
function, and demonstrated that the reason for the semi-rough phenotype of E. coli 
strain Nissle 1917 is a point mutation probably leading to premature translation 
termination of wzy. 
Allelic exchange of wzy in E. coli Nissle 1917 and 536 
Since wzy536 alone was not able to restore the O6 side chain polymerization in strain 
Nissle 1917 to the same level as in the E. coli strain 536, allelic exchange of wzyNissle 
1917 by wzy536 in strain Nissle 1917 and of wzy536 with wzyNissle 1917 in strain 536 was 
carried out. For this purpose wzy536 and wzyNissle 1917 were amplified using primers LG1 
and LG3 and cloned into the suicide vector pCVD442 resulting in the plasmids 
pCVW536 and pCVW1917. These plasmids were used for allelic exchange of wzy in 
E. coli strains Nissle 1917 and 536, respectively (Fig. 25).  
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Fig. 25: Allelic exchange of wzy in E. coli Nissle 1917 and 536. Plasmids pCVW1917 and pCVW536 
were transformed in E. coli Sm10 λpir and used for conjugation E. coli strains 536 and Nissle 1917, 
respectively.  
 
The presence or absence of the wzyNissle 1917-specific point mutation was demonstrated 
by PCR. For this purpose primers which enable detection of the presence of the 
wzyNissle 1917-specific mutation were designed (MUTA-up and MUTA-down (Fig. 
26a)), and furthermore proven by sequence analysis of the wzy gene. The correct 
integration in the wbO6 determinant was demonstrated by PCR (using primers LG8, 
482, LG1, LG2, LG3) and Southern hybridization (Fig. 26b). 
 
 
 
 
 
 
ORF 1 (wzx)   ORF2 (wzy)                                                                                     ORF3     
 
 galF 
Pwb 
JUMP  
Start 
E.coli 536:                              TCA (Ser)
E. coli Nissle 1917                  TAA (Stop)
pCVD442 DNA 
E. coli Nissle 1917               TAA (Stop) 
E.coli 536:                              TCA (Ser) 
 
 
 
 
ORF 1 (wzx)         ORF2 (wzy)    ORF3       
 galF 
Pwb 
JUMP  
Start 
E.coli Nissle 1917:                     TAA (Stop) 
E. coli 536:                                 TCA (Ser)
 
 
ORF 1 (wzx)         ORF2 (wzy)    ORF3       
 
 galF 
Pwb 
JUMP  
Start 
E .coli 536:                                  TCA (Ser)
E. coli Nissle 1917                      TAA (Stop)
Integration of the entire plasmid  pCVW536 
or pCVW1917 by homologous 
recombination into the wbO6 gene cluster.  
Loss of the plasmid DNA through second 
homologous recombination.  
pCVW536 or pCVW1917 
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   A.                                                                   B. 
 
Fig. 26: Verification of proper allelic exchange of wzy gene by PCR and Southern blot hybridization. 
A. PCR detection of wzyNissle 1917-specific mutation using primers MUTA-up and MUTA-down: lane 1, 
E. coli 536; lane 2 - 4, E. coli 536-wzyNissle 1917; lane 5, E. coli Nissle 1917; lane 6 – 7, E. coli Nissle 
1917-wzy536; lane 8, 1 kb DNA ladder. B. SDS-PAGE analysis of the O6-specific LPS side chain 
length: lane 1, E. coli 536; lane 2, E. coli Nissle 1917-wzy536; lane 3, E. coli 536-wzyNissle 1917. B. Lane 1, 
E. coli MG1655; lane 2, E. coli Nissle 1917; lane 3, E. coli 536; lane 4, E. coli Nissle 1917 
(pBWB536); lane 5, E. coli Nissle 1917-wzy536; lane 6, E. coli 536-wzyNissle 1971. 
 
 
Positive PCR signal was detected only in the strains carrying the E. coli strain Nissle 
1917-specific mutation in the wzyO6 gene. Presence of only one hybridization signal of 
expected size confirmed the proper integration of the wzyO6 gene in wbO6 in the E. coli  
strains Nissle 1917-wzy536 and 536-wzyNissle 1917. The clones were tested for O6 side 
chain polymerization by PAGE (Fig. 27).  
 
              1       2       3 
 
 
 
 
 
 
Fig. 27: Detection of O6 side chain expression by SDS-PAGE: lane 1, E. coli 536; lane 2, E. coli 
Nissle 1917-wzy536; lane 3, E. coli 536-wzyNissle 1917. 
 
The resulting strain E. coli Nissle 1917-wzy536 exhibited smooth phenotype with 
reduced amount of polymerized O antigen, whereas the E. coli 536-wzy Nissle 1917 was 
semi-rough. Since wzy536 alone was not able to restore the O6 side-chain 
polymerization at the same extent as in E. coli 536, it is tempting to speculate that 
some of the enzymes encoded by wb Nissle 1917 is less active than in E. coli 536, 
resulting in weaker O6 side-chain units synthesis. This presumption is in accordance 
   1        2         3        4       5        6       7        M           1      2        3        4        5         6 
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with the observation that the wb 536 (pBWB536) cluster is able to fully restore the O6 
side-chain polymerization when transformed in Nissle 1917. 
Screening of O6-serotype E. coli isolates for the presence of Nissle 1917-specific 
mutation in the wzy gene 
In order to find out if the mutation in wzyNissle 1917 is present in other O6 isolates, the 
MUTA PCR was performed and the results were verified by sample sequencing of the 
amplified wzy genes. The conditions of the PCR amplification were carefully 
optimized (annealing temperature = 34.9 °C) Sixteen serum-resistant, as well as 
serum-sensitive O6-serotype E. coli strains, expressing different capsule types, were 
screened (Tab. 7). In no any of them the Nissle 1917-specific mutation was identified. 
This result indicates that probably this mutation was a unique event in the evolution of 
Nissle 1917 strain, and is not widely distributed between the O6 strains. The 
established MUTA PCR can be used for further screening of more O6-serotype E. coli 
isolates. 
 
Table 7: Screeening of different E. coli O6 isolates for the presence of the E. coli strain 
Nissle 1917-specific mutation in wzy. 
 
Strain  Serotype Presence of the E. coli 
strain Nissle 1917 - 
specific mutation in 
wzy 
O6 smooth 
phenotype 
Serum resistance 
Nissle 1917 O6:K5:H1 + - - 
536 O6:K15:H31 - + + 
RZ439 O6:K5 - + - 
RZ442 O6:K5 - + + 
RZ526 O6:K5 - - - 
RZ533 O6:K5 - + + 
RZ446 O6:K53:H1 - + + 
RZ537 O6:K53:H1 - + - 
RZ424 O6:K14:H- - + - 
RZ436 O6:K13:H1 - - + 
RZ447 O6:K13:H1 - + - 
RZ502 O6:K2:H- - + + 
RZ496 O6:K+:H- - - - 
RZ532 O6:K+:H31 - + - 
RZ411 O6:K-:H1 - + - 
RZ412 O6:K-:H1 - + + 
RZ418 O6:K-:H1 - + - 
RZ501 O6:K-:H1 - + - 
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3.2 Molecular characterization of determinants of E. coli strain Nissle 1917 
required for biofilm formation 
 
The ability of bacterial cells to bind to abiotic surfaces, the surface of eukaryotic 
cells, as well as to express specific extracellular matrix substances, can result in the 
formation of multicellular bacterial communities (biofilm). This requires expression 
of definite factors – fimbrial and non-fimbrial adhesins, surface proteins, extracellular 
matrix polymers (Stoodley et al., 2002). Biofilm formation of Enterobacteriaceae is 
believed to play a significant role for the colonization and establishment of infections 
on mucosal surfaces and may also enhance microbial survival in the environment  
(Boddicker et al., 2002; Cookson et al., 2002). The expression of type 1- and curli 
fimbriae is known to contribute to the ability of E. coli to form biofilm, as well as the 
cellulose biosynthesis, flagella, colanic acid and agn43 expression (Zogaj et al., 2001; 
Römling et al., 1999; Hanna et al., 2003; Ferrieres et al., 2003; Danese et al., 2000).  
In addition, deletion mutation of the rfaH-encoded transcriptional antiterminator was 
recently found to attenuate virulence of UPEC strain 536 and to enhance its ability to 
form biofilm under continuous culture conditions (Michaelis, K., and Dobrindt, U., 
unpublished data). 
 
3.2.1 Sequence analysis of the fimNissle 1917 –containing pCos3YC6 
 
In order to identify a cosmid clone containing the type 1 fimbriae-encoding gene 
cluster (fim), the genomic library of E. coli strain Nissle 1917 was screened by PCR  
using primers which enable specific amplification of fimANissle 1917 (Blum-Oehler et 
al., 2003). The clone pCos3YC6 was identified and transformed in the fimbriae-
deficient E. coli K-12 strain AAEC189. The expression of type 1 fimbriae was proven 
by mannose-dependent agglutination of yeast cells of strain AAEC189 (pCos3YC6). 
The presence of the fim genes was also demonstrated by Southern hybridization and 
sample sequencing. The entire cosmid insert was subsequently sequenced (Fig. 28; 
see section VIII, Tab. 6). The sequence analysis confirmed that the fimB gene, coding 
for tyrosine recombinase mediating the fimbrial phase switch, was found to be 
truncated by IS element as reported before (Stentebjerg-Olesen, et al., 1999). The 
fimH gene, coding for the FimH adhesin, is known to be highly variable among the E. 
coli strains and is responsible for the quantitative differences in binding to mannan 
and for the variability in binding specifities (Sokurenko et al., 1994). The fimHNissle 
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1917 gene shows 99 % amino acid homology to that of the E. coli K-12 strain MG1655 
and the EHEC strain EDL933 (see section VIII, Tab. 6). The chromosomal DNA 
context and localization of fimNissle 1917 does not differ from that of the already 
sequenced E. coli strains. 
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Fig. 28: Characterization of the fim determinant of the E. coli strain Nissle 1917. Genetic organization of the fim gene cluster and 
flanking regions of E. coli strain Nissle 1917. B. G+C content of the DNA in the cosmid insert. 
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3.2.2 Cloning, sequence-, and mutational analysis of cellulose biosynthesis gene 
cluster (bcs) of the E. coli strain Nissle 1917  
 
The E. coli strain Nissle 1917 expresses at 30 °C and 37 °C the so-called rdar 
morphotype on congo red agar plates (Zogaj et al., 2001) which is characterized by  
intensive red colored colonies with a dry colony surface and strong cell-cell 
interactions. This morphotype is considered to be due to co-expression of curli 
fimbriae and cellulose. In comparison, the uropathogenic E. coli strain 536 expresses 
the rdar morphotype only at 30 °C and strain CFT073 does not express rdar 
morphotype neither at 30 °C or 37 °C.  
The cellulose biosynthesis is known to play a significant role for the biofilm 
formation, but does not contribute to the virulence of Salmonella enteritidis (Solano 
et al., 2002). In order to find out if strain Nissle 1917 expresses cellulose, the entire 
bcsNissle 1917 gene cluster was amplified (using primers bcs-up and bcs-down), 
subsequently sequenced (Fig. 29; see section VIII, Tab. 7), cloned into pGEM-T 
Easy® thus resulting in pGBC1917. The strain DH5α (pGBC1917) exhibited red-
pink-colored colonies when grown on congo red agar plates, thus proving that the 
bcsNissle 1917 gene cluster alone is able to mediate cellulose biosynthesis at 30 °C and 
37 °C (called pdar morphotype: pink dry and rough; Zogaj et al., 2003). In addition, a 
bcsNissle 1917 deletion mutant (strain Nissle 1917∆bcs) was created, as depicted in 
Fig. 29. Deletion of all coding ORFs in the cloned bcsNissle 1917 (pGBC1917) operon 
was created using the enzymes KpnI and McsI. Consequently, blunt ends were 
generated and the linearized plasmid was religated resulting in pGDB1917. The 
insert was cloned into pCVD442 using SphI and SacI  thus resulting in pCDB1917. 
After allelic exchange of the bcsNissle 1917 in the chromosome of the E. coli strain 
Nissle 1917 using pCDB1917, clones carrying deletion in bcsNissle 1917 were identified 
(Fig. 29). Chromosomal deletion of bcsNissle 1917 was confirmed by PCR, Southern 
hybridization and phenotypically by growth on congo red agar plates. 
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Fig. 29: Construction of E. coli strain Nissle 1917∆bcs strain.  
 
The E. coli strain Nissle 1917∆bcs lost the ability to express rdar morphotype and 
exhibited brown-colored colonies due to the expression of curli fimbriae alone, when 
grown on congo red plates at 30 °C and 37 °C, and thus expressed the bdar 
morphotype (brown dry and rough; Fig. 30).  
McsI 
pGBC1917
KpnI 
bcsC          bcsZ      bcsB            bcsA  yhjQ   yhjR  
bcsC          bcsZ      bcsB            bcsA  yhjQ   yhjR  
∆bcsC ∆yhjR 
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pCBC1917
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A.       B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.3 Sequence determination of csgD and the promoter region of csg 
gene cluster of E. coli strains Nissle 1917 and 536 
 
The csgD gene encodes transcriptional regulator protein CsgD which has been shown 
to positively control the expression of curli fimbriae and cellulose biosynthesis (rdar 
morphotype; Römling et al., 1998). Mutations in its promoter region may influence 
the mutlicellular behaviour of Salmonella typhimurium. Therefore, using primers curli 
1 and curli 2, this region was amplified from chromosomes of E. coli strains 536, 
Nissle 1917 and Nissle 1917 CR- (congo red-negative spontaneous mutant strain) and 
PCR products were subsequently sequenced (see section VIII.1). Any sequence 
differences have been detected between the wild type E. coli strain Nissle 1917 and 
the congo red binding-negative mutant strain Nissle 1917 CR-. In addition, no 
sequence differences in genes which are known to play a role in regulation of the rdar 
morphotype have been observed between the two strains (crl, ompR, mlrA; data not 
shown). According to these results it is tempting to speculate that there are other 
factors contributing to the rdar morphotype of strain Nissle 1917.  
 
 
 
 
Fig. 30: Manifestation of the rdar morphotype in E. coli strains – congo red binding assay. 
Investigated E. coli strains are designated for every colony; E. coli Nissle 1917 congo red-negative 
spontaneous mutant strain is designated as Nissle 1917 CR-. A. 30°C incubation temperature. B. 37°C 
incubation temperature. 
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1                            2         
Fig. 31: Western hybridization of whole-cell 
protein extract. The RfaH-specific band is 
showed with arrow. lane 1, E. coli Nissle 
1917rfaH-; lane 2, E. coli Nissle 1917. 
3.3 Amplification of the chu determinant 
 
In order to prove the presence of the haeme iron uptake system in the chromosome of 
strain Nissle 1917, the entire chu gene cluster was amplified (data not shown) using 
primers chu1 and chu4. The resulting DNA fragment was of expected size (11 kb) and 
sample sequencing of the PCR product confirmed the presence of the chu determinant 
in the genome of E. coli strain Nissle 1917. 
 
3.4 Characterization of the role of rfaH for gene expression in E.coli 
strain Nissle 1917 
 
In order to construct a rfaH mutant of 
strain Nissle 1917, the pCVD442-based 
plasmid pMSK5 was used ( Kupfer, M., 
2000; Nagy, G., 2000). This plasmid 
contains the rfaH gene inactivated by 
insertion of the cat casette. The plasmid 
was conjugated into the E. coli strain 
Nissle 1917, and allelic exchange was 
carried out as described above.  
Candidate rfaH mutants were screened  
for proper integration of the cat gene into the chromosome by PCR and Southern 
hybridization, using cat- and rfaH-specific probes (data not shown). Finally, the lack 
of RfaH in the E. coli strain Nissle 1917rfaH- was proven by Western blot 
hybridization, by using an anti-RfaH rabbit monoclonal antibody (Dobrindt, U., 
personal communication; Fig. 31).  
No effect of the rfaH inactivation on the microcin and aerobactin expression of Nissle 
1917 was observed when phenotypic tests were performed, as well as no clear 
influence on the rdar morphotype at 30 °C or 37 °C (data not shown).  
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4. Screening of commensal and uropathogenic E. coli strains for the presence of 
E. coli Nissle 1917-specific sequences and analysis of the genome content of 
strain Nissle 1917 by DNA-DNA hybridization using DNA arrays 
 
4.1 Screening of commensal and uropathogenic E. coli strains for the presence of 
E. coli Nissle 1917-specific sequences by PCR  
 
 In order to detect E. coli Nissle 1917–specific sequences in the genome of different 
E. coli strains, PCR reactions were designed for the amplification of DNA regions 
containing genes encoding for (putative) fitness-factors, E. coli Nissle 1917-specific 
insertion sequences, or the regions located at the borders of GEI INissle 1917 and GEI 
IINissle 1917 (see section VIII, Tab. 8). 68 uropathogenic E. coli isolates of serotype 
O6:K5 were investigated (Zingler er al., 1992; Zingler et al., 1993), as well as 40 non-
pathogenic faecal isolates (Boyd et al., 1997; Mühldhofer et al., 1996) were screened 
for the presence of the above mentioned DNA regions. Generally, the results show a 
wide distribution of the E. coli Nissle 1917-specific sequences among the O6:K5 
isolates, but also the presence of these DNA regions in non-pathogenic faecal isolates 
which are phylogenetically unrelated to E. coli strain Nissle 1917 (Tab. 8; see section 
VIII, Tab. 8).  
Table 8: Percentage distribution of the investigated E. coli Nissle 1917-specific sequences between 
uropathogenic and commensal E. coli strains. 
 
Interestingly, two of the investigated O6:K5 isolates (RZ442 and RZ525) were 
positive for all of the E. coli Nissle 1917 PCR reactions, suggesting a common clonal 
origin of these strains and strain Nissle 1917. Both strains contain one (pMUT1) of 
the two plasmids present in strain Nissle 1917, as indicated by a pMUT1-specific 
PCR reaction (primers Muta5 and Muta6; Blum-Oehler et al., 2003). They were 
negative for pMUT2 when tested with pMUT2-specific primers (primers MUTA7 and 
Muta8; Muta9 and Muta10). Despite the high similarity on the genomic level between 
the E. coli strains RZ442, RZ525 and E. coli Nissle 1917, they do not express the rdar 
morphotype, neither on 30 °C or 37 °C. These findings support the view that the E. 
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coli strain Nissle 1917 exhibits a specific pattern of fitness factors which might 
contribute to its colonization efficiency and survival in the host body, but lacks 
prominent virulence factors. 
 
 
4.2 Analysis of the genome content of strain Nissle 1917 by DNA-DNA 
hybridization using DNA arrays 
 
In data provided from U. Dobrindt the overall genome content was analyzed by 
DNA-DNA hybridization experiments with E. coli K-12-specific arrays and the “E. 
coli Pathoarray” (Dobrindt et al., 2003). The results of the DNA-DNA hybridization 
of genomic DNA isolated from strain Nissle 1917 with E. coli K-12 gene arrays 
demonstrated that 90.7 % of all translatable ORFs of E. coli K-12 strain MG1655 
were detectable in strain Nissle 1917. The majority of these missing ORFs can be 
functionally grouped as coding for hypothetical, not experimentally classified or 
unknown gene products. A great diversity of ORFs which represent mobile genetic 
elements or which code for structural components of the cell in the K12 genome were 
not detectable in strain Nissle 1917 as well. Ten prophages described in E. coli strain 
MG1655 were not detected in strain Nissle 1917 (data not shown). Several variable 
chromosomal regions among the studied isolates contain ORFs with homology to 
ORFs of other accessory genetic elements, e.g. IS elements. The chromosomal 
context of several tRNA-encoding genes (e. g., serX, argW, ileY, pheV, leuX) was 
also found to contain alterations in strain Nissle 1917 in comparison to the 
corresponding sequences in E. coli MG1655 implying the presence of horizontally 
acquired genetic information downstream of these tRNA loci. 
The genome of strain Nissle 1917 was also screened for the presence of DNA 
sequences which belong to the flexible gene pool of UPEC strain 536, as well as for 
typical virulence- and fitness-associated genes of extraintestinal pathogenic E. coli 
(ExPEC) and intestinal pathogenic E. coli (IPEC) including Shigella using the 
previously described "E. coli Pathoarray" (Dobrindt et al., 2003). 55 % of the probes 
specific for PAI I-V536-ORFs and 37 % of the probes specific for other ExPEC 
virulence-associated genes spottet on the Pathoarray have been detected in the 
genome of strain Nissle 1917. Generally, the hybridization signals confirmed the 
results obtained from the characterization of GEIs of strain Nissle 1917. About 18 % 
of the probes specific for virulence-associated genes of intestinal pathogenic E. coli 
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showed a clear hybridization signal. Most of these probes are complementary to 
fimbrial determinants of enterotoxigenic E. coli (indicating possible cross-reaction of 
probes designed for the detetction of ExPEC fimbriae-encoding determinants) with or 
to putative ORFs present on PAIs of the enterohemorrhagic E. coli O157:H7 strain 
EDL933 (Perna et al., 2001). Importantly, known protein toxin-encoding determinants 
of pathogenic E. coli have not been detected by this approach in strain Nissle 1917. 
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VI. Discussion 
 
1. Genome plasticity and evolution of E. coli species 
 
The species Escherichia coli comprises a variety of commensal, as well as of 
pathogenic isolates with striking differences regarding the diseases they cause, i. e., 
sepsis, local infections of the intestine, kidney, bladder and brain in different hosts 
(humans, monkeys, horses, birds). The broad spectrum of pathogenic features and 
different clinical symptoms cause by E. coli pathotypes mirrors the presence of 
different subsets of virulence-associated genes in certain pathotypes which are absent 
in commensal isolates (Dobrindt et al., 2003). The genomes of different E. coli strains 
exhibit remarkable size variations (4 – 5.5 Mb; Bergthorsson and Ochman, 1998). 
This indicates the high variability in the gene content among different E. coli strains, 
that is mainly due to the acquisition of foreign DNA elements and the deletion of 
genetic information. Thus, horizontal gene transfer and genome reduction contribute 
to the evolution of prokaryotes, leading to the appearance of new species, subspecies 
and pathotypes. The acquisition of plasmids, phages and large DNA regions termed 
“genomic islands” is important for the adaptation and microbial fitness in a specific 
environment or host. The deletion of certain DNA regions or inactivation of specific 
genes can also contribute to a definite way of successful survival or disease 
development for some strains (Jin et al., 2002).  
Since E. coli is part of the normal intestinal microflora of humans (commensal strains) 
it is of great importance to investigate the genetic mechanisms by which pathogenic 
variants evolve. It is well known that the normal intestinal flora is the main source of 
E. coli strains causing UTI, new-born meningitis, and sepsis. Therefore, the microbial 
composition of the intestine plays crucial role for the development of these 
extraintestinal diseases, as well as for diarrheagenic disorders. It was shown that 
commensal E. coli isolates share some common genetic features with ExPEC 
(extraintestinal pathogenic E. coli) and IPEC (intestinal pathogenic E.coli strains) 
(Dobrindt et al., 2003). Most of these features can be considered fitness-contributing 
factors (e.g., iron-uptake systems, bacteriocins, fimbriae and other adhesins, some 
specific O- and K-serotypes). Nevertheless, they are commonly associated with 
pathogenic isolates. Thus, the question whether certain E. coli strains will develop 
into pathogenic or successful commensal variants can be considered as the 
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evolutionary balance between the acquisition of sufficient foreign genetic information 
increasing bacterial fitness to ensure the successful multiplication and colonization of 
the host on one hand, and the parallel process of acquisition of genetic determinants 
contributing to pathogenesis on the other. To make this speculative picture more clear, 
one should also have in mind the accompanying processes of gene silencing and 
inactivation, deletions and genome reduction.  
 
2. E. coli strain Nissle 1917 and UPEC O6 strains: common phenotypic features 
and differences 
 
The E. coli strain Nissle 1917 is a non-pathogenic, faecal isolate which has been used 
for decades as a probiotic in medicine (Mutaflor®), e. g. for the treatment of wide 
range of intestinal disorders and reconstruction of the intestinal flora of immuno-
supressed individuals. It has been shown that strain Nissle 1917 is serum-sensitive, 
and non-invasive. This strain does not exhibit a uropathogenic virulence potential and 
does not provoke intestinal disorders. At the same time the strain is able to multiply 
successfully in the human intestine, which indicates that it possesses sufficient fitness-
conferring determinants ensuring its survival and colonization capacity. These include 
fimbrial adhesins, whose expression is important for the adhesion to the epithelial 
cells: the type 1, F1C and curli fimbriae. The type 1 fmbriae (encoded by the fim gene 
cluster) and the curli adhesin (encoded by the csg gene cluster) are widely distributed 
among pathogenic and non–pathogenic isolates exhibit a conserved chromosomal 
localization. The F1C fimbriae are mostly associated with uropathogenic strains and 
do not belong to the E. coli core genome. Thus, their genes are believed to be 
acquired by horizontal gene transfer. They are a member of the S family of fimbrial 
adhesins (Dobrindt et al., 2001) and the corresponding determinant is located on 
genomic islands. E. coli strain Nissle 1917 is also known to express microcins, which 
probably contribute to its fitness as a result of the antagonistic competition with other 
inhabitants of the intestine. 
This strain also possesses a striking number of iron uptake systems, which facilitate 
its survival in the human body. The presence of the entire chu determinant required 
for haemine uptake in the genome of Nissle 1917 was demonstrated in this study by 
long-distance PCR. Some of the iron acquisition systems are frequently detected in 
pathogenic strains (salmochelin, iro; aerobactin, iuc; haemine-uptake, chu). Others are 
also widely distributed among non-pathogenic isolates (enterobactin, ent; 
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yersiniabactin, ybt; ferric dicitrate uptake system, fec). The majority of them have a 
conserved chromosomal localization (ent, chu, ybt). Nevertheless the ybt gene cluster 
represents the “high-pathogenicity island” (Schubert et al., 1999) which is known to 
be horizontally-transfered mobile genetic element. Although the fec genes are present 
in the core genome of E. coli K-12, they might also be part of a pathogenicity island 
(Luck et al., 2001). The aerobactin-encoding iuc gene cluster is either present on 
plasmid (Braun et al., 1983) or on chromosomal island (Purdy et al., 2001; Vokes et 
al., 1999).  
The E. coli strain Nissle 1917 expresses a K5 capsule, which is widely distributed 
among UPEC strains and presumably the K5-specific kps gene cluster is also part of a 
genomic island. The K5 capsule expression is important for adhesion and 
colonization, but does not contribute to serum resistance (Herias et al., 1997; Burns et 
al., 1998). The K5 capsule belongs to the Group 2 capsules, which are encoded by a 
gene cluster which is organized in three regions (regions 1, 2 and 3). Region 1 and 3 
are conserved among all group 2 capsule-encoding operons and code for eight Kps 
proteins responsible for the transport of the capsule polysaccharides. Region 2 is 
serotype-specific and encodes enzymes for the polymerization of the polysaccharide 
molecule and, if necessary, for the biosynthesis of specific monosaccharide 
components (Whitfield and Roberts, 1999). 
UPEC strains express a number of fitness factors, as well as different toxins. The P-
related, F1C-, and S-fimbriae (encoded by the pap/prf, foc, sfa gene clusters) are 
widely distributed among UPEC and are usually localized on genomic islands. They 
play role for cell adhesion, but their inactivation in UPEC strain CFT073 did not alter 
the virulence of this strain (Mobley et al., 1994; Smyth et al., 1996). Thus, these 
fimbriae are factors contributing to the infectious potential, but they are not 
necessarily sufficient by themselves to cause infection and disease.  
Toxins expressed by the majority of the UPEC isolates, like α-haemolysin (hly), the 
cytotoxic-necrotizing factor 1 (CNF-1), cytolethal distending (CDT) or some 
autotransporter toxins (sat) are considered prominent virulence factors. Nevertheless, 
it has been shown that although the secreted autotransporter toxin Sat of the UPEC E. 
coli strain CFT073 exhibits a vacuolating cytotoxic effect on bladder and kidney 
epithelial cells, its inactivation did not impair the virulence potential of strain CFT073 
(Guyer et al., 2002). Thus, this serine protease might be considered more as a fitness 
factor providing peptides for the bacterium. It is noteworthy to emphasize that the E. 
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coli strain Nissle 1917 does not express any of these toxins connected with virulence 
of UPEC isolates. 
In this study, the genome structure and genetic organization of several fitness- and 
virulence factor-encoding determinants has been compared between the well studied 
UPEC strains 536, CFT073 and the non-pathogenic strain Nissle 1917. All three 
strains exhibit an O6-serotype, but differ in the capsule type they express (K15, K2 
(?), and K5, respectively). Although all strains express S-fimbrial adhesins, strain 
Nissle 1917 does not express P-related fimbriae. Whereas both UPEC strains are 
serum-resistant, smooth, and express α-haemolysin, strain Nissle 1917 is serum-
sensitive, semi-rough and does not express α-haemolysin. The sequence analysis of 
the genes coding for fitness-contributing factors of E. coli strain Nissle 1917 revealed 
a surprisingly higher structural similarity with the pathogenic isolate CFT073 than 
with strain 536. The chromosomal localization of “black holes” in the genome of 
strain Nissle 1917 were identified, where virulence determinants which are present in 
the genome of the UPEC strains are deleted or replaced by a transposon-like element 
in GEI IINissle 1917, e. g. the pap-operon which is partially deleted in GEI IINissle1917. 
Typical virulence determinants have so far not been detected in the genome of E. coli 
strain Nissle 1917.  
In spite of the similarity of the genome organization of strain Nissle 1917 and the 
UPEC strains 536 and CFT073, this non-pathogenic strain exhibits some intriguing 
phenotypic features which are not typical for the UPEC isolates, like presence of two 
plasmids (Blum et al., 2003) and the so-called rdar morphotype (Römling et al., 
1998). The latter is due to the strong, temperature-independent curli fimbriae and 
cellulose expression and is not characteristic for UPEC strains including CFT073 and 
536 (Dobrindt et al., personal communication).  
 
3. The lipopolysaccharide of E. coli Nissle 1917 
 
Together with E. coli O1, O4 and O18 strains, those expressing the O6 antigen belong 
to the most frequent extraintestinal pathogenic E. coli isolates (Ørskov et al., 1977). 
However, E. coli strains of serotype O6 are also commonly detected among intestinal 
isolates (Bettelheim et al., 1997; Hartley et al., 1979; Lidin-Janson et al., 1978; 
Sonnenborn and Greinwald, 1991). In the case of uropathogenic O6 strains, the gut 
may thus serve as a reservoir of infectious microorganisms for recurrent urinary tract 
infections (Appelmelk et al., 1994). The R1-type core is the most frequently occurring 
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core type in clinical E. coli isolates (Amor et al., 2000). 
The entire wa* and wb* gene clusters of E. coli strain Nissle 1917, which are required 
for biosynthesis of the E. coli LPS R1 core type and of the O6 antigen, respectively, 
have been cloned, sequenced, and analyzed. The nucleotide sequence of the waO6 
determinant is 97 % identical to already known sequences of other R1 core type-
specific wa* gene clusters (e.g. E. coli strain F470; Heinrichs et al., 1998). The wbO6 
gene cluster had not been sequenced so far. In E. coli strain Nissle 1917, this 
determinant is chromosomally located between the genes galF and gnd as reported for 
other wb* clusters (Coimbra et al., 1998). As also described for other O antigen-
encoding gene clusters, all putative ORFs of this strain‘s wb* gene cluster, with the 
exception of manC and manB, have a relatively low G+C content suggesting that 
these genes may have been acquired by horizontal transfer from other species. 
According to the corresponding deduced amino acid sequences, five putative ORFs 
specific for the O6 LPS serotype have been identified: one putative ORF coding for 
the O6 antigen flippase wzx, the O6 antigen polymerase-encoding gene wzy, four 
putative glycosyl transferase-encoding genes and a putative epimerase-encoding gene 
(Fig. 20, Tab. 6). Although ORF 2 shows no marked similarity to other wzy genes, it 
was considered the putative O antigen polymerase-encoding gene as this ORF is 
located downstream of the putative wzx gene. In addition, 12 transmembrane helices 
have been predicted from the deduced amino acid sequence. This is also the case for 
the putative Wzy proteins of an E. coli O113 and O8:K40 strain (AF172324 and 
AF013583), respectively. Generally, the number of transmembrane helices of Wzy 
proteins of other E. coli serogroups is variable ranging from 8 (E. coli O157:H7 
strains EDL933, Sakai and an E. coli O7 strain (AAG57099, BAB36267, AF125322), 
to 10 in isolates of serogroup O55, O104 and O111 (AAL67557, AAK64372, 
AAD46730) or 11 in serogroup O4 (U39042) and in K-12 (AAB88404). The function 
of ORF6 could not clearly be defined according to sequence similarity. As N-acetyl-
galactosamine was identified to be present in the O6 O-repeating unit structure, an 
UDP-N-acetylglucosamine-4-epimerase should be encoded within the wbO6 gene 
cluster. However, the deduced amino acid sequence of ORF6 shows a higher 
similarity to UDP-glucose-4- and UDP-galactose-4-epimerases than to the UDP-N-
acetylglucosamine-4-epimerase of E. coli O55 (AF461121) (Wang et al., 2002) (see 
section V.3.1.2, Tab. 6). 
To correlate the genetic and structural analyses (Grozdanov et al., 2003; Fig. 32), the 
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cloned O6 antigen gene cluster of the smooth E. coli strain 536 was compared with 
that of the semi-rough strain Nissle 1917. It was shown that the entire wbO6 gene 
cluster of strain 536 was able to restore full-length O6 side chain synthesis and to 
complement the semi-rough phenotype of E. coli strain Nissle 1917. Therefore, it was 
concluded that the predicted mutation is located in this strain‘s O6 antigen gene 
cluster. Following sequence annotation, a C to A transition within wzyNissle 1917 was 
identified which results in a premature stop codon (TAA). Since the rest of the 
nucleotide sequence of wzy in the E. coli strains Nissle 1917 and 536 was identical, 
the strain Nissle 1917 was complemented with the entire wzy536 as well as with the 
shorter form representing the size of the strain Nissle 1917-specific wzy gene and it 
was proven that only the intact wzy536 is functional and able to restore the O6 side 
chain synthesis in E. coli Nissle 1917.  
 
 
 
Fig. 32: Structure of the complete semi-rough LPS from E. coli Nissle 1917 containing O-antigen-core 
oligosaccharide and lipid A. Incomplete substitution with Etn-P is shown by dashed lines. 
 
Although chromosomally complemented derivatives of strain Nissle 1917 which carry 
one copy of wzy536 in the chromosomal attachment site of the bacteriophage λ, 
expressed less LPS side chains than strain 536, the results demonstrated that 
expression of a functional O6-specific wzy gene results in polymerization of multiple 
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repeating units within the O6 side chains of strain Nissle 1917. The different 
promoter::wzy536 fusions may not be in accordance with the "optimal arrangement" of 
genes and the optimal distance between promoter and wzy translational start as it is in 
the wb* operon. In order to clarify if wzy536 alone is able to restore fully the O6-
antigen polymerization when introduced in wbNissle 1917, allelic exchange was 
performed. The results (Fig. 27) indicated that the entire wb*536 cluster is necessary to 
restore the O6 side chain polymerization in the same degree as in the E. coli strain 
536 and CFT073, whereas the wzyNissle 1917 gene is sufficient to cause a semi-rough 
phenotype when introduced into wb*536. Weaker expression of repeating units in all 
Nissle 1917 strains complemented with wzy536 alone, compared to strains 
complemented with the plasmid-encoded wb* determinant of strain 536, may be 
indicative of other factors which impair proper wb* expression in strain Nissle 1917. 
Since the O6 serotype is widely distributed among wild type (pathogenic and non-
pathogenic) E. coli strains, we studied the importance of full length O6 LPS side 
chains for serum resistance of different derivatives of E. coli strain Nissle 1917 (Fig. 
24b) as this trait represents an important biological feature of this therapeutically used 
E. coli strain with respect to its biosafety. The results showed that the O6 antigen 
expression contributes to serum resistance of these strains. Serum resistance of E. coli 
Nissle 1917 was quantitatively related to the amounts of O6 antigen. This example 
underlines the impact of point mutations for evolution of Enterobacteriaceae in 
addition to DNA rearrangements as well as to acquisition and deletion of large genetic 
determinants. Recent studies showed that the O antigen chain length is critical for the 
virulence properties of Salmonella (Murray et al., 2002), thus supporting the 
presumed contribution of the Nissle 1971 semi-rough phenotype to the biological 
safety and non-pathogenicity of this strain. The O antigen synthesis and chain-length 
regulation is also known to be important for the Shigella flexneri invasion and 
virulence (Hong and Payne, 1997). 
 
4. Structural analysis and sequence comparison of GEI INissle 1917 
 
The GEI INissle 1917 was identified by screening for a cosmid clone coding for 
microcins. The same clone encoded F1C fimbriae, and it was concluded that since 
two fitness factors which are not part of the E. coli K-12 core genome are clustered 
together, this cosmid contains genetic information which might represent a part of a 
genomic island. This island was subsequently sequenced and exhibits genetic 
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organization which is very similar to that of the serX-associated island of UPEC strain 
CFT073. The PAI III536 contains the S-fimbriae-encoding determinant, as well as the 
entire iro gene cluster and some microcin-related sequences. Thus, GEI INissle 1917 and 
PAI III536 exhibit some common structural features and represent examples of one and 
the same “S-fimbrial” island family (Dobrindt et al., 2002; Fig. 10). Nevertheless, 
they differ significantly in their composition and in the fitness factors that are encoded 
(e.g., microcin). In addition, PAI III536 is integrated into the thrW tRNA gene, whereas 
the Nissle 1917-specific thrW gene is probably an integration site for another genomic 
island, since the tRNA screening revealed the same gene located downstream of thrW 
as in the E. coli strain CFT073 genome (c0391).  
 GEI INissle 1917 represents a fitness island, since adhesion- , microcin- , and iron 
uptake-conferring determinants are present, but not any toxin-encoding genes. The 
microcin expression is probably involved in the antagonistic action of E. coli strain 
Nissle 1917, contributing to the successful competition with other bacteria present in 
the intestine during colonization and is therefore believed to be important for its 
probiotic effect. 
 
5. Structural analysis and sequence comparison of GEI IINissle 1917 
 
The identification of an aerobactin-encoding cosmid clone led to the discovery and 
characterization of GEI IINissle 1917. This island comprises a DNA region of about 
100  kb and is integrated into the pheV tRNA gene, that is immediately followed by a 
P4-like integrase-encoding gene. GEI IINissle 1917 contains the determinants coding for 
aerobactin (iuc), a serine protease (sat), an Ag43-homologue (sap), an adhesin (iha), 
and the K5 capsule (kps), thus representing an island responsible for the expression of 
several important fitness traits. Many putative ORFs coding for hypothetical proteins 
with unknown functions are also located on GEI IINissle 1917, together with a 
surprisingly high number (21) of mobility-associated DNA elements, such as 
transposases and IS elements. This suggests that GEI IINissle 1917 has been acquired 
lately during the evolution of E. coli strain Nissle 1917 and is probably unstable, due 
to possible deletion events and rearrangements.  
The expression of the aerobactin iron uptake system is important for the fitness of 
strain Nissle 1917 in the light of the limited availability of iron in the human body. 
Thus, together with the expression of other iron uptake systems (encoded by ent, fec, 
ybt, chu) it contributes to the successful survival and colonization. The aerobactin 
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gene cluster is widely distributed among pathogenic and non-pathogenic Escherichia 
coli and Shigella spp., and is located on plasmids or on genomic islands of different 
structure, composition, and chromosomal localization (Braun et al., 1983; Purdy et al., 
2001; McDougall et al., 1984; Vokes et al., 1999; Welch et al., 2002) . The iha gene 
codes for Iha, a putative non-fimbrial adherence-conferring molecule, which has 
initially been identified as putative siderophore receptor molecule present in the 
genomes of EHEC strains as well as in the genome of UPEC strain CFT073 (Tarr et 
al., 2000; Schmidt et al., 2001). It has been demonstrated that Iha is a non-functional 
adhesin in strain CFT073, but functional in the investigated EHEC strains.  
The serine protease-encoding gene sat is located between the iuc gene cluster and iha 
in GEI IINissle 1917. The secretion of the Sat autotransporter protein and its protease 
activity were demonstrated. Interestingly, although this protein exhibits a cytopathic 
effect, it has been shown that its inactivation did not attenuate virulence of E. coli 
strain CFT073 (Guyer et al., 2002). That is why it cannot be considered a true 
virulence- , but a fitness factor. Another putative autotransporter gene (sap), is also 
located on GEI IINissle 1917 which codes for antigen 43-homologue. It is well known that 
Ag43 expression is important for biofilm formation of E. coli (Danese et al., 2000; 
Kjaergaard et al., 2000; Michaelis, K., and U. Dobrindt, personal communication). 
Therefore, Sap expression may contribute to cell-cell interactions and aggregation of 
E. coli strain Nissle 1917. The K5 capsule-encoding kps gene cluster is also located 
on GEI IINissle 1917 (Fig. 12) and consequently three putative adhesion factors are 
encoded on GEI IINissle 1917 (iha, sap, kps).  
The pheV-associated GEI IINissle 1917 is very similar in its structure and DNA content to 
the pheV-associated island of E. coli strain CFT073, but also exhibits some important 
differences with respect to the genetic determinants located there, gene order, stability 
and presence of mobile genetic elements (Fig. 12). Whereas the K5-specific gene 
cluster is present in GEI IINissle 1917, the K2(?)-specific gene cluster is part of the pheV 
island of CFT073 (pheV-associated GEI CFT073). Although the genes kpsF, E, D, U 
(region 1) and kpsM, T (region 3) are highly homologous and identically organized in 
GEI IINissle 1917 and pheV-associated GEI CFT073, the two kps clusters differ in region 2 
(kfi genes) exhibit no sequence homology. The localization of both kps gene clusters 
with respect to the DNA context in the “CFT073 backbone“ is identical in both 
strains.  
Another striking difference between the two islands is the organization and DNA 
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content of the iuc/sat/iha-region. The genomic islands are often able to delete entirely 
or partially from the chromosome, due to homologous recombination or with the 
participation of different mobile genetic elements (Turner et al., 2001). In GEI IINissle 
1917 these three determinants are located within a possibly deletable DNA region that 
is flanked by two IS2 elements with opposite orientation and that also contains three 
IS/transposase-related ORFs and two putative ORFs of unknown function (IS2-iuc-
sat-ORFs-iha-IS2; Fig. 15a; see section VIII, Tab. 3). The spontaneous deletion of 
this DNA region was shown by exclusion PCR and sequence analysis of the resulting 
PCR product (Fig. 16). Such a deletion event presumably results in 
aerobactin/Sat/Iha-negative Nissle 1917 derivative, whose fitness and colonization 
capacity is likely to be reduced. On other hand, the deletion of sat would abolish the 
cytotoxic activity of the Sat protease. In comparison, in pheV-associated GEI CFT073 
only one copy of the IS2 elements is present and the gene order is different (iha-IS2-
sat-iuc; Fig. 13). The sat and iuc genes have a reversed orientation compared to GEI 
IINissle 1917 and the five ORFs located downstream of iuc are not present in pheV-
associated GEI CFT073.  In this way, the iuc/sat/iha genes are stable, since they are not 
flanked by IS2. One can speculate that the immobilization of iuc and sat in pheV-
associated GEI CFT073 might have played a role for the evolution of E. coli strain 
CFT073, increasing its pathogenic potential.  
In the DNA region between pheV and iha in pheV-associated GEI CFT073, the α-
haemolysin-encoding hly gene cluster and the P-fimbriae-encoding pap operon are 
located, together with other ORFs coding for proteins of unknown or putative 
function. The hly and pap determinants comprise a 30 kb region, which presumably is 
of crucial importance for the virulence properties of E. coli strain CFT073 (Hull et al., 
1994; Johanson et al., 1992; Brauner et al., 1995; Hacker et al., 1986; Linggood and 
Ingram, 1982). Interestingly, only remnants of the pap operon are present in the same 
DNA context in GEI IINissle 1917. Instead of the 30 kb hly/pap region only a fragment of 
papA (papA') and the intact papI gene are present. Immediately upstream of papA' a 
transposon-like element is present. This Tn10-like structure (Fig. 15b; see section 
VIII. Tab. 3) consists of two IS10 elements in opposite orientation, flanking a 
transposase-encoding gene (yedA transposase of Tn10). The transposase gene is 
adjacent to remnant DNA sequences of the papX gene. It is tempting to speculate that 
the intact pap gene cluster had initially been located on GEI IINissle 1917. Later in the 
evolution of strain Nissle 1917 it has been disrupted due to insertion of IS10/Tn10. 
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Having the similar organization and DNA content of GEI IINissle 1917 and pheV-
associated GEI CFT073 in mind, one cannot exclude the possibility that the hly gene 
cluster has also been deleted from GEI IINissle 1917 due to the insertion of the Tn10-like 
element. Since this insertion is responsible for the inactivation of the P-fimbrial and 
probably of the α-haemolysin expression, it represents an important evolutionary 
event, dramatically reducing the virulence capacity of the ancestral proto-Nissle 1917 
strain. The 4 kb Tn10-like structure is putative mobile genetic element which may 
still contribute to the dynamic of genome plasticity of strain Nissle 1917. 
Interestingly, the pheV-associated island PAI V536 of UPEC strain 536 contains the 
kps gene cluster, coding for the K15 capsule expression (Schneider, G., unpublished 
data). Immediately downstream of pheV identical P4 integrase-encoding gene (c3556) 
as in GEI IINissle 1917 and pheV-associated GEI CFT073 is located. Nevertheless, GEI 
IINissle 1917 and PAI V536 exhibit no sequence similarity with exception of the conserved 
kps region 1 and region 2 genes. Thus, although GEI IINissle 1917 and PAI V536 might be 
considered members of one and the same family of pheV-associated capsule-encoding 
islands of E. coli spp. (including pheV-associated GEI CFT073), they seem to be 
evolutionary more distant from each other, than GEI IINissle 1917 and pheV-associated 
GEI CFT073. It is noteworthy that a putative pap-like fimbrial gene cluster (pix) is 
present on PAI V536, although it exhibits homology to pap only on protein, but not on 
DNA level, and most likely it is not functional (Lugering et al.,, 2003; Schneider, G., 
unpublished data). 
 
6. Initial characterization of determinants involved in biofilm formation of E. 
coli strain Nissle 1917 
 
The biofilm formation of E. coli is due to the expression of specific genetic 
determinants which contribute to adhesion to inert surfaces and multicellular 
behaviour of bacteria. The exact mechanism contributing to and importance of 
biofilm formation for colonization of the host or survival in the environment need to 
be further investigated. It is well known that type 1 and curli fimbrial adhesion 
expression is important for the adherence to abiotic surfaces (Cookson et al., 2002). 
Therefore we revealed the complete sequence of the type 1 fimbrial determinant of 
strain Nissle 1917. It is already known that strain Nissle 1917 exhibits an altered type 
1 fimbriation due to a truncation of the fimB recombinase gene due to an insertion 
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element. This fimB inactivation results in an abolished expression of type 1 fimbriae 
under shaking growth conditions in batch cultures, but does not influence the 
expression under static conditions growth (Stentebjerg-Olesen et al., 1999). Five 
different copies of fimBE-like genes have been identified in the genome of E. coli 
strain CFT073, suggesting that phase variation by inversion of a DNA region may 
occur at other regions than the type 1 fimbrial determinant in strain Nissle 1917. The 
manner of the type 1 fimbrial expression in E. coli Nissle 1917 is probably of 
significance for the biofilm formation on abiotic surfaces and especially on 
eukaryotic cell surfaces. It is also known that variations in the FimH adhesin amino 
acid sequence influence this process (Boddicker et al., 2002).  
Expression of curli fimbriae and cellulose is of crucial importance for biofilm 
formation and multicellular behavior of E. coli spp. (Römling et al., 1998; Solano et 
al., 2002). The E. coli strain Nissle 1917 expresses the so-called rdar morphotype 
forming typical tight, dry–looking colonies on agar plates since it co-expresses curli 
fimbriae and cellulose in a temperature-independent manner,. The rdar colonies are 
able to absorb the dye congo red,, adhere better to plastic surfaces and glass, and form 
a pellicle with a tight bacterial network at the air-liquid surface when grown as a 
static culture in rich medium at room temperature. It is not known if this phenotype 
contributes to the successful colonization of the host, but it probably plays a role for 
the survival of E. coli outside the host and may be associated with the probiotic 
character of strain Nissle 1917. Inactivation of the cellulose biosynthesis-encoding 
bcsNissle 1917 gene cluster abolished the rdar morphotype, confirming the critical role of 
the cellulose biosynthesis for biofilm/rdar morphotype formation. Interestingly, the 
rdar morphotype is only rarely distributed among pathogenic and non-pathogenic E. 
coli isolates. The UPEC strain 536 expresses curli fimbriae and cellulose only at 30°C 
(bdar morphotype), whereas strain CFT073 does not express curli fimbriae even at 
30°C (saw morphotype: smooth and white). Thus, it is tempting to speculate that 
strain Nissle 1917 is more adapted for survival outside the host than  pathogenic 
isolates. The fact that the bcs and csg operons are widely distributed among non-
pathogenic and pathogenic E. coli strains, that they are part of the core genome but 
their expression differs dramatically, mirrors (together with the identified frame-shift 
mutation in the wzy gene) a process of accumulation of vertically acquired DNA 
regions and sequence alterations, which contribute to the evolution of the non-
pathogenic, successful colonizing E. coli strain Nissle 1917.  
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Interestingly, a spontaneous loss of the rdar morphotype of Nissle 1917, when 
cultivated on congo red agar plates has been observed (Nagy, G., Grozdanov, L., 
Dobrindt, U., unpublished observation; Fig. 30).  
In addition, the expression of several other determinants located on the chromosome 
may contribute to biofilm formation, e. g. that of Ag43 homologues (e.g., sap, located 
on GEI IINissle 1917)(Kjaergaard et al., 2000). Since the expression of the Ag43-like 
homologues is upregulated upon inactivation of the transcriptional antiterminator 
RfaH protein, a mutant strain Nissle 1917rfaH- was created. Increased cell-to-cell 
interaction, as well as cell-surface aggregation was observed in the strain 536rfaH- 
and Nissle 1917rfaH- during cultivation in microfermentors (Dobrindt et al., 
unpublished data).  
 
7. The genome of the E. coli strain Nissle 1917 
 
In this study, the organization of the fitness determinants of the E. coli strain Nissle 
1917 was revealed. These data were combined with two whole-genome approaches: 
PFGE and PCR-based tRNA screening. Thus, an integrated picture of the E. coli 
strain Nissle 1917 genome was created, allowing to speculate on the evolution of this 
strain (Fig. 33).  
All together, more than 350 kb of the E. coli strain Nissle 1917 genome were 
sequenced (Tab. 9), including the known fitness determinants. Three tRNA genes-
associated genomic islands were identified and completely characterized, on which 
most of the fitness determinants are clustered together. Several new putative fitness 
determinants were identified within these islands (sat, iha, shiA, iro) as well as many 
putative ORFs coding for hypothetical proteins of unknown functions (Tab. 10). 
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Table 9: Compilation of the fitness determinants of strain Nissle 1917 analyzed in this 
study. 
Features, traits encoded Construct Determinants Size [kb] 
Type 1 fimbriae pCos3YC6 fim 36.4 
R1 core LPS  pCos8YA1 wa*, selC, int 47.5 
 GEI IIINissle1917: 
autotransporters 
pCos1YA7 argW 37.9 
pCos9YB4 shiA, iuc, sat 41.4 
pCos2YE4 sat, iha 44.1 
 GEI IINissle1917: aerobactin,  
serine protease,  
put. adhesin, K5 capsule pCos2RF2 kps, sap 39 
pCos3YE4 foc, mcm/mch, iro 48.2  GEI INissle1917:  
F1C fimbriae, microcin pCos2RA4 put. ORFs 38.9 
O6 side-chain LPS pGBW1917 wbO6 11.8 
Cellulose biosynthesis pGBC1917 bcs 10.9 
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Fig. 33: Integrated map of the E. coli strain Nissle 1917chromosome. The position of the putative insertion sites and DNA content of the investigated genomic islands 
(GEIs Nissle 1917) and islets is depicted . The localization of the tRNA genes screened for the presence of non-K-12 DNA sequences as well as the positions of the CeuI 
restriction sites are shown . The presence of putative aspV-associated genomic island is indicated with interrupted lines. 
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Table 10: Number and characteristics of the ORFs identified in the E. coli strain Nissle 1917-specific DNA sequences characterized in this study.  
 
 
 
 
 
 
 
 
cosmid/ 
plasmid/ 
island 
 
ORFs/deleted 
known genes or 
pseudogenes 
 
tRNA 
genes 
 
autotransporters 
 
cell 
structure-
related 
 
hypothetical 
protein; 
unknown 
 
regulation 
 
Tn/IS 
 
fimbriae/ 
adhesion 
nucleotide 
metabolism; 
DNA/RNA 
restr., 
modification; 
methylases 
 
iron 
uptake 
 
microcin-
related 
 
enzymes; 
methabolism 
 
transport 
 
LPS/capsule 
synthesis 
pCos8YA1 43/2 1 - - 7 3 1 - 11 - - 5 3 12 
pBWB1917 9/1 - - - - - - - - - - - - 9 
pCos1YA7 33 1 1 1 13 1 - 5 1 - - 6 4 - 
 GEI INissle 
1917 
68/1 - - - 20 - 6 11 1 5 10 14 1 - 
 GEI IINissle 
1917 
82/3 - 2 2 26 2 21 5 - 5 - 4 1 14 
pCos3YC6 31 - - - 5 3 4 8 2 - - 6 3 - 
pGBC1917 6 - - - - - - - - - - 6 - - 
all 
together: 
272/6 2 3 3 71 9 32 29 15 10 10 41 12 35 
VI. Discussion                                                                                            128 
 
 
 
Fig. 34: Comparative genomic maps of the non-pathogenic and pathogenic E. coli O6 strains Nissle 1917, CFT073 and 536. The chromosomal localization of the major genomic 
islands and islets is depicted. The interrupted lines indicate the presence of islands whose DNA content is still not known. 
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The genomic organization of E. coli Nissle 1917 has been compared with that of the very 
well studied uropathogenic strains 536 (Dobrindt et al., 2002) and the completely 
sequenced strain CFT073 (Welch et al., 2002; Fig. 34). The strain 536 was isolated from 
a patient with pyelonephritis (Blum et al., 1994) and the strain CFT073 was isolated from 
the blood of a patient with acute pyelonephritis (Mobley et al., 1990), whereas the strain 
Nissle 1917 is a faecal isolate. Interestingly, the strain Nissle 1917 shares striking 
similarities concerning the chromosomal structure and organization of the fitness 
determinants (Fig. 34) with the strain CFT073. Having the PFGE data in mind, it is 
tempting to speculate that these two strains have a common clonal origin. Although the 
genetic structure of the investigated genomic islands on which the important fitness-
conferring factors are encoded is very similar, the DNA content differs: no α-haemolysin 
and P-related fimbriae are encoded on the chromosome of strain Nissle 1917. On the 
contrary, the hly and pap gene clusters are located on the pheV-associated GEI CFT073 and 
an additional pap-encoding island is integrated next to the pheU tRNA gene in the 
genome of strain CFT073. The hly and pap genes seem to be replaced by a transposon-
like genetic structure in GEI IINissle 1917, whereas the entire pheU-associated GEICFT073 
island seems to be absent from the genomes of the strains Nissle 1917 and 536. The 
GEI INissle 1917 is almost completely identical to serX-associated GEICFT073 island, and 
probably considerably contributes to the fitness of both strains during colonization. From 
the results of the PCR-based tRNA screening it is evident that most of the tRNA-
associated foreign DNA elements present in the genome of strain CFT073 are also 
present in the genome of strain Nissle 1917. Despite of the similarity in the localization 
and structure of the horizontally acquired foreign DNA between the E. coli strains Nissle 
1917 and CFT073 revealed by the tRNA-screening and the sequence analysis, one should 
have in mind that the DNA content of the genomic islands is not the same. For instance, 
highly homologous P4-like prophage integrases are present downstream of selC tRNA-
encoding gene in the genomes of E. coli strains EDL933, CFT073 and 536, but the selC-
assotiated islands in those strains differ completely. The same is true for the pheV-
associated islands of those strains. 
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The second biggest genomic island of strain CFT073 located at aspV is at least partially 
present in strain Nissle 1917 (since the gene located immediately downstream of aspV is 
identical in both strains), but absent in strain 536. In spite of these similarities between 
the two strains, some differences were identified by screening the sequence context of 
tRNA genes, such as the absence of the pheU-associated island in the genome of strain 
Nissle 1917.  
It is remarkable that the organization and structure of the pathogenicity-related 
determinants of UPEC strains CFT073 and 536 differ considerably with regard to their 
localization and DNA content. The analogous “island pairs” pheV-associated GEI CFT073 - 
PAI V536 and serX-associated GEICFT073 - PAI III536 have different chromosomal 
integration sites and also differ with respect to the presence of some additional fitness  
determinants in the strain CFT073 (iuc, mch/mcm, sat, iha; Fig. 34) which are absent in 
E. coli strain 536. The functional integrity of the virulence factors expressed from both 
UPEC strains, which are absent in the non-pathogenic Nissle 1917, is evident: α-
haemolysin (encoded on PAI I536, PAI II536, and pheV-associated GEI CFT073), P-related 
fimbriae (encoded on PAI II536, pheV-associated GEI CFT073, and pheU-associated 
GEICFT073), and serum resistance-conferring full-length O6 LPS side-chain expression 
(galF-island). Analogous islands coding for adhesins of the S-fimbrial family are present 
in all three strains (serX-located islands of strains CFT073, Nissle 1917 and PAI III536 of 
strain 536). Since there is no clear evidence that S- or F1C-fimbrial expression alone is 
contributing to virulence, one could consider these adhesins fitness factors playing a role 
for colonization. One should also not exclude the possibility that some of the putative 
ORFs are coding for hypothetical proteins which are also important for fitness or 
virulence properties of the investigated strains.  
It is notworthy that the non-pathogenic E. coli strain Nissle 1917 strain possesses a 
surprisingly large set of iron uptake systems (iuc, ybt, fec, ent, chu, iro) compared to the 
UPEC strains, which might significantly contribute to its fitness.  
To further substantiate the analysis of the genome structure of strain Nissle 1917, the 
overall genome content was analyzed by DNA-DNA hybridization experiments with E. 
coli K-12-specific arrays, as well as with the “E. coli Pathoarray”, thus enabling detection 
of virulence- and fitness-associated genes of pathogenic E. coli from different 
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pathogroups (Dobrindt, U., and Plaschke, B., personal communication). The results 
demonstrate again that e.g., adhesins, iron uptake systems and proteases do not 
necessarily have to be considered as virulence-associated factors but can also contribute 
to the fitness and adaptability of bacteria. Although many DNA regions which belong to 
the flexible gene pool of pathogenic E. coli or at least homologoues thereof can be 
detected in the genome of non-pathogenic strain Nissle 1917, those coding for important 
virulence factors of uropathogenic E. coli are absent (protein toxin- or P fimbriae-
encoding genes). 
Having in mind the data on the genomic organization of the E. coli strains Nissle 1917, 
CFT073 and 536 it is tempting to speculate on the evolution of uropathogenicity and 
“non-pathogenicity” of these E. coli strains (Fig. 35). It seems that strain Nissle 1917 
acquired a set of important fitness determinants during evolution, which guarantees 
successful survival and colonization of the human body and most likely represents the 
genetic background for the probiotic action of this E. coli strain. At the same time no 
important virulence factors were identified, suggesting that either “by good fortune” such 
genetic factors were not horizontally transfered to the strain Nissle 1917, or they were 
present but subsequently deleted from the chromosome during adaptation as a non-
virulent successful colonizer of the human intestine. Additionally, the strain Nissle 1917 
exhibits some phenotypic features which are not typical for the UPEC isolates 536 and 
CFT073: the temperature-independent rdar morphotype, a non-FimB dependent type 1 
fimbrial switch, the presence of two plasmids, a semi-rough LPS resulting in serum 
sensitivity. These features might mirror the process of evolutionary withdrawing from 
the pathogenic lineages, probably due to adaptation to the non-pathogenic lifestyle or 
survival in the environment outside the human body. The striking similarities of the 
genome structure between the strain Nissle 1917 and the virulent UPEC strain CFT073 
suggest that these strains have a common evolutionary origin from an ancestral strain, 
but at some time point have been separated and adapted to different lifestyles (Fig. 35).  
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Fig. 35: Schematic representation of the presumed evolutionary relationships between the investigated E. 
coli O6 strains. The interrupted arrows represent possible ways for evolution of the non-pathogenic strain 
Nissle 1917. The interrupted circle indicates the putative presence of an environmentally-adapted proto-
Nissle 1917 variant. 
 
The E. coli strains 536 and CFT073 differ significantly in their structural organization of 
their virulence determinants, but at the end of their, probably independent and separate, 
evolution is a similar virulence capacity and a type of disease they cause.  
Taken all together, the results of this study show that the E. coli strain Nissle 1917 
exhibits a specific combination of phenotypic features due to acquisition of foreign DNA 
elements, loss of genetic information and minor genetic events (e. g., point mutations), 
which contribute to its probiotic nature and distinguish this strain from UPEC O6 strains 
as well as from other non-pathogenic E. coli isolates studied so far. 
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Table 1: Primers for amplification of PAI III536-specific sequences (Dobrindt et al., 2001). 
 
PCR number Position Gene name Primer Sequence (5‘ > 3‘) PCR product 
(bp) 
1  thrW thrW CCACCGTGATTCACGTTCG  
 1404-1422 SfX integrase III.1 AGGCACTATCACGCAGTGG 1455 
2 1404-1422 SfX integrase III.2 CCACTGCGTGATAGTGCCT  
 3583-3601 IS100 integrase III.3 AGCCCATCGCTATTGCCAG 2198 
3 3583-3601 IS100 integrase III.4 TCTGGCAATAGCGATGGGC  
 5606-5624 pifA III.5 CCACACGCAGACAACCTTC 2042 
4 5606-5624 pifA III.6 GAAGGTTGTCTGCGTGTGG  
 7700-7018 DAHP-Synthetase III.7 GGCGAGCATATCGTATCCC 2112 
5 7700-7018 DAHP-Synthetase III.8 GGGATACGATATGCTCGCC  
 9875-9893 LEE, IS tnpA III.9 TGCTGACGAAATGCCGGAG 2193 
6 9875-9893 LEE, IS tnpA III.10 ACTCCGGCATTTCGTCAGC  
 11908-11926 ColV III.11 TCATTCCCGTCACCTCCAG 2052 
7 11908-11926 ColV III.12 TCTGGAGGTGACGGGAATG  
 14064-14082 unknown/int  
Shigella 
III.13 CTGCTGAACAAAACGCCGG 2174 
8 14064-14082 unknown/int  
Shigella 
III.14 GCGCGCTTTACTGTGTCTG  
 15701-15719 sfaC III.15 GGTATGGTTCAGCGCTCTC 1760 
9 15701-15719 sfaC III.16 GAGAGCGCTGAACCATACC  
 17301-17319 sfaA III.17 CTTTAAAGGTGGCGTCGGC 2571 
10 17301-17319 sfaA III.18 GCCGACGCCACCTTTAAAG  
 19423-19441 sfaF III.19 ACCACGGGCCTGATTACTC 1965 
11 19423-19441 sfaF III.20 TGAGTAATCAGGCCCGTGG  
 21597-21615 sfaG III.21 ACTGCCGCAGGAGGTTAAC 2401 
12 21597-21615 sfaG III.22 GTTAACCTCCTGCGGCAGT  
 23526-23544 sfaH III.23 TCACTGACTGGACAGCACC 1739 
13 23526-23544 sfaH III.24 GGTGCTGTCCAGTCAGTGA  
 25825-25843 iroN III.25 GTGCAAGAGTGAGCCTCTG 1674 
14 25825-25843 iroN III.26 CAGAGGCTCACTCTTGCAC  
 27959-27977 iroE III.27 TAGCGCCTGAAGCGGTTTG 2194 
15 27959-27977 iroE III.28 ATGCCGGAGTTACCGCATC  
 30188-30206 iroD III.29 GCGAAGCTGAGTCGCTGAA 2249 
16 30188-30206 iroD III.30 TTCAGCGACTCAGCTTCGC  
 32242-32260 iroC III.31 CCAGCGACACAAGACGATG 2072 
17 32242-32260 iroC III.32 CATCGTCTTGTGTCGCTGG  
 34415-34433 iroB III.33 CCACAAATCGTCTTCGGCC 2192 
18 34415-34433 iroB III.34 GGCCGAAGACGATTTGTGG  
 36505-36523 IS 4 III.35 GATGCAACTGAGCAGGCTG 2108 
19 40206-40224 HmuR HmuR.1 AGGCAGCGACCAGTCATTC  
 42067-420085 HmuR.2 AGTTCTGCCTGAAAGCGGC 1880 
20 42166-
42184 
NMA1686 NMA1686.1 TTGTCTGACAGCATCGGGG  
 42900-
42919 
 NMA1686.2 TCGGGAGAAGCTTAAGGTTG 752 
21 43217-
43235 
Protein  
B. halodurans 
Bachalo.1 ATGGTTTCCTTGGCGCAGG  
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 44323-
44341 
 Bachalo.2 CACCTGATTGCCACCAGAC 1130 
22 37574-
37592 
IS-ORFs 9-11 III-22.1 TACGCTGCTTGCCAGCTTG  
 39412-
39430 
 III-22.2 TCTGTCCTGATGTACGCCC 1866 
23 44212-
44230 
IS100-Tnp III-23.1 ATGGGGCGGTTTGGAGACA  
 46321-
46339 
 III-23.2 TTGCACGCAGTTATGCCGG 2127 
24 46321-
46339 
IS fragments 17-19 III-24.1 CCGGCATAACTGCGTGCAA  
 48430-
48448 
 III-24.2 TGCAAGCACTCAGCAGTGC 2127 
25 48430-
48448 
iciA III-25.1 GCACTGCTGAGTGCTTGCA  
 49203-
49221 
 III-25.2 GTTTTACAGAGCGGCCCGA 791 
26 49415-
49442 
lysU-like III-26.1 ATTCCCAGACCTGCAGTCG  
 50759-
50777 
 III-26.2 TAAGACAACTTCGCGCCCG 1353 
27 50759-
50777 
ORF22 III-27.1 CGGGCGCGAAGTTGTCTTA  
 52075-
52093 
 III-27.2 GGTCTGTATCGAAAGGCGG 1334 
28 52075-
52093 
cadA III-28.1 CCGCCTTTCGATACAGACC  
 54063-
54081 
 III-28.2 GCACTGAACTGGCTGGTTG 2006 
29 54063-
54081 
cadB III-29.1 CAACCAGCCAGTTCAGTGC  
 55409-
55427 
 III-29.2 TCTTCCTGCAAGTCTGGCG 1364 
30 59322-
59340 
sap III-30.1 TCTGGATGTGCTGAGCGGA  
 61211-
61229 
 III-30.2 ATGTTACTGCCGGCTGCGG 1907 
31 65528-
65547 
unknown/int Shigella III-31.1 TATTGAACAGGCCAGGGAAG  
 67207-
67225 
 III-31.2 GCATCTGGTGGCTATGGAAT 1698 
32 70163-
70182 
Haemoglobin protease III-32.1 ACGGTATCCGACTTCTGCAC  
 71943-
71962 
 III-32.2 TTGGTTATGGACGGCTCAGC 1801 
33 73105-
73124 
Haemoglobin protease/ISO-IS1 III-33.1 AAGAGGGCAGGATGCTATGA 
 74985-
75005 
 III-33.2 ATTTTGCCGGTCAGGTATTTC 1900 
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Table 2: Characteristics of the ORFs located the  GEI INissle1917. 
 
Putative 
ORF 
nt positions 
[bp] 
Accession no. DNA 
homology to 
Similar of the encoded protein Identity of the aa 
sequence (%)  
 
Function  
ORF1 776-1264 AE016758 
 
partial c1176 
 
Hypothetical protein  
 
163/163 (100%) 
NP_753101  
unknown 
ORF2 2275-2775 AE016758 c1179 
(Escherichia 
coli K-12 
B3128 
pseudogene) 
 
D-galactarate dehydratase  
 
145/165 (87%) 
NP_755750  
putative enzyme 
ORF3 2857-3318 AE016758 partial c1180  D-galactarate dehydratase  77/95 (81%) 
NP_755750 
putative enyzme 
ORF4 3278-3782 AE016758 c1183 
 
D-galactarate dehydratase  
 
 
123/174 (70%) 
NP_755750 
unknown 
ORF5 4556-5785 AE016758 c1186 
 
Putative beta-ketoacyl-ACP synthase 
 
409/409 (100%) 
NP_753105 
 
putative enzyme; Fatty acid biosynthesis: 
Fatty acid and phosphatidic acid 
biosynthesis 
ORF6 5782-6513 AE016758 c1187 3-oxoacyl-[acyl-carrier protein] reductase 
 
229/243 (94%) 
NP_753106 
 
enzyme; Fatty acid and phosphatidic acid 
biosynthesis 
 
ORF7 6513-6977 AE016758 c1188 Conserved hypothetical protein 
 
145/154 (94%) 
NP_753107 
unknown 
ORF8 6974-8152 AE016758 c1189 Putative 3-oxoacyl-[ACP] synthase 
 
362/392 (92%) 
NP_753108 
putative enzyme; Fatty acid biosynthesis: 
Fatty acid and phosphatidic acid 
biosynthesis 
ORF9 8145-8729 AE016758 c1190 Conserved hypothetical protein 
 
184/194 (94%) 
NP_753109 
unknown 
ORF10 8736-11044 AE016758 c1191 Conserved hypothetical protein 
 
 687/769 (89%) 
NP_753110 
unknown 
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ORF11 11013-11618 AE016758 c1192 Conserved hypothetical protein 
 
191/201 (95%) 
NP_753111 
unknown 
ORF12 11615-12037 AE016758 c1193 Hypothetical protein 
 
139/140 (99%), 
NP_753112 
unknown 
ORF13 12041-13717 AE016758 c1194 Putative enzyme 
 
540/540 (100%) 
NP_753113 
putative enzyme  
ORF14 14048-15406 AE016758 c1197 Putative enzyme 452/452 (100%),  
NP_753116 
putative enzyme; Fatty acid biosynthesis: 
Fatty acid and phosphatidic acid 
biosynthesis 
 
ORF15 15403-15984 AE016758 c1198 Conserved hypothetical protein  
 
142/193 (73%) 
NP_753117 
unknown 
ORF16 15989-16240 AE016758 c1199 Putative acyl carrier protein 
 
83/83 (100%) 
NP_753118 
putative carrier; Fatty acid biosynthesis: 
Fatty acid and phosphatidic acid 
biosynthesis 
ORF17 16252-16509 AE016758 c1200 Putative acyl carrier protein 
 
85/85 (100%) 
NP_753119 
putative carrier; Fatty acid biosynthesis: 
Fatty acid and phosphatidic acid 
biosynthesis 
ORF18 16484-17323 AE016758 c1201 Putative phospholipid biosynthesis 
acyltransferase 
224/279 (80%) 
NP_753120 
putative enzyme  
ORF19 17302-18024 AE016758 c1202 Conserved hypothetical protein 
 
240/240 (100%) 
NP_753121 
unknown 
ORF20 18065-19123 AE016758 c1203 Putative O-methyltransferase 
 
352/352 (100%) 
NP_753122 
putative enzyme 
ORF21 19188-19577 AE016758 c1204 Conserved hypothetical protein 
 
129/129 (100%) 
NP_753123 
unknown 
ORF22 20468-22869 AE016758 partial c1205 Hypothetical protein  
 
786/799 (98%) 
NP_753124 
unknown 
ORF23 22828-25632 AE016758 c1206 
c1207 
Putative member of ShlA/HecA/FhaA exoprotein 
family  
788/930 (84%) 
NP_752286  
putative enzyme 
ORF24 25469-26077 AE016758 partial to c1207 Hypothetical protein 53/53 (100%) 
NP_752286 
unknown 
 
 
VIII. Supplements         
  
150
Table 2 continued 
ORF25 26153-26530 AE016758 c1208 Hypothetical protein 
 
75/104 (72%) 
NP_753127 
unknown 
ORF26 27395-27814 AE016758 partial c1209 
c1210 
c1211 
Hypothetical protein  
 
135/139 (97%) 
NP_755482 
unknown 
ORF27 27909-28481 AE016758 partial c1211 
c1212 
Hypothetical protein  
 
154/201 (76%) 
NP_755482  
unknown 
ORF28 29010-29213 AE016758 partial c1213 Hypothetical protein 67/67 (100%) 
NP_753130 
unknown 
ORF29 29374-29664 AE016758 partial c1214 Cea protein 
 
35/52 (67%) 
NP_753131 
putative 
ORF30 30287-30496 AE016758 c1215 Entry exclusion protein 2  
 
69/69 (100%) 
NP_753132 
putative 
ORF31 30656-30856  partial c1216 
c1217 
Hypothetical protein 
 
38/39 (97%) 
NP_753133; 
19/19 (100%) 
NP_753134 
unknown 
ORF32 31185-31688 AE016758 c1218 Hypothetical protein 167/167 (100%) 
NP_753135 
unknown 
ORF33 31660-32061 AE016758 partial c1219 Putative Transposase 
 
133/133 (100%) 
NP_753135 
putative transposase  
ORF34 31968-32204 AE016758 partial c1219 Putative Transposase 78/78 (100%) 
NP_753135 
putative transposase  
ORF35 32605-32793 AF302690 
 
ORF6 PAI 
III536 
Hypothetical protein  62/62 (100%) 
CAD66177  
unknown 
ORF36 33354-34388 AF302690 ORF7 PAI 
III536 
Hypothetical protein  330/344 (95%) 
CAC43413  
unknown 
ORF37 32265-36206 AE016758 c1223 
c1224 
Transposase of insertion element IS3  
 
281/284 (98%) 
CAC43414  
IS, phage, Tn; Transposon-related 
functions 
ORF38  37234-37353 AJ009631 mchX Protein (MchX) 
 
18/39 (46%) 
O86199  
 
required for microcin H47 production. 
possibly involved in a regulatory loop 
modulating its own expression and that of 
mchB and mchB. 
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ORF39  37422-37631 AJ009631  
 
mchI Microcin H47 immunity protein (MchI) 
 
 51/69 (73%) 
CAA66217  
protects microcin H47 producing cell 
against microcin H47 
ORF40  37648-37875 AJ009631  
 
mchB (MchB) protein 
 
AAN79685  
 
putative, microcin production 
ORF41  38147-39697 AE016758 mchC (MchC) protein 
 
516/516 (100%) 
NP_753143  
putative, microcin production 
ORF42  39723-40175 AE016758  
 
mchD (MchD) protein  
 
150/150 (100%) 
NP_753144 
putative, microcin production 
ORF43  40361-41599 AE016758 mchE Microcin H47 secretion protein (MchE) 
 
394/413 (95%) 
NP_753145 
putative, microcin secretion 
ORF44  41595-43691 AE016758 mchF Probable microcin H47 secretion ATP-binding 
protein (MchF) 
671/698 (96%) 
NP_753146 
putative, microcin production 
ORF45  43727-43948 AF302690 ORF11 PAI 
III536 
Hypothetical protein 58/73 (79%) 
CAC43416  
putative, microcin production 
ORF46  43945-44223 AF302690  
 
ORF12 PAI 
III536 
microcin V bacteriocin  
 
29/70 (41%) 
AAC16357 
putative, microcin production 
ORF47  44398-45084 AF302690 partial ORF13 
PAI III536 
Hypothetical protein 221/228 (96%) 
CAC43418  
putative, microcin production 
ORF48 45184-45654 AF302690 ORF14 PAI 
III536 
Hypothetical protein 152/156 (97%) 
CAC43419 
unknown 
ORF49 47698-47919 AF302690 sfaC 
 
regulatory protein (SfaC) 73/73 (100%) 
CAC16949  
involved in regulation of Shigella fimbriae 
expression; putative F1C and S fimbrial 
switch regulatory protein 
 
ORF50 48338-48446 AE016758 sfaB (SfaB) protein  
 
36/36 (100%) 
CAC43422 
involved in regulation of Shigella fimbriae 
expression; putative F1C and S fimbrial 
switch regulatory protein 
ORF51 49039-49581 AE016758 focA 
 
F1C major fimbrial subunit precursor (FocA) 
 
180/180 (100%) 
NP_753153  
structural component; surface structures 
 
ORF52 49667-50191 AE016758 sfaD Putative minor subunit precursor (SfaD) 173/173 (100%) 
NP_753154 
structural component; surface structures 
 
ORF53 50232-50927 AE016758 focC F1C periplasmic chaperone (FocC) 
 
231/231 (100%) 
NP_753155  
structural component; surface structures 
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ORF54 50997-53627 AE016758 focD F1C fimbrial usher (FocD) 876/876 (100%) 
NP_753156 
membrane; outer membrane constituents 
 
ORF55 53640-54167 AE016758 focF F1C minor fimbrial subunit F precursor 
(FocF) 
175/175 (100%) 
NP_753157 
structural component; surface structures 
 
ORF56 54189-54692 AE016758 focG F1C minor fimbrial subunit protein G precursor 
(FocG) 
167/167 (100%) 
NP_753158 
structural component; surface structures 
ORF57 54754-55653 AE016758 focH F1C Putative fimbrial adhesin precursor 
(FocH) 
299/299 (100%) 
NP_753159 
structural component; surface structure 
ORF58 55957-56697 AE016758 c1246 
 
Hypothetical protein 246/246 (100%) 
NP_753160 
unknown 
ORF59 56895-57396 AE016758 focX Putative Regulatory protein (FocX) 
 
166/166 (100%) 
NP_753161 
putative regulator 
ORF60 57721-58758 AE016758 c1248 Hypothetical protein  
 
345/345 (100%) 
NP_753162 
putative transposase related 
ORF61 58988-61165 AE016758 iroN Siderophore receptor (IroN) 
 
711/725 (98%) 
NP_753164 
membrane; transport of small molecules 
 
ORF62 61210-62166 AE016758 iroE IroE protein 
 
302/318 (94%) 
NP_753165 
putative exported protein 
 
ORF63 62251-63480 AE016758 iroD IroD protein, ferric enterochelin esterase 
 
398/409 (97%) 
NP_753166 
putative esterase 
ORF64 63584-67369 AE016759 iroC ATP binding cassette (ABC) transporter 
homolog (IroC) 
1150/1245 (92%), 
NP_753167 
putative transport 
ORF65 67383-68498 AE016759 iroB Putative glucosyltransferase (IroB) 
 
359/371 (96%) 
NP_753168 
putative sugar transferase 
ORF66 69513-69796 AE016759 partial to c1256 Hypothetical protein 
 
94/94 (100%) 
AAN78568  
putative transposase related 
ORF67 70063-70310 AE016759 partial to 
c1256, c1257 
Hypothetical protein 75/78 (96%) 
CAD66180 
putative IS, Tn related 
 
ORF68 70098-70460 AE016759 partial to  
c1257 
Hypothetical conserved protein 75/78 (96%) 
CAD66180 
putative IS, Tn related 
 
ORF69 71335-71769 AE016759 c1259 Hypothetical protein 100/118 (84%) 
NP_753173 
unknown 
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tRNA 71977-72053 AE016759 c5534 tRNA arg - tRNA 
ORF 70 72332-72790 AE016759 c1260 Putative Transposase 151/152 (99%) 
NP_753174 
 
putative enzyme; transposases insertion 
sequence associated 
ORF 71 72802-73695 AE016759 ORF35 (PAI 
III536) 
Hypothetical protein (PAI III) 265/297 (89%) 
CAD66183 
unknown 
ORF 72 74041-76011 AE016759 c1265 Outer membrane heme/hemoglobin receptor, 
membrane; Transport of small molecules:Cations 
645/656 (98%) 
NP_753179 
 
putative membrane-related; transport of 
small molecules:cations 
ORF 73 76030-76821 AE016759 c1266 Hypothetical protein  263/263 (100%) 
NP_753180  
 
unknown 
ORF 74 77085-78284 AE016759 partial to c1267 Hypothetical protein 386/399 (96%) 
NP_753181 
 
unknown 
ORF 75 79235-80371 AE016759 c1269 Hypothetical protein 354/378 (93%) 
NP_753183 
 
unknown 
ORF 76 80407-80494 AE016759 c1270 Hypothetical protein 180/180 (100%) 
NP_753184 
unknown 
ORF 77 81888-82247 AE016759 - Hypothetical protein 30/118 (25%) 
P02985 
 
unknown 
ORF 78 82456-82785 AE016759 - Hypothetical protein 33/87 (37%) 
NP_294168 
 
unknown 
ORF 79 82799-83104 AE016759 - Hypothetical protein - unknown 
ORF 80 83880-84791 AE016759 c1272 Hypothetical protein (YeeP) 290/290 (100%) 
NP_753186 
 
putative structure 
ORF 81 84966-88241 AE016759 c1273 Antigen 43 precursor 1064/1091 (97%) 
NP_753187 
 
membrane; outer membrane constituents 
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ORF 82 88356-90878 AE016759 c1274 Hypothetical protein (YeeR) 749/829 (90%) 
NP_753188 
unknown 
ORF 83 90954-91409 AE016759 c1275 Hypothetical protein 151/151 (100%) 
NP_753189 
unknown 
ORF 84 91820-92641 AE016759 c1278 Hypothetical protein (yafZ) 271/271 (100%) 
NP_753193 
 
unknown 
ORF 85 92898-93857 AE016759 c1281 Hypothetical protein 319/319 (100%) 
NP_753195 
unknown 
ORF 86 94172-94816 AE016759 c1285 Hypothetical protein  214/214 (100%) 
NP_753198  
 
unknown 
ORF 87 94758-95240 AE016759 partial to 
c1285, c1286, 
c1287 (entire),  
Hypothetical protein 151/160 (94%) 
AAL67343 
 
unknown 
ORF 88 95185-95667 AE016759 partial to 
c1287, entire 
c1288 
Hypothetical protein (YeeV) 126/126 (100%) 
NP_753201  
 
unknown 
ORF 89 95664-96152 AE016759 c1289 Unknown protein encoded within prophage 149/162 (91%) 
NP_753202 
phage or prophage related 
ORF 90 95935-96369 AE016759 partial to 1289, 
c1290 
Hypothetical protein  77/94 (81%) 
AAD32187 
unknown 
tRNA 97477-97534 AE016759 c5535 tRNA serX - tRNA 
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Table 3: Characteristics of the ORFs located the  GEI IINisle 1917. 
 
Putative 
ORF 
nt positions 
[bp] 
Accession no. DNA 
homology to 
Similar of the 
encoded protein 
Identity of the aa sequence (%)  
 
Function  Putative ORF 
tRNA 1-76 AE016766 tRNA pheV - - - tRNA 
ORF1 274-1539 AE016766 c3556 
 
1263/1263 (100%) Prophage P4 integrase 
 
421/421 (100%) 
NP_755431  
IS, phage, Tn; Phage-related 
functions and prophages 
ORF2 1765-2838 AE016766 c3557 1069/1074 (99%)  
 
ShiA homolog 
 
344/347 (99%) 
NP_755432 
unknown 
ORF3 2891-3211 AE016766 c3558 222/231 (96%) 
 
Hypothetical protein 
 
75/76 (98%) 
NP_756355  
unknown 
ORF4 3368-3643 J01729 M25736 insA 276/276 (100%) 
 
Hypothetical protein (InsA) 91/91 (100%) 
CAA11401  
putative IS10-related 
ORF5 3562-4065 J01729 M25736 insB 501/504 (99%) 
 
Hypothetical protein (InsB) 166/167 (99%) 
AAK97138  
putative IS10-related 
ORF6 4531-4947 AE016766  
 
∆papX (last 
135 nt lacking) 
398/417 (95%) 
 
PapX protein 131/138 (94%) 
NP_755457  
not functional; surface 
structures, Pap-fimbriae 
synthesis 
ORF7 5088-6296 AP000342  
 
yedA 1206/1209 (99%)  
 
Transposase of Tn10 402/402 (100%) 
AAB28848  
putative transposon-related 
8 6312-6528 AE016766 ∆papX (first 
335 nt lacking) 
208/217 (95%) 
 
PapX protein 64/72 (88%) 
NP_755457 
not functional; surface 
structures, pap-fimbriae 
synthesis 
ORF9 6800-7303 J01729 M25736 insB 501/504 (99%) 
 
Hypothetical protein (InsB) 166/167 (99%) 
AAK97138  
putative IS10-related 
ORF10 7222-7497 J01729 M25736 insA 276/276 (100%) 
 
Hypothetical protein (InsA) 91/91 (100%) 
CAA11401 
putative IS10-related 
11 7967-8127 AE016766 
 
∆papA lacking 
149 nt from the 
beginning  
151/161 (93%) 
 
PapA fimbrial protein precursor 
 
47/53 (88%) 
NP_755467 
 
not functional; surface 
structures, pap-fimbriae 
synthesis 
ORF12 9020-9253 AJ494981 
 
papI (prfI) 230/234 (98%) 
 
Transcription regulator (PapI)  
 
74/77 (96%) 
RGECPI  
transcription regulation 
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ORF13 9904-10515 AE016766 c3594 
c3595 
1292/1310 (98%) 
350/358 (97%) 
Putative transposase IS629 
 
284/296 (95%) 
NP_757061 
putative enzyme; 
Transposases 
ORF14 10704-
11030 
AE016766 c3596 323/327 (98%) 
 
Hypothetical protein in IS 
 
81/108 (75%) 
CAC37925  
Insertion Sequence 
Associated 
ORF15 11770-
12516 
AE016766 c3597 735/747 (98%) 
 
Putative Transposase 
 
224/248 (90%) 
AAF60967 
Insertion Sequence 
Associated 
ORF16 12575-
13071 
AE016766 partial c3598 314/315 (99%) 
 
Hypothetical protein 90/104 (86%) 
AAC61723  
unknown 
ORF17 13068-
13328 
AE016766 c3599 257/257 (100%) 
 
Hypothetical protein 86/86 (100%) 
NP_755474 
unknown 
ORF18 13370-
13930 
AE016766 c3600 559/561 (99%)  
 
Hypothetical protein 184/186 (98%) 
NP_755475 
unknown 
ORF19 13940-
14398 
AE016766 c3601 457/459 (99%) 
 
Hypothetical protein 150/152 (98%) 
NP_755476 
unknown 
ORF20 15679-
16335 
AE016766 partial c3602 646/657 (98%) 
 
IS2-related hypothetical protein 
(transposase) 
215/218 (98%) 
NP_755486  
putative IS2-related 
21 15016-
16346 
AB079602  
 
IS2 1294/1331 (97%) 
 
IS2-repeat region; Insertion element 
IS2A hypothetical 48.2 kDa protein; 
belongs to transposase family 8. 
283/304 (93%) 
P51026  
Transposable element 
 
ORF22 16448-
17641 
AE016766 shiF 1189/1194 (99%)  
 
ShiF protein 
 
370/397 (93%) 
NP_709453  
putative membrane protein 
ORF23 17720-
19501 
AE016766 iucA 1772/1782 (99%)  
 
IucA protein 583/593 (98%) 
AAD44746  
putative aerobactin 
siderophore synthetase 
ORF24 19502-
20449 
AE016766 iucB 941/948 (99%) 
 
IucB protein 313/315 (99%) 
NP_755501  
putative siderophore 
biosynthesis  
ORF25 20449-
22191 
AE016766 iucC 1707/1740 (98%)  
 
IucC protein 576/580 (99%) 
NP_755500  
putative siderophore 
biosynthesis 
ORF26 22188-
23465 
ECU90207  
 
iucD 1268/1268 (100%)  L-lysine 6-monooxigenase (lysine N6-
hydroxylase) (IucD) 
425/425 (100%) 
P11295 
putative siderophore 
biosynthesis 
ORF27 23547-
25748 
ECDF13RE 
 
iutA 2188/2202 (99%) 
 
Ferric aerobactin receptor precursor 
(IutA)  
701/733 (95%) 
P14542 
putative siderophore 
biosynthesis 
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ORF28 26692-
30579 
AE016766 sat 3854/3888 (99%) 
 
Secreted autotransporter toxin (Sat)  1258/1295 (97%) 
NP_755494  
serine protease 
ORF29 31176-
32276 
AJ278144  
 
ORF13 1096/1098 (99%)  Hypothetical protein IS30-related (InsI); 
putative transposase 
350/366 (95%) 
P37246  
IS, phage, transposon-
related  
ORF30 33665-
34483 
AE016766 c3575 818/819 (99%) 
 
Transposase insF for insertion sequence 
IS3A/B/C/D/E/Fa 
251/272 (92%), 
NP_755450 
IS, phage, transposon-
related  
ORF31 35250-
35933 
AF336309 
 
77-626 nt 
homologous to 
588-1137 nt of 
pYVe8081 
 
441/550 (80%)  
 
Hypothetical protein 71/191 (37%) 
NP_052891 
 
unknown; possible 
transposase 
ORF32 36476-
36898 
AF386526  
 
CP0118 
 
406/418 (97%)  
 
IS1353 putative transposase-like protein 135/139 (97%) 
AAL72503  
IS, phage, transposon-
related  
ORF33 38092-
38364 
AF081285  
 
r8 272/273 (99%) neurotensin receptor R8 
 
89/90 (98%) 
AAC61726  
putative 
ORF34 38873-
39121 
AF081285 r7 248/249 (99%) 
 
maltopentaose forming amylase R7 59/82 (71%) 
AAC61727  
enzyme, sugar methabolism 
ORF35 40343-
42433 
AE016766 iha 2085/2091 (99%) 
 
Putative receptor/adhesin (Iha) 
 
667/696 (95%) 
NP_309387 
 
putative membrane; ell 
envelope: Outer membrane 
constituents 
ORF36 42933-
43589 
AE016766 partial c3612 646/657 (98%) 
 
IS2-related hypothetical protein 
(transposase) 
215/218 (98%) 
NP_755486  
putative IS2-related 
37 42922-
44252 
AB079602  
 
IS2 1294/1331 (97%) 
 
IS2-repeat region; Insertion element IS2 
hypothetical 48.2 kDa protein; belongs 
to transposase family 8. 
283/304 (93%) 
P51026  
Transposable element 
 
ORF38 44313-
45302 
AE016766 c3630 
 
989/989 (100%) 
 
Hypothetical protein YjhS precursor  329/329 (100%) 
NP_755505  
unknown 
ORF39 45392-
45760 
AE016766 partial c3631 319/343 (93%) 
 
Hypothetical transcriptional regulator 
(YhcK)  
70/114 (61%) 
NP_755846 
putative regulator 
ORF40 46169-
47104 
AE016766 partial c3632 913/939 (97%) 
 
Hypothetical protein  
 
268/318 (84%) 
NP_755508 
unknown 
ORF41 47154-
48263 
AE016766 c3634 1076/1110 (96%) 
 
Hypothetical protein YjhT precursor  368/369 (99%) 
NP_755509 
unknown 
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ORF42 48276-
48986 
AE016766 c3635 
 
446/453 (98%) 
 
Hypothetical protein YjhA precursor 226/236 (95%) 
NP_755510 
unknown 
ORF43 49032-
49862 
AE016766 c3636 815/831 (98%) 
 
Hypothetical protein 
 
268/269 (99%) 
NP_755511 
unknown 
ORF44 49866-
51338 
AE016766 c3637 1473/1473 (100%) Putative sialic acid transporter  474/490 (96%) 
NP_755512 
transport; murein sacculus, 
peptidoglycan 
ORF45 51387-
52262 
AE016766 c3638 876/876 (100%) 
 
Hypothetical protein (YhcI) 
 
279/291 (95%) 
NP_755513 
putative regulator 
 
ORF46 52296-
53213 
AE016766 c3639 889/897 (99%) N-acetylneuraminate lyase subunit 305/305 (100%) 
NP_755514 
enzyme; surface 
polysaccharides  
ORF47 54296-
54646 
AE016766 partial c3641 351/351 (100%) 
 
Unknown in ISEc8 
 
116/116 (100%) 
NP_755516 
Insertion sequence 
associated 
ORF48 54677-
55777 
AE016766 c3643 
 
1092/1101 (99%)  
 
Unknown in ISEc8 325/366 (88%) 
NP_755518 
Insertion sequence 
associated 
ORF49 55774-
57312 
AE016766 partial c3645 1539/1539 (100%) Unknown protein encoded by ISEc8 
within prophage 
512/512 (100%) 
NP_755520 
Insertion sequence 
associated 
ORF50 60185-
60481 
AE016766 partial c3650 282/293 (96%) 
 
Hypothetical protein no significant match unknown 
ORF51 60770-
61342 
AE016766 partial c3651 573/573 (100%) 
 
Hypothetical protein 177/190 (93%) 
NP_755526 
unknown 
ORF52 61463-
62953 
AE016766 partial c3652 1472/1491 (98%) 
 
Hypothetical protein (YfjI) 
 
461/496 (92%) 
NP_755527 
unknown 
ORF53 64285-
65157 
AE016766 c3654 873/873 (100%) 
 
Hypothetical protein (YeeP) 
 
290/290 (100%) 
NP_755529 
putative structure 
 
ORF54 65485-
68613 
AE016766 c3655 (sap) 3024/3129 (96%) 
 
Antigen 43 precursor (Sap) 
 
960/1042 (92%) 
NP_755530 
membrane; outer membrane 
constituents 
ORF55 68744-
69835 
AE016766 partial c3664 1088/1092 (99%) 
 
Hypothetical protein (YeeR) 
 
320/352 (90%) 
NP_753188 
unknown 
ORF56 69911-
70366 
AE016766 c3665 
 
456/456 (100%) 
 
Hypothetical protein 151/151 (100%) 
NP_755540 
unknown 
ORF57 70779-
71597 
AE016766 c3668 
 
818/819 (99%)  
 
Hypothetical protein (YafZ) 
 
257/272 (94%) 
NP_755543 
unknown 
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ORF58 71652-
72137 
AE016766 c3669 485/486 (99%) 
 
Hypothetical protein (YfjX) 
 
148/161 (91%) 
NP_755544 
unknown 
ORF59 71706-
72617 
AE016766 c3670 909/912 (99%) 
 
Hypothetical protein 300/303 (99%) 
 NP_755545 
unknown 
ORF60 72626-
73354 
AE016766 c3672 677/683 (99%) 
 
Hypothetical protein 228/242 (94%) 
NP_755547 
unknown 
ORF61 72932-
73576 
AE016766 c3674 629/645 (97%)  
 
Hypothetical protein 
 
209/214 (97%) 
NP_755549 
unknown 
ORF62 73518-
73994 
AF453442  
 
RorfE 
 
452/477 (94%) 
 
Hypothetical protein 145/158 (91%) 
AAL57576  
unknown 
ORF63 74457-
74945 
AE016766 c3678 486/489 (99%) 
 
Conserved hypothetical protein 
 
150/162 (92%) 
NP_755553 
unknown 
ORF64 74728-
75159 
AE016766 partial c3678, 
c3679 
428/432 (99%) 
 
Hypothetical protein 80/110 (72%) 
AAD32187  
unknown 
ORF65 75241-
76089 
AJ488511 z1226 259/278 (93%) 
 
Hypothetical protein 259/278 (93%) 
CAD33792 
unknown 
ORF66 76158-
76553 
AE016766 c3681 
 
395/396 (99%) 
 
Hypothetical protein 130/131 (99%) 
NP_755556 
unknown 
ORF67 76546-
77286 
AE016766 partial c3682 741/742 (99%) 
 
Hypothetical protein 243/243 (100%) 
NP_755557 
unknown 
ORF68 78877-
79860 
X95264  
 
kpsF 984/984 (100%) 
 
KpsF protein 327/327 (100%) 
CAA64561  
K5 capsule biosynthesis 
ORF69 79932-
81080 
X74567  
 
kpsE 1149/1149 (100%) Capsule polysaccharide export inner-
membrane protein (KpsE) 
351/382 (91%) 
P42214  
K5 capsule membrane 
export 
ORF70 81104-
82780 
X74567 kpsD 1674/1677 (99%) 
 
KpsD protein 557/558 (99%) 
NP_755563 
K5 capsule biosynthesis 
ORF71 82790-
83530 
S76943 
 
kpsU 741/741 (100%)  
 
3-deoxy-manno-octulosonate 
cytidylyltransferase (CMP-KDO 
synthetase) (CMP-2-keto-3-
deoxyoctulosonic acid synthetase) 
(CKS) (KpsU) 
246/246 (100%) 
P42216  
 
K5 capsule biosynthesis 
ORF72 83527-
85554 
X74567  
 
kpsC 2007/2028 (98%) Capsule polysaccharide export protein 
(KpsC) 
612/675 (90%) 
P42217 
K5 capsule export 
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ORF73 85589-
86758 
X74567 kpsS 1169/1170 (99%) 
 
Capsule polysaccharide export protein 
(KpsS) 
388/389 (99%) 
P42218  
K5 capsule export 
ORF74 87097-
88275 
X77617  
 
kfiD 1171/1179 (99%)  
 
UDP-glucose 6-dehydrogenase 
(UDPGDH) (KfiD) 
378/392 (96%) 
Q47329  
K5 capsule biosynthesis 
ORF75 88317-
89879 
X77617 kfiC 1539/1563 (98%) 
 
putative glycosyltransferase (KfiC) 
 
519/520 (99%) 
S70198 
K5 capsule biosynthesis 
ORF76 90212-
90484 
X77617 ORF (kfi-
region) 
273/273 (100%) 
 
hypothetical protein kfi-region  
 
72/90 (80%) 
S70194 
unknown 
ORF77 90575-
90877 
X77617 ORF (kfi-
region) 
303/303 (100%) 
 
hypothetical 11.5 KDa  protein  100/100 (100%) 
S70191  
unknown 
ORF78 91171-
92862 
X77617 kfiB 1659/1692 (98%) 
 
KfiB protein 518/563 (92%) 
S70196 
K5 capsule biosynthesis 
ORF79 93294-
94010 
X77617 kfiA 696/717 (97%)  
 
KfiA protein 238/238 (100%) 
S70195  
K5 capsule biosynthesis 
ORF80 94995-
95669 
X53819  
 
kpsT 673/675 (99%) 
 
polysialic acid transport ATP-binding 
protein (KpsT) 
211/224 (94%) 
P24586 
K5 capsule biosynthesis 
ORF81 95666-
96442 
X53819  
 
kpsM 777/777 (100%)  
 
polysialic acid transport protein (KpsM) 246/258 (95%) 
P24584  
K5 capsule biosynthesis 
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Table 4: Characteristics of the ORFs located in the sequence context of argW in strain Nissle 1917. 
 
Putative 
ORF 
nt positions 
[bp] 
Accession no. DNA 
homology to 
Similar protein  Identity of the aa 
sequence (%) 
accession no. 
Function  
ORF1 700-1575 AE016766  
 
c3638 Hypothetical protein (YhcI) 278/291 (95%) 
NP_755513 
putative regulator 
 
ORF2 1624-3096 AE016766 c3637 Putative sialic acid transporter 
 
473/490 (96%) 
NP_755512 
transport; murein sacculus, peptidoglycan 
 
ORF3 3100-3930 AE016766 c3636 Hypothetical protein 
 
268/269 (99%) 
NP_755511 
unknown 
ORF4 3976-4686 AE016766 1-113 and 259-
711 nt 
homologous to 
c3635  
Hypothetical protein (YjhA) precursor  
 
225/236 (95%) 
NP_755510 
 
unknown 
ORF5 4688-5808 AE016766 c3634 Hypothetical protein (YjhT) precursor  368/369 (99%) 
NP_755509 
unknown 
ORF6 5858-6793 AE016766 c3633 Hypothetical protein  
 
267/318 (83%) 
NP_755508 
unknown 
ORF7 6829-7563 AE016766 1-666 nt 
homologous to 
c3632 and 
c3631 
putative GntR-family transcriptional regulator 
[Salmonella enterica subsp. enterica serovar 
Typhi] 
 
120/227 (52%) 
NP_462250 
 
 
putative regulator 
ORF8 7202-7570 AE016766 1-343 nt 
homologous to 
c3631 and 
c3630 
Hypothetical protein; Hypothetical protein 
(YjhS) precursor 
 
69/110 (62%)  
NP_462250 
 
unknown 
ORF9 7660-8160 AE016764 
 
203-501 nt 
homologous to 
c2876 
Hypothetical adenine-specific methylase (YfcB) 
 
84/128 (65%) 
AAN82078  
 
putative methylase 
ORF10 8275-8826 AE016764 c2877 Hypothetical protein (YfcN) 
 
167/167 (100%) 
P77458  
unknown 
ORF11 9146-10003 AE016764 c2878 Hypothetical protein (YfcO) precursor  
 
274/285 (96%) 
AAN81328 
unknown 
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ORF12 10005-10532 AE016764 c2879 Hypothetical fimbrial-like protein (YfcP) 
precursor  
167/175 (95%) 
NP_754761 
putative structure 
 
ORF13 10529-11008 AE016764 c2880 Hypothetical fimbrial-like protein (YfcQ) 
precursor 
159/159 (100%) 
NP_754762 
putative structure 
 
ORF14 11005-11550 AE016764 c2881 Hypothetical protein (YfcR) fimbrial precursor  167/167 (100%) 
NP_754763 
putative structure 
 
ORF15 11525-11277 AE016764 c2882 Hypothetical fimbrial chaperone (YfcS) 
precursor 
228/250 (91%) 
NP_754764 
putative factor 
 
ORF16 12297-14951 AE016764 c2883 Putative outer membrane protein (YfcU) 
 
830/884 (93%) 
NP_754765 
putative membrane 
 
ORF17 150026-15592 AE016764 c2884 Hypothetical fimbrial-like protein (YfcV) 
precursor 
136/156 (87%) 
NP_754766 
putative structure 
ORF18 16159-16644 AE016764 c2785 Phosphohistidine phosphatase (SixA) 
 
161/161 (100%) 
NP_754767 
enzyme; methabolism 
ORF19 16847-18991 AE016764 c2886 Putative fatty oxidation complex alpha subunit; 
Enoyl-CoA hydratase; 3-hydroxyacyl-CoA 
dehydrogenase; 3-hydroxybutyryl-CoA 
epimerase 
675/714 (94%) 
NP_754768 
putative enzyme 
ORF20 18991-20301 AE016764 c2887 Probable 3-ketoacyl-CoA thiolase 
 
425/436 (97%) 
NP_754769 
putative enzyme 
ORF21 21131-22477 AE016764 c2889 Long-chain fatty acid transport protein precursor 
 
448/448 (100%) 
NP_754771 
enzyme; Transport of small molecules: 
Carbohydrates, organic acids, alcohols 
ORF22 22539-23294 AE016764 c2890 Lipoprotein precursor (VacJ) 
 
251/251 (100%) 
NP_754772 
membrane; Macromolecule synthesis, 
modification: Lipoprotein 
ORF23 23588-24520 AE016764 c2892 Hypothetical protein (YfdC) 
 
283/310 (91%) 
NP_754773 
putative transport 
 
tRNA 24596-24670 AE016764 argW - - tRNA-Arg 
ORF24 25108-25638 AE016764 c2893 Hypothetical protein 
 
164/176 (93%) 
NP_754775 
unknown 
ORF25 25686-31691 AE016764 1-1024 and 
1085-5940 nt 
homologous to 
c2894, c2895 
putative autotransporter protein [Yersinia pestis 
CO92] (YapH) 
 
 
624/2029 (30%) 
CAC89847 
 
unknown 
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ORF26 31616-32254 AE016760 
 
7-639 nt 
homologous to 
c1857 
Hypothetical protein (YdcO)  
 
183/199 (91%) 
NP_753758  
 
putative transport 
ORF27 32253-32789 AE016760 c1858 Hypothetical protein (YdcN) 
 
178/178 (100%) 
NP_753759 
unknown 
ORF28 33162-34823 AE016760 c1859 Putative protease (YdcP) precursor 
 
553/553 (100%),  
NP_753760 
putative enzyme 
ORF29 34915-35145 AE016760 c1860 Hypothetical protein (YncJ) precursor 
 
76/76 (100%) 
NP_753761 
putative 
ORF30 35639-36604 AE016760 
(c1863) 
AE000500 
(yhjF) 
 
1-682 nt 
homologous to 
c1863; 679-966 
nt homologous 
to yjhF  
Hypothetical protein (YdcR) 
 
229/237 (96%) 
NP_753764  
 
unknown 
ORF31 36284-37006 AE000500  
 
34-723 nt 
homologous to 
yjhF 
Putative transport system permease 
 
168/208(80%) 
AAC77252  
 
putative transport 
 
ORF32 36744-37217 AE000500 yjhF Hypothetical protein 3-197 aa 37/65 (56%) 
AAC77252;  
382-474 aa 31/31 
(100%) P39358  
unknown 
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Table 5: Characteristics of the wa* gene cluster and flanking regions. 
 
Putative 
ORF 
nt positions 
[bp] 
Accession no. DNA homology 
to 
Similar of the encoded protein Identity of the aa 
sequence (%)  
 
Function  
ORF1 24-662 AE016768 waaC 
 
lipopolysaccharide heptosyltransferase-1 (WaaC) 
 
213/213 (100%),  
 
enzyme; macromolecule metabolism: 
lipopolysaccharide 
 
ORF2 735-1988 AE016768 waaL lipid A-core, surface polymer ligase (WaaL) 
 
388/417 (93%) 
 
enzyme, R1 core LPS synthesis 
ORF3 2034-3017 AE016768 waaV putative beta1,3-glucosyltransferase (WaaV) 
 
327/327 (100%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
 
ORF4 3099-4127 AE016769 waaW 
 
UDP-galactose:(galactosyl) LPS alpha1,2-
galactosyltransferase (WaaW) 
 
342/342 (100%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
 
ORF5 4153-4845 AE016769 waaY lipopolysaccharide core biosynthesis protein 
(WaaY) 
 
217/217 (100%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
 
ORF6 4855-5850 AE016769 waaT lipopolysaccharide 1,2-glucosyltransferase 
(WaaT) 
 
331/331 (100%) 
 
enzyme; surface polysaccharides  
and antigens 
 
ORF7 5867-6883 AE016769 waaO lipopolysaccharide 1,3-galactosyltransferase 
(WaaO) 
 
327/327 (100%) 
 
enzyme; surface polysaccharides  
and antigens 
 
ORF8 6899-7696 AE016769 waaP lipopolysaccharide core biosynthesis protein 
(WaaP) 
 
251/265 (94%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
 
ORF9 7689-8813 AE016769 waaG glucosyltransferase I (WaaG) 
 
374/374 (100%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
 
ORF10 8810-9832 AE016769 waaQ lipopolysaccharide core biosynthesis glycosyl 
transferase (WaaQ) 
 
316/316 (100%) 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
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ORF11 10281-11558 AE016769 kdtA 3-deoxy-D-manno-octulosonic-acid transferase 
(KdtA) 
 
367/387 (94%) 
 
enzyme; surface polysaccharides  
and antigens 
 
ORF12 11398-12045 AE016769 kdtB putative phosphopantetheine adenylyltransferase 
(KdtB)  
 
159/159 (100%), 
 
enzyme; macromolecule metabolism:  
lipopolysaccharide 
ORF13 12084-12893 AE016769 mutM formamidopyrimidine-DNA glycosylase (MutM) 
 
256/269 (95%) 
 
enzyme; DNA - replication, repair,  
restriction/modification 
 
ORF14 13632-14276 AE016769 radC DNA repair protein (RadC) 
 
214/214 (100%) 
 
enzyme; DNA - replication, repair,  
restriction/modification 
 
ORF15  AE016769 dfp DNA/pantothenate metabolism flavoprotein 
(Dfp) 
 
378/430 (87%) 
 
phenotype; DNA - replication, repair, 
restriction/modification 
 
ORF16 15673-16125 AE016769 dut deoxyuridine 5'-triphosphate nucleotidohydrolase 
Dut 
 
151/151 (100%) 
 
enzyme; 2'-deoxyribonucleotide 
metabolism 
 
ORF17 16193-16828 AE016769 ttk Ttk protein 
 
201/212 (94%) 
 
putative regulator 
 
ORF18 16871-17509 AE016769 pyrE orotate phosphoribosyltransferase (PyrE) 
 
213/213 (100%) 
 
enzyme; pyrimidine ribonucleotide  
biosynthesis 
 
ORF19 17607-18291 AE016769 rph ribonuclease PH 
 
207/228 (90%) 
 
enzyme; degradation of RNA 
 
ORF20 18418-19297 AE016769 yicC protein (yicC) 
 
153/169 (90%) 
 
unknown 
 
ORF21 19492-20325 AE016769 dinD DNA-damage-inducible protein D (Din D) 278/278 (100%) 
 
phenotype; DNA - replication, repair, 
restriction/modification 
ORF22 20566-21234 AE016769 yicG hypothetical protein (yicG) 
 
163/223 (73%) 
 
unknown 
ORF23 21237-22922 AE016769 yicF hypothetical DNA ligase-like protein (yicF) 
 
561/562 (99%) 
 
putative 
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ORF24 23174-23794 AE016769 gmk guanylate kinase (Gmk) 
 
75/91 (82%) 
 
enzyme; purine ribonucleotide  
biosynthesis 
 
ORF25 23852-24127 AE016769 rpoZ DNA-directed RNA polymerase omega chain 
 
688/702 (98%) 
 
enzyme; RNA synthesis, modification,  
DNA transcription 
 
ORF26 24146-26251 AE016769 spoT guanosine-3',5'-bis(diphosphate) 3'-
pyrophosphohydrolase (spoT) 
 
688/702 (98%) 
 
enzyme; global regulatory functions 
 
ORF27 26261-26947 AE016769 spoU tRNA (guanosine-2'-O-)-methyltransferase 229/229 (100%) 
 
putative methyltransferase-related 
 
ORF28 26956-29037 AE016769 recG ATP-dependent DNA helicase (RecG) 
 
638/693 (92%) 
 
enzyme; DNA - replication, repair,  
restriction/modification 
 
ORF29 29047-30276 AE016769 gltS sodium/glutamate symport carrier protein (Get S) 
 
338/401 (84%) 
 
transport; transport of small molecules: 
amino acids, amines 
 
ORF30 30556-31944 AE016769 yicE putative purine permease (YicE) 
 
449/463 (96%) 
 
putative transport of purine 
 
ORF31 32068-33774 AE016769 yicH hypothetical protein (YicH) 
 
546/546 (100%) 
 
unknown 
ORF32 33821-34501 AE016769 c4481 conserved hypothetical protein 226/226 (100%) 
 
unknown 
 
ORF33 34482-35414 AE016769 c4482 hypothetical protein (YajF) 
 
274/310 (88%) 
 
putative regulator 
 
ORF34 34462-36322 AE016769 c4483 putative aldolase 
 
286/286 (100%) 
 
putative enzyme 
  
ORF35 36403-37257 AE016769 c4484 putative aldolase 
 
275/283 (97%) 
 
putative enzyme 
ORF36 37266-38357 AE016769 c4485 Putative phosphotransferase system (PTS) 
enzyme-ii fructose 
350/363 (96%) putative enzyme; ; degradation of small 
molecules: carbon compounds 
ORF37 38382-38696 AE016769 c4486 PTS system, fructose-like-2 IIB component 1 
 
104/104 (100%) 
 
putative enzyme; degradation of small 
molecules: carbon compounds 
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ORF38 38714-39184 AE016769 c4487 putative phosphotransferase system (PTS) 156/156 (100%) 
 
putative; enzyme; degradation of small 
molecules: carbon compounds 
ORF39 39211-40764 AE016769 c4488 putative transcriptional Antiterminator 
 
509/517 (98%) 
 
putative regulation 
ORF40 41050-43365 AE016769 yicI putative family 31 glucosidase (YicI) 
 
746/772 (96%) 
 
putative enzyme; sugar methabolism 
ORF41 43378-44808 AE016769 yicJ hypothetical symporter (YicJ) 
 
462/477 (96%) 
 
putative transport 
 45050-45144 AE016769 selC - 
 
- tRNA 
ORF42 45445-46653 AE016769 intC, 8-251 and 
269-1059 88 % 
homologous to 
intC from E. 
coli CFT073 
putative prophage integrase (Int C) 
 
375/390 (96%) 
 
IS, phage, Tn 
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Table 6: Characteristics of fimNissle 1917 gene cluster and flanking sequences. 
 
Putative 
ORF 
nt positions 
[bp] 
Accession no. DNA 
homology to 
Similar of the encoded protein Identity of the aa 
sequence (%)  
 
Function  
ORF1  473-1303 AE000500  
 
yjhH (partial) 
 
putative lyase/synthase (YjhH9 263/277 (94%) 
NP_418718 
putative enzyme; not classified 
ORF2 1257-2042 AE000500 yjhI putative regulator (YjhI) 
 
261/262 (99%) 
NP_418719 
putative regulator; not classified 
 
ORF3 2348-3127 AE000500 sgcR putative DeoR-type transcriptional regulator 
(SgcR) 
259/260 (99%) 
NP_418720 
putative regulator; not classified 
ORF4 3147-3776 AE000500 sgcE putative epimerase (SgcE) 197/210 (93%) 
NP_418721 
putative enzyme; not classified 
ORF5 3788-4219 AE000500 sgcA putative PTS system enzyme II A component 
(SgcA) 
141/143 (98%) 
NP_418722 
putative transport; not classified 
ORF6 4353-5156 AE000501 sgcQ 
 
putative nucleoside triphosphatase (SgcQ) 
 
268/268 (100%) 
NP_418723 
putative enzyme; not classified 
 
ORF7 5172-6482 AE000501 sgcC putative PTS system enzyme IIC component 
(SgcC) 
418/437 (95%) 
NP_418724 
putative transport; not classified 
 
ORF8 6772-7920 AE000501 sgcX putative lyase/synthase (SgcX) 
 
368/383 (96%) 
NP_418725 
putative enzyme; not classified 
 
ORF9 8680-9423 AE000501 yjhP putative methyltransferase (YjhP) 
 
238/248 (95%) 
NP_418726 
putative enzyme; not classified 
 
ORF10 9479-10026 AE000501 yjhQ orf, hypothetical protein (YjhQ) 
 
163/172 (94%) 
NP_418727 
orf; unknown 
 
∆ORF11 10839-
11635 
AE000498 5-797 nt 
homologous to 
b4285 
putative transposase 
 
253/254 (99%) 
CAD48134  
IS, phage, Tn; not classified 
 
ORF12 12169-
13185 
AE000501 yjhR putative frameshift suppressor (YjhR) 
 
332/338 (98%) 
NP_418728 
phenotype; not classified 
 
ORF13 13771-
14748 
AE000501 yjhS orf, hypothetical protein (YjhS) 
 
315/326 (96%) 
NP_418729 
orf; unknown 
 
ORF14 14813-
16026 
AE000501 yjhT orf, hypothetical protein (YjhT) 398/404 (98%) 
NP_418730 
orf; unknown 
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ORF15 15941-
16663 
AE000501 yjhA orf, hypothetical protein (YjhA) 240/241 (99%) 
NP_418731 
orf; unknown 
16 18298-
20211 
AF188737 
 
put. IS Unknown 406/406 (100%) 
AAF60967; 
89/166 (53%) 
NP_754342 
insertion element  
 
ORF17 18342-
19559 
AF188737 put. 
transposase 
transposase 406/406 (100%) 
AAF60967  
IS element-related 
ORF18 19581-
20096 
AF188737 put. 
transposase 
unknown 172/172 (100%) 
AAF60966  
IS element-related 
ORF19 21126-
21674 
AE000502 fimE recombinase involved in phase variation; 
regulator for fimA (FimE) 
183/183 (100%) 
NP_418733 
regulator; surface structures 
 
ORF20 22156-
22703 
D13186  
 
fimA major subunit of type 1 fimbriae (FimA) 
 
154/182 (84%) 
AAG35675  
structural component; surface structures 
 
ORF21 22661-
23305 
AP002569 
 
fimI fimbrial protein (FimI) 
 
213/215 (99%) 
NP_418735 
structural component; surface structures 
ORF22 23344-
24067 
AE000502 fimC periplasmic chaperone, required for type 1 
fimbriae (FimC) 
238/241 (98%) 
BAB38698 
structural component; surface structures 
ORF23 24137-
26770 
AE000502 fimD outer membrane protein; export and assembly of 
type 1 fimbriae (FimD) 
842/878 (95%) 
BAB38699  
membrane; outer membrane constituents 
ORF24 26783-
27310 
AE000502 fimF fimbrial morphology (FimF) 
 
172/176 (97%) 
BAB38700  
structural component; surface structures 
 
ORF25 27326-
27826 
AP002569 
 
fimG fimbrial morphology (FimG) 151/167 (90%) 
NP_757247  
structural component; surface structures 
 
ORF26 27885-
28748 
AP002569 fimH minor fimbrial subunit, D-mannose specific 
adhesin (FimH) 
286/288 (99%) 
NP_418740  
structural component; surface structures 
ORF27 28928-
30268 
AE000503 gntP gluconate transport system permease 3 
(GntP) 
413/447 (92%) 
NP_313307  
transport; transport of small molecules: 
carbohydrates, organic acids, alcohols 
ORF28 30608-
31789 
AE000502 
 
uxuA mannonate hydrolase (UxuA) 
 
394/394 (100%) 
NP_757250  
enzyme; degradation of small molecules: 
carbon compounds 
ORF29 31873-
33330 
AE000503 
 
uxuB D-mannonate oxidoreductase (UxuB) 
 
486/486 (100%) 
NP_290939  
enzyme; degradation of small molecules: 
carbon compounds 
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ORF30 33548-
34318 
AE000503 uxuR regulator for uxu operon (UxuR) 
 
257/257 (100%) 
NP_313310  
regulator; degradation of small molecules: 
carbon compounds 
ORF31 34462-
35248 
AE000503 yjiC orf, hypothetical protein (YjiC) 
 
208/229 (90%) 
NP_313311  
orf; unknown 
 
 
 
 
 
 
 
Table 7: Characteristics of the ORFs located in the bcsNissle 1917 gene cluster. 
 
Putative 
ORF 
nt 
positions 
[bp] 
Accession no. DNA 
homology to 
Similarity of the encoded protein Identity of the aa 
sequence (%) 
accession no. 
Function  
ORF1 237-3710 AE016768 bcsC/yhjL Cellulose synthase operon protein C (YhjL) 1122/1157(96%) 
NP_756204 
Putative cellulose biosynthesis-related 
ORF2 3692-
4798 
AE016768 bcsZ/yhjM Putative cellulose biosynthesis-related (YjhM) 367/368 (99%) 
NP_756205 
Putative cellulose biosynthesis-related 
ORF3 4805-
7144 
AE016768 bcsB/yhjN Cellulose synthase regulatory subunit (YjhN) 
 
735/779 (94%) 
NP_756206 
Cyclic di-GMP binding protein precursor 
ORF4 7155-
9773 
AE016768 bcsA/yhjO Cellulose synthase catalytic subunit [UDP-forming] 
(YjhO) 
860/872 (98%) 
NP_756207 
Putative cellulose biosynthesis-related 
ORF5 9770-
10522 
AE016768 yhjQ Hypothetical protein (YhjQ) 
 
227/227 (100%) 
NP_756208 
Putative cellulose biosynthesis-related 
ORF6 10534-
10722 
AE016768 yhjR Hypothetical protein (YhjR) 
 
62/62 (100%) 
NP_756209  
Putative regulator of cellulose 
biosynthesis-related; putative cellulose 
synthase 
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Table 8: Detection of  the presence of E. coli Nissle 1917-specifc DNA regions in the genomes of 
different E. coli strains by PCR. For positive control  reaction E. coli Nissle 1917 genomic DNA  was 
used as a template; for negative control reaction E. coli MG1655 genomic DNA was used as a 
template. 
” –“ – negative PCR reaction; “+”- positive PCR reaction; “(+)” – presence of PCR product of correct 
size, but weaker compare to the positive control.  
 
Strain/PCR  mcmD focG iroB iuc 
(iucB 
– 
iucC) 
sat iha GEI III 
(ORF23-
ORF24) 
HPI 
3 R 
(irp1 
– 
ybtT) 
 
HPI 4 
L 
(irp2) 
GEI I 
left 
(Z4866) 
GEI I 
right 
(c1274) 
GEI 
II left 
(shiA) 
GEI 
II 
right 
(kfiC) 
IS2-
left 
(IS2–
iuc 
shiF) 
IS2-
right 
(IS2–
iha) 
ECOR7 
(A) 
- - - - - - - - - - - - - - - 
ECOR1 
(A) 
- - - - - - - - - - - - - - - 
ECOR23 
(A) 
- - - - - - - - - - - - - - - 
ECOR25 
(A) 
- - - - - - - - - - - - - - - 
ECOR28 
(B1) 
- - - - - - - - - - + + - - - 
ECOR32 
(B1) 
+ - - - - - - - - + - + - - - 
ECOR42 
(E) 
- - - - - - - - - + + - - - - 
ECOR59 
(B2) 
- - - + - - - + + - - + - - - 
F18 - - + + - - - + + - - + - - - 
M1/5 - - - + + + - + + - - + + + + 
M1/6 - - - - - - - - - - - - - - - 
M1/32 - - - - - - - - - - + - - - - 
M1/49 - - - - - - - - - - - - - - - 
M2/24 - - + - - - - - - - - - - - - 
M2/39 - - + + - - - - - - - - - - - 
M2/40 - - - - - + - - - - - - - - - 
M2/43 - - - + - + - - - - - + - - - 
M3/6 - - - - - - - - - - - - - - - 
M3/15 - - - - - + - - - - + + - - - 
M3/26 - + - + + + - + + + + + - - + 
M1/13 - - - - - - - - - - - + - - - 
M1/43 - - - - - - - - - - - - - - - 
M1/14 - - - - - - - - - - + - - - - 
M1/15 - - - - - + - - - + + - - - - 
M1/30 - - + + + - - + + - + + - - - 
M1/37 - - + + - - - - - + - + - - - 
M2/16 - - + + - + - + + - - + - - - 
M2/37 + - + + - - - - - + (+) + - - - 
M2/46 - - - - - - - - - - - - - - - 
M3/27 - - - + + + - + + + + + - - + 
M3/29 - + + + + + - - - + + + - - - 
M3/22 - - + + - + - - - + + + - - - 
M3/36 - - + + + - - - - + + + - - - 
M2/17 - - + + - - - - - - + + - - - 
M1/18 + + + + + + - - - + +  + + - 
M2/31 - - + - - - - - - + + + - - - 
M1/36 - - - - - - - - - - + - - - - 
M2/1 - - - + + + - - - + + + - - + 
M2/47 + - - + - + - - - - + - - - - 
M3/3 + - + + - + - - - + + +  - - 
Nissle 1917 + + + + + + + + + + + + + + + 
MG1655 - - - - - - - - - - - - - - - 
RZ411 - - + + + + + + + + + + - - - 
RZ412 - - + + + + + + + - - + - - - 
RZ418 + + + + - + - + + + + + - - - 
RZ422 - - + + - - - + + + + + - - - 
RZ423 - - + - - - - + + + + + - - - 
RZ424 + + + + - + - + + + + + + - - 
RZ430 + + + - - - - + + + + + - - - 
RZ436 + - + - - - - + + - + + - - - 
RZ446 + - + - - - - + + + + + - - - 
RZ447 + - + - - - - + + + + + - - - 
RZ448 + - + - - - - + + + + + - - - 
RZ449 + + + + + + - + + + + + + - + 
RZ451 - - + + - - - + + - + + - - - 
RZ454 - - + - - - - + + + + + - - - 
RZ458 + + + + + + + + + - + + - - - 
RZ460 - - + - - - - + + + + + - - - 
RZ461 + - + - - - - - + + + + - - - 
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RZ462 - - + - - - - + + + + + - - - 
RZ463 - - + - - - - - + + + + - - - 
RZ467 + + + + + + - + + + + + - - - 
RZ470 - - - + - + - + + - + + - - - 
RZ479 - - - - - - - + + + - + - - - 
RZ484 - - + - - - - + + + + + - - - 
RZ485 - - + - - - - + + + + + - - - 
RZ486 - + - + + + - + + + - + - - - 
RZ496 - - + - - - - + + + + + - - - 
RZ501 + + + + + + - + + + + + + - + 
RZ502 - - + - - - - + + + + + - - - 
RZ504 - - + - - - - + + + + + - - - 
RZ505 + + + - - - + + + + + + - - - 
RZ507 + + + + - + - + + + + + - - - 
RZ532 + - + - - - - + + + + + - - - 
RZ536 + - + - - - - + + + + + - - - 
RZ536/1 + - + - - - - + + + + + -   
RZ537 + + + + + + - + + + + + - - - 
RZ439 + + + + + + - + + + + + + - + 
RZ442 + + + + + + + + + + + + + + + 
RZ471 + + + + + + - + + + + + + + + 
RZ525 + + + + + + + + + + + + + + + 
RZ498 - - + + + + - + + + + + + + + 
RZ495 + + + + + + - + + + + + + + - 
RZ440 + + + + + + - + + + + + + - + 
RZ441 + + + + + + - + + + + + + - + 
RZ468 + + + + + + - + + + + + + - + 
RZ475 + + + + + + + + + + + + + - + 
RZ526 + + + + + + + + + + + + + - + 
RZ450 + + + - + + + + + + + + + - - 
RZ414 + + + + + + + + + + + + + - + 
RZ419 + + + + + + + + + + + + + - + 
RZ420 + + + + + + + + + + + + + - + 
RZ521 + + + + + + + + + + + + + - + 
RZ522 + + + + + + + + + + + + + - - 
RZ500 + + + + + + + + + + + + + - - 
RZ466 + + + + + + + + + + + + + - + 
RZ452 + + + + + + + + + + + + + - + 
RZ453 + + + + + + + + + + + + + - - 
RZ465 + + + + + + + + + + + + + - - 
RZ443 + + + + + + + + + + + + + - + 
RZ512 + + + + + + + + + + + + + - - 
RZ513 + + + + + + + + + + + + + - - 
RZ533 + + + + + + - + + + + + + - - 
RZ421 + + + + + + + + + + + + + - + 
RZ429 + + + + + + + + + + + + + + + 
RZ477 + - + + + + + + + + + + + - + 
RZ519 + + + + + + + + + + + + + - + 
RZ523 + + + + - + + + + + + + + - - 
RZ499 + + + + + + + + + + + + + - - 
RZ524 + + + + + + + + + + + + + + + 
 
1. Sequence determination of csg promoter – csgD region of E. coli strains Nissle 
1917, Nissle 1917 CR- and 536 
E. coli Nissle 1917: 
     1 attctgccgc cacaatccag cgtaaataac gtttcatggc tttatcgcct 
gaggttatcg tttgcccagg aaaccgcttg 80     
    81 tgtccggttt tttacggcta tcttcttgaa aagattataa agatgcgttt 
taaccgtatt ttcgctgatg aacaacgaac 160    
   161 gagcgatctc gttattagac gcgccgatac gcagcttatt caggatctct 
ttttcccgat gagtaaggag ggctgattcc 240    
   241 gtgctgttat aacgatagtt acctgaatgc gtaatcaggt aactggcaag 
cttttgcgta aagtagcatt cgccgcgcag 320    
   321 gacgccttgc aacccattga caacacgttc ttgatcctcc atggcataaa 
aaacgccgtt gatatgaggc cagttttcaa 400    
   401 tgtcgcggta cgggtaatct tcaggcgtat ttagcaacaa tattttgata 
ttgttgtttt tcctgctcaa agtatcctgc 480    
   481 caataatgga taagcttttt atccgcttcc atcatatcca gaagaataat 
agagcctgaa gatatatcgt ccagagaacg 560    
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   561 ttgaatatta tgtaattttc ctgtaattgc cagcgattgt ttaaggtgct 
gcaagagagc tgtcgcctgc aaagaaggtt 640    
   641 tagtgatcaa caataatgta tgaccatgaa tactatggac ttcattaaac 
atgatgaaac cccgcttttt ttattgatcg 720    
   721 cacacctgac agctgcctct aaaatagaag caccagaagt actgacagat 
gttgcactgc tgtgtgtagt aataaatcag 800    
   801 ccctaaatgg gtaaaatata aaactaatgg attacatctg atttcaatct 
agccattaca aatcttaaat caagtgttaa 880    
   881 acatgtaact aaatgtaact cgttatatta aaatgttaac cttaaggttt 
tattaagttt ataaatgata gaaaagttgt 960    
   961 acatttggtt tttattgcac aattttaaaa aatcatacaa atggtgctaa 
cttactaata atgcatataa aaaatatttc 1040   
  1041 gctgtagtcc tttcgtcatg aaaaacgttc ttgttttttc tccataccac 
cgtggacaat tttttactgc aaaaagacga 1120   
  1121 ggtttgtcac ggcttgtgcg caagacatat cgcagcaatc agcgacgggc 
aagaagaatg actgtctggt gatttttgat 1200   
  1201 agcggaaaac ggagatttaa aagaaaacaa aatatttttt tgcgtagata 
acagcgtatt tacgtgggtt ttaatacttt 1280   
  1281 ggtatgaaca aaaaaagaaa aatacaacgt gcgggtgagt tattaaaaat 
atttccgcag acatactttc catcgtaacg 1360   
  1361 cagcgttaac aaaatacagg ttgcgttaac aaccaagttg aaatgattta 
atttcttaaa tgtacgacca ggtccagggt 1440   
  1441 gacaacatga aaaacaaatt gttatttatg atgttaacaa tactgggtgc 
g                                1491   
 
E. coli Nissle 1917 CR-: 
 
     1 attctgccgc cacaatccag cgtaaataac gtttcatggc tttatcgcct 
gaggttatcg tttgcccagg aaaccgcttg 80     
    81 tgtccggttt tttacggcta tcttcttgaa aagattataa agatgcgttt 
taaccgtatt ttcgctgatg aacaacgaac 160    
   161 gagcgatctc gttattagac gcgccgatac gcagcttatt caggatctct 
ttttcccgat gagtaaggag ggctgattcc 240    
   241 gtgctgttat aacgatagtt acctgaatgc gtaatcaggt aactggcaag 
cttttgcgta aagtagcatt cgccgcgcag 320    
   321 gacgccttgc aacccattga caacacgttc ttgatcctcc atggcataaa 
aaacgccgtt gatatgaggc cagttttcaa 400    
   401 tgtcgcggta cgggtaatct tcaggcgtat ttagcaacaa tattttgata 
ttgttgtttt tcctgctcaa agtatcctgc 480    
   481 caataatgga taagcttttt atccgcttcc atcatatcca gaagaataat 
agagcctgaa gatatatcgt ccagagaacg 560    
   561 ttgaatatta tgtaattttc ctgtaattgc cagcgattgt ttaaggtgct 
gcaagagagc tgtcgcctgc aaagaaggtt 640    
   641 tagtgatcaa caataatgta tgaccatgaa tactatggac ttcattaaac 
atgatgaaac cccgcttttt ttattgatcg 720    
   721 cacacctgac agctgcctct aaaatagaag caccagaagt actgacagat 
gttgcactgc tgtgtgtagt aataaatcag 800    
   801 ccctaaatgg gtaaaatata aaactaatgg attacatctg atttcaatct 
agccattaca aatcttaaat caagtgttaa 880    
   881 acatgtaact aaatgtaact cgttatatta aaatgttaac cttaaggttt 
tattaagttt ataaatgata gaaaagttgt 960    
   961 acatttggtt tttattgcac aattttaaaa aatcatacaa atggtgctaa 
cttactaata atgcatataa aaaatatttc 1040   
  1041 gctgtagtcc tttcgtcatg aaaaacgttc ttgttttttc tccataccac 
cgtggacaat tttttactgc aaaaagacga 1120   
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  1121 ggtttgtcac ggcttgtgcg caagacatat cgcagcaatc agcgacgggc 
aagaagaatg actgtctggt gatttttgat 1200   
  1201 agcggaaaac ggagatttaa aagaaaacaa aatatttttt tgcgtagata 
acagcgtatt tacgtgggtt ttaatacttt 1280   
  1281 ggtatgaaca aaaaaagaaa aatacaacgt gcgggtgagt tattaaaaat 
atttccgcag acatactttc catcgtaacg 1360   
  1361 cagcgttaac aaaatacagg ttgcgttaac aaccaagttg aaatgattta 
atttcttaaa tgtacgacca ggtccagggt 1440   
  1441 gacaacatga aaaacaaatt gttatttatg atgttaacaa tactgggtgc 
g                                1491   
 
E. coli 536: 
 
     1 attctgccgc cacaatccag cgtaaataac gtttcatggc tttatcgcct 
gaggttatcg tttgcccagg aaaccgcttg 80     
    81 tgtccggttt tttacggcta tcttcttgaa aagattataa agatgcgttt 
taaccgtatt ttcgctgatg aacaacgaac 160    
   161 gagcgatctc gttattagac gcgccgatac gcagcttatt caggatctct 
ttttcccgat gagtaaggag ggctgattcc 240    
   241 gtgctgttat aacgatagtt acctgaatgc gtaatcaggt agctggcaag 
cttttgcgta aagtagcatt cgccgcgcag 320    
   321 gacgccttgc aacccattga caacacgttc ttgatcctcc atggcataaa 
aaacgccgtt gatatgaggc cagttttcaa 400    
   401 tgtcgcggta cgggtaatct tcaggcgtat ttagcaacaa tattttgata 
ttgttgtttt tcctgctcaa agtatcctgc 480    
   481 caataatgga taagcttttt atccgcttcc atcatatcca gaagaataat 
agagcctgaa gatatatcgt ccagagaacg 560    
   561 ttgaatatta tgtaattttc ctgtaattgc cagcgattgt ttaaggtgct 
gcaagagagc tgtcgcctgc aaagaaggtt 640    
   641 tagtgatcaa caataatgta tgaccatgaa tactatggac ttcattaaac 
atgatgaaac cccgcttttt ttattgatcg 720    
   721 cacacctgac agctgcctct aaaatagaag caccagaagt actgacagat 
gttgcactgc tgtgtgtagt aataaatcag 800    
   801 ccctaaatgg gtaaaatata aaactaatgg attatatctg atttcaatct 
agccattaca aatcttaaat caagtgttaa 880    
   881 acatgtaact aaatgtaact cgttatatta aaatgttaat ctcaaggttt 
tattaagttt ataaatgata gaaaagttgt 960    
   961 acatttggtt tttattgcac aattttaaaa aatcatacaa atagtgctaa 
cttactaata atgcatataa aaaatatttc 1040   
  1041 gctgtagtcc tttcgtcatg aaaaacgttc ttgttttttc tccataccac 
cgtggacaat tttttactgc aaaaagacga 1120   
  1121 ggtttgtcac ggcttgtgcg caagacatat cgcagcaatc agcgacgggc 
aagaagaatg actgtctggt gatttttgat 1200   
  1201 agcggaaaac ggagatttaa aagaaaacaa aatatttttt tgcgtagata 
acagcgtatt tacgtgggtt ttaatacttt 1280   
  1281 ggtatgaaca aaaaaagaaa aatacaacgc gcgggtgagt tattaaaaat 
atttccgcag acatactttc catcgtaacg 1360   
  1361 cagcgttaac aaaatacagg ttgcgttaac aaccaagttg aaatgattta 
atttcttaaa tgtacgacca ggtccagggt 1440   
  1441 gacaacatga aaaacaaatt gttatttatg atgttaacaa tactgggtgc 
g                                1491   
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2. Acronyms and abbreviations  
 
A   amper 
aa   amino acid 
Ap/ApR  ampicillin/ampicillin resistence 
APS   NH4-persulfate 
bp   base pair 
°C   grad celsius 
cat   chloramphenicol-acetyl-transferase 
Da   dalton 
dATP   desoxyadenosin-5'-triphosphate 
dCTP   desoxycytosin-5'-triphosphate 
dGTP   desoxyguanosin-5'-triphosphate 
dH2O   distilled water 
DNA   desoxyribonucleic acid 
dNTP   desoxynucleotide 
dTTP   desoxythymidin-5'-triphosphate 
E.   Escherichia 
EDTA   ethylene-diamin-tetraacetate 
et al.   et alili (and others) 
EtBr   ethidium bromide 
EtOH   ethanol 
Fig.   figure 
g   gram 
GEI   genomic island 
h   hour 
IPTG   isopropyl-β-D-thiogalactopyranosid 
kb   kilobase (pairs) 
Km/KmR  kanamycin/kanamycin resistence 
l   liter 
LB   Luria Bertani broth 
LPS    lipopolysaccharide 
m   meter; milli (1 × 10-3) 
M   molar, mega (1 × 106) 
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mg   milligram 
min   minute 
ml   milliliter 
OD   optical density 
ON   overnight 
ORF   open reading frame 
ori   origin of replication 
PAA   polyacrylamid 
PAI   pathogenicity island 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
RNA   ribonucleic acid 
RNase   ribonuclease 
RT   room temperature 
SDS   sodium-dodecyl-sulfate 
sec   second 
Sm/SmR  streptomycin/streptomycin resistence 
SSC   standart saline citrate 
t   time 
Tab.   table 
TAE   Tris-acetate-EDTA 
TBE   Tris-borate-EDTA 
TCA   trichloroacetic acid 
TE   Tris-EDTA 
TEMED  N,N,N`,N`-tetramethyldiamin 
Tris   Tris-(hydroxymethyl)-aminomethan 
U   enzyme unit (1 U=1 µmol substrate × min-1) 
UV   ultraviolet irradiation 
V   volt 
v/v   volume/volume 
W   watt 
w/v   weight/volume 
WT   wild type 
X-gal   5-bromo-4-chloro-3-indolyl-β-glucoside 
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YT   yeast triptone 
µ   micro (1 × 10-6) 
µg   microgram 
µl   microliter 
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Publications and poster presentations at international meetings: 
 
Publications: 
 
1. Grozdanov, L., Zähringer, U., Blum-Oehler, G., Brade, L., Henne, A., Knirel, 
Y. A., Schombel, U., Schulze, J., Sonnenborn, U., Gottschalk, G., Hacker, J., 
Rietschel, E. T., and U. Dobrindt. 2003. A single nucleotide exchange in the wzy 
gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum 
sensitivity of the Escherichia coli strain Nissle 1917. J. Bacteriol. 184:5912-5925. 
2. Grozdanov, L., Raasch, C., Schulze, J., Sonnenborn, U., Gottschalk, G., 
Hacker, J., and U. Dobrindt. 2003. Analysis of the genome structure of probiotic 
Escherichia coli strain Nissle 1917. Manuscript submitted. 
 
Poster presentations at international meetings: 
 
1. A genomic analysis of the probiotic E. coli strain DSM6601. Grozdanov, 
L., Blum-Oehler, G., Dobrindt , U., and Hacker, J. Meeting of the European 
Graduate College “Gene regulation in and by microbial pathogens”, 16–20 
October 2000, Schloß Zeilitzheim, Germany.  
 
2. Comparative genomic analysis of the probiotic E. coli strain DSM6601. 
Grozdanov, L., Blum-Oehler, G., Dobrindt, U., Gottschalk, G., and Hacker, J. 
International Workshop “Microbial-Host Interactions; Approaches and 
Molecular Tools”, June 10-16, 2001, Umeå, Sweden. 
 
3. Molecular characterization of the O6 lipopolysaccharide-encoding genetic 
determinant of the E. coli strain DSM6601. Grozdanov, L., Dobrindt, U., 
Blum-Oehler, G., Henne, A., Gottschalk, G., Schulze, J., Sonnenborn, U., and 
Hacker, J. H-48. ASM general Meeting, 2002, Salt Lake City, USA. 
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Bulgaria 
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Master of Science, major subjects: Molecular Biology and 
Microbiology 
 
1998  Master Thesis (“Molecular taxonomy analysis of Bacillus 
sphaericus strains of different environmental origin”) at the 
Department of Genetics, Institute of Microbiology, Bulgarian 
Academy of Science and successfully passed Master Thesis 
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1998 –  
September 1999 Participation in the European TEMPUS Project “Second 
Master Degree in Environmental Biotechnology“ 
 
1999  Second Master Thesis at the Institute for Microbiology and 
Genetics, Georg–August Universität, Göttingen, Germany 
(“Physiological role of the 2-phosphoglycolate phosphatase for 
the autotrophic growth of Ralstonia eutropha”) and 
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September 1999   Ph.D. thesis at the Institute for Molecular Biology of Infectious 
Diseases, University of Würzburg, Germany. Title of the Ph.D. 
project: “Comparative genomic analysis of the the probiotic 
Escherichia coli strain Nissle 1917 (O6:K5:H1)”. Scientific 
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supervisors: Prof. Dr. Dr. h. c. Jörg Hacker 
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regulation in and by microbial pathogens” of the Universities of 
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Lebenslauf 
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Geburtsdatum: 18.10.1975 
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1998 –  
September 1999 Teilnahme am Magisterprogramm im Rahmen des TEMPUS 
Projektes “Second Master Degree in Environmental 
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